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When a double-stranded break (DSB) occurs in mammalian genomes, the local chromatin
is altered through the modification of histones (notably the phosphorylation of H2AX)
and the binding of DNA damage response factors (e.g. MDC1, 53BP1). Although several
lines of evidence have pointed to a role for some of these factors in DSB repair through
non-homologous end-joining (NHEJ), the mechanism of their contribution has not been
established.
To study the regulation of NHEJ, we have used as a model system dysfunctional
telomeres, which are uncapped by the removal of the shelterin component, TRF2. As a
consequence of TRF2 loss, deprotected chromosome ends trigger a sequence of events
normally activated by the presence of DSBs. These include the instigation of ATMmediated activation of cell cycle checkpoints and the accumulation of DNA damage
response factors at the telomeric chromatin. In addition, the NHEJ pathway repairs
deprotected telomeres to generate chromosome end-to-end fusions.
We have examined the roles of the Mre11/Rad50/NBS1 (MRN) complex, H2AX,
MDC1, and 53BP1 in the NHEJ of dysfunctional telomeres. We have demonstrated that
among these factors, 53BP1 is required for the fusion of telomeres, whereas the MRN
complex, H2AX, and MDC1 only stimulate the efficiency of the repair process, most
likely by mediating the recruitment of 53BP1 to uncapped chromosome ends.

Furthermore, we have revealed the mechanism by which 53BP1 acts. We have shown
that upon deprotection, telomeres become more dynamic and explore larger territories in
a 53BP1-dependent manner. Faster mobility of DNA ends increases the chance that
dysfunctional telomeres, which are uniformly scattered throughout the nucleus, will find
one another and fuse. We have proposed that the dynamic behavior of DNA ends may be
required to promote long-distance repair in general, and that it may play a role in other
instances of NHEJ, such as during recombination in the immunoglobulin genes, where
the DNA ends are initially at a distance.
Furthermore, we have shown that the mechanism that promotes the mobility of
uncapped chromosome ends requires microtubules. This finding suggests an
unprecedented role for microtubules in the process of DNA repair in mammalian
interphase cells. Moreover, it points to the existence of a trans-nuclear envelope bridge
between damaged chromatin and cytoplasmic microtubules. Accordingly, our data
indicate that mobility depends on the acetylation status of chromatin, signifying that
specific chromatin modifications are involved in establishing that connection.
Finally, we have preliminary evidence that the dynamic process that we have
uncovered might play a role in the repair of all DNA lesions. We speculate that a
microtubule-dependent chromatin mobility provides a proofreading mechanism
preventing HDR between non-sister chromatids, possibly by physically pulling apart
inappropriate connections. Overall, this thesis presents a novel view on how the dynamic
behavior of DNA ends might be required for efficient and accurate repair of DNA
lesions.
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CHAPTER 1: INTRODUCTION
PART I: CELLULAR RESPONSE TO DNA DAMAGE
Double-strand breaks are a threat to genome integrity
A single unrepaired double-strand break (DSB) can lead to significant loss of genetic
information, as acentric fragments cannot be properly segregated during mitosis.
Furthermore, incorrect repair of a single DSB can be mutagenic and result in
chromosome rearrangements, potentially giving rise to alterations of gene expression or
unstable dicentric chromosomes.
DSBs can arise spontaneously or result from programmed events during immunereceptor rearrangements in lymphocytes and recombination in germ cells. In addition,
exposure to ionizing radiation (IR) or radiomimetic agents, accidentally in the
environment as well as intentionally as part of a cancer treatment, also generate extensive
DNA damage. Finally, the linear nature of eukaryotic chromosomes presents the problem
of DNA ends that have to be actively shielded by the telomeric nucleo-protein complex in
order to prevent recognition as DSBs. When the protective function of telomeres is
disrupted, chromosomes can enter bridge-breakage-fusion cycles that can lead to
disastrous alterations of genome organization. To neutralize the potential dangers posed
by exogenous and endogenous sources of DNA damage, an extensive network of DNA
damage response factors has evolved to ensure the integrity of the genome.
The DNA damage response machinery detects disruptions in DNA and executes
checkpoint response and DNA repair. These events are elegantly coordinated so that even
a single DSB is sensed immediately, within seconds, and a signaling cascade efficiently
1

promotes delay in cell cycle progression while repair takes place. Normal cell cycle
progression resumes only when DNA repair has been successfully completed. In the
event when the DNA lesion cannot be repaired, persistent checkpoint signaling promotes
permanent cell cycle arrest or induces apoptosis, which eliminates the damaged cell
thereby minimizing potential transformation events.
ATM kinase
ATM kinase is a central component of the response to DSBs
At the core of the DSB response machinery is the ATM (ataxia-telangiectasia mutated)
kinase, mutated in the rare autosomal recessive human disorder A-T 1. The hallmarks of
cells derived from A-T patients are chromosome breakage and sensitivity to γ-irradiation
and other genotoxic agents 2,3. As a consequence of the impaired response to DSBs, A-T
patients are predisposed to cancer, highlighting the essential role of ATM in maintaining
genome stability. It is not clear whether the other characteristic manifestations of A-T,
cerebellar degeneration and immunodeficiency, are also a result of defective DNA
damage response 4.
ATM is a serine-threonine kinase and a member of the phospho-inositol 3-kinase
related kinase (PIKK) family 1,5, which also includes ATR (ATM and Rad3-related), the
major kinase responding to DNA lesions with single-stranded DNA, and DNA-PKcs
(DNA-dependent protein kinase, catalytic subunit), a kinase involved in the nonhomologous end-joining (NHEJ) repair pathway 6. ATM kinase is activated under
physiological and pathological conditions that induce DSBs and phosphorylates proteins
involved in cell cycle control, apoptotis, and DNA repair.
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The consensus target sequences for PIKKs are S/TQ sites 7,8. Since many ATM
targets have multiple S/TQ sites, it has been difficult to determine which sites are
functionally important. In some cases, it has been established that phosphorylation at a
particular site is essential for a specific functional aspect (e.g. p53 S15 9), whereas in
other cases, phoshorylation of multiple sites in S/TQ cluster domains (SCDs) might be
necessary to overcome an activation threshold (e.g. Chk2 SCD 10).

The mechanism of ATM activation
The mechanism of ATM activation has been a controversial subject over the past several
years. Initially, Kastan and colleagues observed that ATM is sequestered as an inactive
dimer or higher order multimer in unperturbed cells 11. They identified a site within
ATM, S1981, which is autophosphorylated upon the induction of DSBs 11. They
proposed that this autophosphorylation event releases inhibitory contacts between the
catalytic domain in one ATM molecule and the region surrounding S1981 in another,
resulting in the dissociation of ATM dimers into active monomers. Autophosphorylation
of ATM at S1981 has since been commonly accepted as an indicator for ATM activity. In
addition, because they observed a relatively large number of ATM molecules being
rapidly phosphorylated in response to a small number of DSBs, Bakkenist and Kastan
argued against a model where ATM activation requires a direct contact with DSBs.
Instead, they proposed that the introduction of DNA breaks must somehow signal to
ATM molecules at a distance, for example, by causing a rapid change in some aspect of
the higher-order chromatin structure 11. Global chromatin relaxation has indeed been
detected as a consequence of DSBs 12. Furthermore, DSBs generated at I-PpoI
3

endonuclease-specific endogenous sites have been suggested to lead to local disruption of
the nucleosome structure 13. However, both of these changes in chromatin structure were
found to require ATM function, suggesting that they are a consequence rather than the
cause of ATM activition.
Recent data have implicated that autophosphorylation at S1981 is neither
sufficient nor required for ATM activation. In the first place, Kozlov et al. identified two
additional ATM autophosphorylation sites, S367 and S1893 14. In their study,
introduction of S367A, S1981A, or S1893A ATM mutants into A-T cells failed to rescue
the defects of ATM deficiency. These data argued that there are at least three functionally
important radiation-induced autophosphorylation events required for ATM activation.
Another set of data demonstrated that autophosphorylation at S1987 (mouse
residue corresponding to S1981 in human ATM) is dispensable for murine ATM
activation in vivo 15. B-cells isolated from ATM-/- mice, expressing ATM S1987A mutant
from a BAC transgene were proficient in the phosphorylation of well-established ATM
targets, SMC1 (Structural maintenance of chromosomes 1) and Chk2, in response to
DSB-inducing agents 15. In addition, lymphocyte development and genomic stability
were restored in B- and T-cells isolated from ATM-/- mice expressing the S1987A mutant
allele. Although it is possible that the mechanism for ATM activation may operate
differently in murine and in human cells, this set of evidence demonstrated that
phosphorylation at S1987 is not causative to activation of ATM, and also, importantly, it
is not required for ATM activity.

4

The role of the MRN complex in ATM activation
As discussed below, mounting evidence argues that the MRN complex is an activator of
ATM kinase 16-21. The model speculates that ATM is recruited to chromatin via the MRN
complex, which senses the presence of DSBs. After this initial recruitment event, ATM is
locally converted to a catalytically active conformation. Subsequently, high local
concentration of ATM proximal to DNA lesions might facilitate rapid
autophosphorylation of the nucleoplasmic pool of ATM molecules.

The role of ATM kinase in regulating cell cycle progression
Once activated, ATM phosphorylates a series of substrates to alter cell cycle progression
at G1/S, in S phase, and at the G2/M transition (Figure 1.1).
In the presence of DSBs in G1, phosphorylation and stabilization of the p53
protein induces p21, which is a negative regulator of CDKs (cyclin-dependent kinases),
thereby preventing entry into S-phase. ATM is a central player in this pathway. In the
first place, ATM directly phosphorylates p53 on serine 20 leading to its activation and
stabilization 22. In addition, ATM phosphorylates and deactivates the negative regulator
of p53, Mdm2, thus promoting p53 accumulation through an independent pathway 23.
Indeed, in A-T cells, p53 phosphorylation as well as the accumulation of p53 protein are
diminished following treatment with IR, resulting in defective G1/S checkpoint 24.
Finally, ATM phosphorylates the checkpoint factor, Chk2, which in turn contributes to
the G1/S checkpoint both by phosphorylating p53 and by inhibiting Cdc25A activity 25.
An additional checkpoint defect in A-T cells is manifested as a radioresistant
DNA synthesis (RDS) phenotype. In normal cells, exposure to IR provokes a rapid
5

decrease in DNA synthesis through the activation of the intra-S-phase checkpoint (Figure
1.1). ATM contributes to the intra-S-phase checkpoint by phosphorylating and activating
Chk2 kinase, which, in turn, phosphorylates Cdc25A and marks it for proteasomal
degradation. Absence of Cdc25A results in persistence of phosphorylated CDK2, which
remains bound to cyclin E and A in inactive complexes, preventing the initiation of DNA
synthesis 26. In the absence of ATM, this pathway is impaired due to reduced Chk2
phosphorylation. Regulation of the intra-S-phase checkpoint further appears to be
dependent on several ATM phosphorylation targets, including NBS1 (Nijmegen breakage
syndrome 1), SMC1, and BRCA1 (Breast cancer 1) 27,28.
Failure to arrest before mitosis represents a third checkpoint defect in A-T cells
(Figure 1.1). In response to DSBs, the G2/M transition is inhibited by ATM-mediated
phosphorylation of Chk2, which in turns leads to phosphorylation of Cdc25C
phosphatase, resulting in its inactivation and translocation to the cytoplasm 10,29-32. In
absence of Cdc25C, the cyclin B/Cdc2 complex remains in its inactivated phosphorylated
state, thus preventing entry into mitosis.
In addition to its role in checkpoint signaling, ATM-dependent phosphorylation
also promotes the accumulation of multiple DNA damage response factors at the
chromatin surrounding DNA lesions in structures referred to as DNA damage foci or
irradiation-induced foci (IRIFs). The constitution of these ATM-dependent DNA damage
foci is discussed at length below, whereas their function is the primary focus of this thesis
work.
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Figure 1.1. ATM-mediated checkpoint response to DSBs
In response to IR, it has been proposed that the MRN complex signals the presence of DNA
lesions and promotes the activation and autophosphorylation of the ATM kinase. Depending on
the cell cycle stage when DNA damage is induced, ATM phosphorylates downstream checkpoint
factors to trigger cell cycle arrest at the G1/S transition, in S-phase, or at the G2/M checkpoint.
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The Mre11/Rad50/NBS1 complex
Structure of the MRN complex
The MRN complex is a highly conserved protein complex involved in multiple aspects of
the response to DSBs, including ATM activation, cell cycle control, and DNA repair.
Here we discuss the arsenal of recently characterized structural and biochemical features
that allow the MRN complex to accomplish these various tasks.
The MRN complex is composed of two Mre11, two Rad50, and an unknown
number of NBS1 molecules 33. Initial analysis by scanning force microscopy revealed
that the overall architecture of the MRN complex appears as two highly flexible
intramolecular coiled-coils emanating from a central globular DNA binding domain 34.
The globular domain consists of an Mre11/Rad50 dimer, in which each Mre11 molecule
interacts with the Walker A and B ATPase domain of the corresponding Rad50 molecule
33

. The polypeptide that separates the two Walker motifs in Rad50 folds back on itself to

form a protruding coiled-coil structure, whose apex contains a pair of cysteine residues
capable of coordinating a Zn ion if paired with two analogous cysteines from another
Rad50 molecule 35,36. NBS1 is also a component of the globular domain and a binding
partner of Mre11 but its stoichiometry within the complex is uncertain.
These striking architectural features allow the MRN complex to facilitate DNA
repair by tethering two DNA ends 34. On the one hand, upon binding to DNA, the Mre11
dimer adopts a conformation that promotes the parallel alignment of DNA ends and
stimulates their short-range synapsis 37. On the other hand, long-range tethering of DNA
strands is supported by the ability of Rad50 to oligomerize via intramolecular Zn
coordination 36,38-40.
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Nuclease activities of the MRN complex and its associated factor, Sae2/CtIP
In addition to its ability to interact with and tether DNA ends, in vitro analysis has
established that the Mre11/Rad50 complex possesses several DNA processing activites
including: DNA annealing, Mn2+ -dependent 3’ -5’ ds exonuclease, ssDNA
endonuclease, and DNA unwinding 35,41-47. The nuclease activity of Mre11 has been of
special interest because the MRN complex promotes the initial steps of HDR in all
organisms 48 and contributes to NHEJ in budding yeast 49. Recent studies in mammalian
cells have dissected the role of the nuclease activity in various aspects of the DNA
damage response and have determined that it is required for cell viability as well as for
DNA replication, especially in stress conditions, but it does not play a promonent role in
ATM dependent checkpoint signaling or NHEJ 44,50-53. These data suggest a specialized
role for the Mre11nuclease activity in the processing of a subset of complex DNA
replication intermediates 54.
In S. cerevisiae, deletion of Mre11 causes a general defect in DNA resection at
DSBs processed by homology-directed repair (HDR) 55-57. This phenotype cannot be
explained by loss of the nuclease activity alone, as it does not have the correct polarity to
perform 5’-3’ resection, which is required during HDR 42. This apparent discrepancy has
been resolved with the identification of Sae2 (referred to as CtIP in mammalian cells and
Cpt1 in S. pombe). Sae2 is a novel factor with potential intrinsic nuclease activity that
associates and functions closely with the MRN complex 58-64. MRN/Sae2 promotes a 5’3’ resection step, which generates an essential intermediate in the HDR pathway.
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The role of NBS1 in the MRN complex
NBS1 is required for the nuclear transportation of the MRN complex and is an important
regulator of MRN function. The NBS1 protein contains an amino-terminal FHA (forkhead associated) domain adjacent to putative BRCT (BRCA1-related C-terminal) repeats
and several S/TQ motifs at a central region, suggesting its potential role in multiple
phospho-dependent interactions 65. In particular, the serine residues at 278 and 343 are
phosphorylated by ATM in response to radiation both in vitro and in vivo, and these
phosphorylations are associated with the role that NBS1 plays in the intra-S-phase
checkpoint 66,67.
The MRN complex localizes to DSBs in response to radiation exposure 68. This is
accomplished, however, through an interaction that is not DNA damage-dependent. The
BRCT repeats of NBS1 recognize and bind to the constitutively phosphorylated S-T-Drich region of MDC1 69-73. Therefore, as described later in this chapter, the current model
argues that NBS1 is passively recruited to the chromatin at DSBs when MDC1 binds to γH2AX. In turn, NBS1, which contains an Mre11-interacting domain at its carboxyterminus, is required for the association of Mre11/Rad50 with DSBs.
In addition, NBS1 binds directly to ATM through a short motif located at its
carboxy-terminus 21,74,75. This interaction contributes to the signal amplification loop that
promotes foci formation at the chromatin near DSBs and it may also be required for the
initial recruitment and activation of ATM.
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The role of the MRN complex in the ATM pathway
Over the years, the MRN complex has emerged as an essential component of the ATM
signaling pathway. Most of the initial studies were performed using cells derived from
patients with Nijmegen Breakage Syndrome (NBS) or Ataxia-Telangiectasia-like
disorder (A-TLD), which are caused by hypomorphic alleles of NBS1 76,77 or Mre11
(Meiotic recombination 11) 78 genes, respectively. Since NBS and A-TLD patients
exhibited features similar to A-T, including ionizing radiation sensitivity, chromosomal
instability, and defects in cell cycle checkpoints, the MRN complex appeared
functionally connected to ATM 78,79. Indeed, NBS1 is phosphorylated in an ATMdependent manner after DNA damage on multiple serines at positions 278, 343, and 615
27,80

. In particular, serine 343 has been shown to be functionally important in the ATM

pathway since expression of the S343A mutant in NBS cells fails to rescue the
checkpoint defects of NBS1 deficiency 16,26,27,79,81.
These studies indicate that MRN is an important component of the ATM pathway
but one outstanding question is whether the MRN complex fulfills the criteria to be
characterized as the sole sensor for DSBs and thus the activator of the ATM pathway.
The capacity of the MRN complex to interact with DNA ends and bind to ATM make it a
plausible candidate for a DNA damage sensor. This model is further corroborated by the
observation that ATM-mediated phosphorylation is not required for the localization of
NBS1 at DSBs, as shown by the proficient radiation-induced foci formation in NBS1
S343 cells 82. In addition, Mre11 foci are detected at DSBs and dysfunctional telomeres
in caffeine-treated cells and hence can form through a PIKK-independent mechanism
68,83

.
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Arguing against this model is the observation that the extent of RDS is greater in
A-T cells than either in NBS or in A-TLD cells 26. To explain the difference, it has been
proposed that parallel pathways contribute to the intra-S-phase checkpoint: the NBS1dependent ATM/NBS1/SMC1 84,85 and ATM/FANCD2 pathways 86, and the NBS1independent ATM/Chk2/Cdc25A/CDK2 pathway 26. In the first two pathways, ATMmediated phosphorylation of the effectors SMC1 and FANCD2 requires the
phosphorylation of NBS1, suggesting that NBS1 might serve as an adaptor between
ATM and its targets. Data have been controversion with regard to the third pathway.
Whereas in some studies the phosphorylation of Chk2 and Cdc25A has been reported as
normal both in NBS and in A-TLD cells, several independent studies have indicated a
requirement for NBS1 at low damage levels, suggesting a partial involvement.
Irradiation-induced delays at the G1/S and G2/M transitions are also partial in
NBS cells. In the absence of a functional MRN complex, the cellular levels of p53 and
the phosphorylation of Mdm2 and Chk2 is sub-optimal but not abolished 17,78,87,88. These
findings argue that defects in the MRN complex reduce but do not abolish the activation
of checkpoint factors, raising the possibility that MRN might not be absolutely required
for ATM activation but may only contribute to the recruitment of specific substrates by
ATM 74.
A drawback in the interpretation of these studies is the potential ability of another
PIKK, in particular ATR kinase, to complement the absence of active ATM. This has
been a significant concern, especially in the case of experiments analyzing the
consequences of IR- or laser-induced DNA damage. Both methods generate large
amounts of single-stranded DNA in addition to multiple DSBs. In these instances, the
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ATR kinase, which is activated via an MRN-independent pathway, can promote the
phosphorylation and activation of ATM and downstream checkpoint factors 89.
Another complication arises from the fact that the MRN complex is essential for
cellular viability, and therefore the in vivo experiments have been performed in cell lines
bearing hypomorphic alleles, likely to underestimate the contribution of MRN.
Multiple studies have attempted to circumvent these difficulties. For example,
using adenoviral infections as a model system that elicits an ATM-specific response, it
has been found that the MRN complex is required for activation of ATM and for
execution of the G2/M checkpoint 16. In a different setting, using I-Ppol endonuclease to
generate site-specific DSBs, it has been demonstrated that NBS1 is required for ATM
autophosphorylation as well as for the association of active ATM with damaged
chromatin 13. Another study determined in vitro that ATM activity is robustly stimulated
by linear DNA only when the MRN complex is present, consistent with the view that
MRN is both an activator of ATM and a sensor for DNA damage 20. These findings
strongly argue that a functional MRN complex is required for the activation of ATM at
DSBs.
This conclusion is further corroborated through the characterization of the Rad50S
allele, which is hypermorphic for DNA damage signaling 90. Rad50S/S cells have
constitutive low-level activation of the DNA damage response even in the absence of
exogenous DNA damage that leads to ATM/Chk2-mediated apoptosis. The ability of the
gain-of-function Rad50 mutant to promote the ATM pathway in the absence of DNA
damage is strongly indicative of a sensor function for the MRN complex. Curiously,
however, the Rad50S allele partially rescues the phenotypes of ATM-deficiency in
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Rad50S/SATM-/- mice, implicating a role for the MRN complex in an ATM-independent
pathway 90.
Recent analysis of cells isolated from mice, carrying a conditional allele for NBS1
(NBS1F/- 18) or Mre11 (Mre11F/-

54

) as well as from mouse models expressing transgenic

mutant alleles 18,54,88,90,91 have provided further support for the model that the MRN
complex is the sensor for ATM. Since deficiency in MRN leads to embryonic lethality,
initial analysis focused on transgenic mice that bore the hypomorphic NBS1ΔB/ΔB and
Mre11ATLD/ATLD alleles, initially characterized in NBS and A-TLD patients, respectively.
Whereas MEFs derived from these mouse models recapitulated closely the phenotypes
observed in NBS and A-TLD cells, their analysis yielded conflicting results as to whether
or not the MRN complex is the sensor in the ATM pathway. On the one hand, these cells
are characterized by severe RDS phenotype, a G2/M checkpoint defect, and irradiationinduced chromosome instability. On the other hand, following IR treatment the
phosphorylation of the ATM targets Chk2 and SMC1, the induction of p53/p21, and the
recruitment of γ-H2AX to DSB are not affected significantly. Interestingly, in NBS1ΔB/ΔB
cells, ATM can be detected in its activated, autophosphorylated form, suggesting that the
ATM pathway is active 18. In contrast, when NBS1 is deleted in NBS1F/- MEFs through
the expression of Cre recombinase, ATM, Chk2, and SMC1 phosphorylation in response
to IR is abrogated 18. These findings confirm that hypomorphic alleles retain some of the
MRN function and that analysis of cells lacking MRN is required to dissect its
contribution to the ATM pathway. However, even in the absence of NBS1, γ-H2AX still
associates extensively with laser-induced DSBs, raising the possibility that ATM can be
activated without the aid of MRN complex 18. In sum, it seems that the MRN complex
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contributes to some but not to all aspect of the ATM pathway. On the background of this
controversial set of data, the findings presented in this thesis and in a recent paper 54
provide uncontestable evidence that at sites of DNA damage, which exclusively activate
the ATM pathway, absence of MRN function precludes the activation of the DNA
damage response (Discussed in more detail in Chapter 2).

ATM-dependent accumulation of DNA damage response factors at sites of DNA
damage: IRIFs
Following ATM activation, the response to DSBs is characterized by a dramatic
relocalization of a number of DNA damage response factors to sites of damage (Figure
1.2) 92,93. In the absence of DNA damage, most DNA damage response factors are
distributed homogeneously in the nucleoplasm. Upon induction of DSBs by γ-irradiation,
these factors accumulate in large foci, referred to as IRIFs. IRIFs are cytologically visible
under the fluorescent microscope as bright speckles and can be used as an indicator for
the presence of DNA damage. It is thought that each IRIF represents one or several DSBs
and that the factors accumulated in each focus are involved in promoting cell cycle arrest
and active repair processing. This initial concept originated from observations that IRIFs
appear within seconds after the induction of DNA damage, concomitant with the
activation of ATM kinase 94. The disappearance of IRIFs, on the other hand, has often
been used as a marker for successful completion of DNA repair although this connection
has not been experimentally proven.
IRIFs are very large structures. Chromatin immunoprecipitation (ChIP)
experiments have shown that IRIF formation is not limited to the immediate vicinity of
15

DSBs but stretches for several megabases on either side of DNA lesions. Phosphospecific interactions between ATM targets and proteins containing phospho-recognition
modules such as FHA and BRCT domains contribute to the formation of IRIFs. In
addition, recent work has established that the recruitment, spreading and retention of IRIF
factors is intimately linked to chromatin modifications induced or exposed in the
presence of DNA damage. Another feature of IRIFs is their dynamic nature as visualized
by real-time photobleaching microscopy imaging. Although IRIFs can persist for many
hours, factors become only transiently immobilized around the DSB-flanking chromatin
and are constantly exchanged 94.
In the past few years, enormous progress has been made towards understanding
the structural organization of IRIFs in mammalian cells. In particular, the factors
involved in IRIF assembly and the steps required for IRIF amplification and maintenance
have been dissected (Figure 1.2). However, the functional contribution of IRIFs to the
DNA damage response and their roles in checkpoint signaling and DNA repair have
remained unclear.
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Figure 1.2. Mechanism of IRIF formation in response to DSBs
IRIF formation is initiated when activated ATM kinase phosphorylates H2AX adjacent to the
DNA lesion to trigger the recruitment of numerous other DNA damage response factors to the
site of damage. γ-H2AX is specifically recognized by MDC1. MDC1 is constitutively
phosphorylated by CK2, a mark recognized by NBS1, which in turn functions to recruit more
active ATM molecules. The ATM kinase, associated with IRIFs, phosphorylates adjacent H2AX,
establishing a signal amplification step, and also phosphorylates MDC1 on its SCD, which is
important for the recruitment of RNF8 to DSBs. At DSBs, RNF8 deposits ubiquitilation marks on
the chromatin flanking the DNA lesion, establishing a platform for the recruitment for DNA
damage repair factors, including the BRCA1 complex and 53BP1. 53BP1 is also recruited via an
independent association with H4-K20diMe.
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IRIF factor: γ-H2AX
PIKK-mediated phosphorylation of an H2A histone variant, H2AX, is at the heart of IRIF
formation (Figure 1.2) 95,96. H2AX makes up 10-15% of total cellular histone H2A and
exists as a component of the nucleosome core structure. In response to DNA lesions,
H2AX is phosphorylated on a conserved serine residue at its carboxy terminal, S139,
located within a S-Q-E-Y motif 97. The phosphorylated form of H2AX (referred to as γH2AX) occupies an extensive region of chromatin flanking the DNA lesion 98, and it is
believed that this event establishes the scaffold for IRIFs 99. In the absense of H2AX or
when the phosphorylation site is mutated, IRIF formation by other DNA damage
response factors is impaired 100,101. For some IRIF factors, such as MDC1 (Mediator of
DNA damage checkpoint 1), the recruitment to DSBs is abolished in H2AX-null cells. In
other cases, including 53BP1 (p53 binding protein 1), NBS1, and BRCA1, the long-term
residence at IRIFs is severely compromised 102.
Mice lacking the H2AX gene show male infertility, in part due to defective repair
of SPO11-induced DSBs in meiosis, and have reduced levels of secondary
immunoglobulin isotypes, indicative of impaired class-switch recombination (CSR), a
process that also involves a DSB repair reaction 100. In addition, cells derived from
H2AX-deficient mice exhibit elevated levels of IR-induced chromosome abnormalities,
indicating that H2AX is involved in the signaling and/or repair of DSBs 100. As H2AX is
dispensable for the activation of irradiation-induced checkpoints at the G1/S transition, in
S phase, and at the G2/M transition 102, it has been suggested that H2AX must play a role
in promoting DNA repair. In support of this model, H2AX phosphorylation appears
tightly correlated with the persistence of un-repaired DSBs 103 and H2AX de18

phosphorylation coincides with successful completion of DNA repair. However, further
studies have indicated that H2AX is not required for NHEJ, but may play a role in HDR
104,105

. In sum, these experiments led to the conclusion that H2AX is not absolutely

required for DNA repair, and although it might contribute to its efficiency 106, the exact
mechanism is not well understood.

IRIF factor: MDC1
The ATM target MDC1 (mediator of DNA damage checkpoint 1) is a large protein that
contains multiple protein-protein interaction domains, including an N-terminal FHA
domain, a unique Ser-Asp-Thr (S-T-D) repetitive motif, and C-terminal tandem BRCT
repeats 107-110. MDC1 is recruited to IRIFs through a direct interaction with γ-H2AX 110112

where it acts as a scaffold for the recruitment of other IRIF factors, including ATM,

the MRN complex, and 53BP1 (Figure 1.2) 107,109,112-114.
The tandem BRCT repeats of MDC1 form a pocket that selectively recognizes
phosphorylated S-Q-E-Y motif of γ-H2AX. The structural basis for this interaction has
been determined from crystallography of the MDC1 BRCT region with a phosphorylated
H2AX C-terminal peptide 111,112. BRCT repeats, first described in BRCA1 but also found
in other DNA damage response factors such as 53BP1 and BARD1, generally recognize
phosphopeptides. In the case of MDC1, however, the BRCT repeats establish a binding
cleft that is exclusively tailored to recognize the free carboxyl terminal of γ-H2AX with
high selectivity and stability. The structural data also identify specific residues in MDC1
that are required for the contact with the H2AX phosphopeptide. Consequently,
mutations in any of these residues within the MDC1 BRCT region, as well as mutations
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in the C-terminal serine or tyrosine residues of H2AX, severely compromise the
accumulation of MDC1 at IRIFs and impair the DNA damage response 112,115.
Consistent with the association between MDC1 and H2AX, MDC1-/- mice have
phenotypes similar to the defects observed in H2AX-deficient mice, including
radiosensitivity, male infertility, and impaired CSR 114. Similarly, analysis of IRIF
formation in MDC1-deficient MEFs has shown that MDC1 is required for the extended
association of factors such as the MRN complex and 53BP1 with DSBs 114. Even though
NBS1 and 53BP1 can transiently be recruited to laser-induced DSB-containing tracks,
they fail to accumulate and prematurely dissociate from DSB sites in absence of MDC1
116

. The phenotypes of MDC1 deficiency are thus reminiscent of the data obtained in

H2AX-deficient cells where the stabilization of MRN and 53BP1 at IRIFs, but not their
initial recruitment, is severely affected by the absence of γ-H2AX 102. MDC1 loss also
leads to impaired phosphorylation of ATM targets Chk2 and SMC1 and the intra-S-phase
checkpoint is compromised in cells treated with low levels (0.5-2 Gy) of γ-irradiation
72,107

. These findings have suggested a potential role for MDC1 as a signal amplifier in

the ATM pathway.

IRIF factor: The MRN complex
Chromatin bound MDC1 recruits other DNA damage response factors to IRIFs, including
the MRN complex. As described in the model above, the MRN complex acts as a sensor
for DSBs and is required for ATM activation and consequently, for γ-H2AX and MDC1
IRIF formation. This initial recognition of DSBs by the MRN complex is an intrinsic
feature of MRN and it may only involve a few molecules (Figure 1.2). In contrast, the
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cytologically discernible prolonged accumulation of MRN complex at IRIFs depends on
ATM and requires γ-H2AX and MDC1 (Figure 1.2).
The interaction between MDC1 and the MRN complex involves a phosphodependent contact between the phosphorylated S-T-D-rich region of MDC1 and the FHA
domain of NBS1 69-73. Interestingly, the conserved S-T-D repeat motif in MDC1 is
constitutively phosphorylated by CK2 (casein kinase 2), which explains why the
interaction between MDC1 and MRN is detectable even in the absence of DNA damage.
One possibility is that some MRN always binds to MDC1 and accumulates at DNA
lesions when MDC1 binds to γ-H2AX.
Since the MRN complex also interacts with ATM through the C-terminal domain
of NBS1 21,117, it can recruit to IRIFs more active ATM kinase, which in turn can
phosphorylate adjacent H2AX, establishing a signal amplification step. One current
model proposes that the spreading of γ-H2AX for several megabases along the chromatin
flanking a DSB is a consequence of the accumulation of chromatin-bound ATM kinase
on the γ-H2AX-MDC1-MRN scaffold 114,118.

IRIF factor: RNF8
An additional level of regulation is exercised by the RING-finger ubiquitin ligase, RNF8,
which localizes to IRIFs through a specific interaction between its FHA domain and the
phosphorylated S/TQ cluster of MDC1 119-122. At sites of damage, RNF8 ubiquitilates γH2AX to promote the retention of 53BP1 and the BRCA1 complex (Figure 1.2). It has
been proposed that MDC1-mediated RNF8-executed histone ubiquitilation licenses the
DSB-flanking chromatin to concentrate repair factors near the DNA lesion 121.
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IRIF factor: 53BP1
Although 53BP1 was first identified in an yeast-two hybrid screen for p53 interacting
factors 123, it is now clear that this protein is an important regulator of genome stability
that protects cells against DSBs 124-128. Recent data has further indicated that 53BP1 is
downregulated during the transition of precancerous stage to carcinoma 129, and loss of a
single 53BP1 allele in mice causes genome instability and lymphoma 130.
The presence of C-terminal BRCT repeats adjacent to a Tudor domain has led to
the speculation that 53BP1 is the human ortholog of yeast Rad9, a central component of
the DNA damage signaling network in S. cerevisiae 131. In contrast to Rad9, however,
downregulation of 53BP1 in human cells by RNAi and 53BP1-deficiency in MEFs only
lead to a partial defect in the intra-S phase checkpoint, and show mild defects in
irradiation-induced G2/M checkpoint after low doses of radiation 126,132. 53BP1 is also
phosphorylated by ATM kinase on multiple sites but little is known about their functional
role in the DNA damage response 133.
The most apparent phenotypes of 53BP1 deficiency are radiosensitivity and
defects in CSR, similar to the phenotypes of H2AX or MDC1 loss 132,134-136. Despite the
similarities, the penetration and severity of the phenotypes can be different. For example,
CSR is more severely compromised in cells lacking 53BP1 than in H2AX- or NBS1deficient B cells. Ward et al. observed that despite equivalent proliferation rates the
percentage of IgG1-positive 53BP1-deficient B cells is reduced 15-fold compared to
wild-type control cells 136. In contrast, CSR is impaired only 6-7 fold in H2AX-/- B cells
100

, and, in NBS1-deficient cells, the reduction of class switching is only about 2-3 fold

compared to control 137.
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53BP1 requires two independent interactions with modified chromatin in order to
stably associate with sites of DNA damage (Figure 1.2). On one hand, the Tudor domain
of 53BP1 forms a pocket that specifically recognizes dimethylated lysine 20 on histone
H4 (H4-K20diMe) at DSBs 138. Structural studies have identified residues essential for
this interaction and mutation in one of these, D1521, abrogates the interaction in vivo 139.
Furthermore, the interaction of 53BP1 with chromatin is stabilized by the S/TQ cluster of
MDC1, which recruits the RNF8 ubiquitin ligase 107,108,110,115,116. It seems that both H4K20diMe and γ-H2AX/MDC1 contribute to the recruitment of 53BP1 to sites of damage.
In MEFs deficient for SUV4-20-h1, -h2 methyltransferases, where dimethylation of H4K20 is abrogated, the accumulation of 53BP1 at DSBs is delayed and diminished 140.
Conversely, as described above, in H2AX- and MDC1-null MEFs, 53BP1 is initially
recruited to laser-induced DSBs but its accumulation is strongly diminished over time
compared to wild-type cells. This suggests that, in the context of intact nucleosomes, the
Tudor domain may support only a transient interaction of 53BP1 with chromatin.
Interestingly, H4-K20diMe is a constitutive chromatin mark, so it has been argued that
the specificity for the recruitment of 53BP1 to IRIFs is likely to come from γH2AX/MDC1. In this regard, it is conceivable that phosphorylation and/or ubiquitilation
of H2AX might expose the H4-K20diMe mark or facilitate its interaction with 53BP1.

The role of IRIFs in amplifying the DNA damage signal
γ-H2AX, MDC1, and 53BP1 seem to play a minor role in DNA damage signaling.
H2AX- and MDC1-deficient cells exhibit mild defects in the phosphorylation of ATM
targets and in the induction of the intra-S-phase checkpoint arrest 102,114, while the
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absence of 53BP1 weakly affects ATM autophosphorylation and Chk2 activation 132. The
decrease in ATM activity is only pronounced at low levels of γ-irradiation, suggesting
that these factors might be involved in amplification of the damage signal 118. In this
regard, it is possible that the stimulating effects on the ATM pathway may be mediated
through stabilization of the MRN complex at IRIFs and its ability to locally activate
ATM 69,70. At the same time, these studies convincingly show that γ-H2AX, MDC1, and
53BP1 are not absolutely required for activation and maintenance of the checkpointsignaling cascade.
The extensive contribution of the MRN complex to checkpoint signaling is due to
its role as a sensor in the ATM pathway. Indeed, MRN participates both in ATMdependent intra-S-phase checkpoint 16,26,27,79, as well as in ATM-mediated arrest at the
G2/M transition 16,81.

Two major pathways for DSB repair: HDR and NHEJ
There are two primary pathways for the repair of DSBs in eukaryotic cells, homologydirecte repair (HDR) and NHEJ. HDR occurs during late S or G2 phases of the cell cycle
when the sister chromatids are in close proximity 141-143. HDR ensures error-free repair
because the break in one chromatid is repaired using the identical information in the sister
chromatid. The HDR pathway has been studied extensively and the functional
contributions of numerous DNA damage repair factors have been implicated. As an
introduction to this thesis work, it is important to point out that in the first step of HDR,
the MRN complex, together with the nuclease Sae2/CtIP, resects DSB ends to generate
short single-stranded overhangs, which are an essential prerequisite for subsequent steps
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of HDR. Interestingly, this resection step appears to be tightly controlled by CDKs,
which can activate Sae2/CtIP through phosphorylation on a conserved C-terminal residue
62,144

. This regulatory step ensures that HDR is only activated in S/G2, in the presence of

sister chromatids. Additionally, CDK-dependent phosphorylation of NBS1 on S432 has
also been identified as a potential regulator of this resection step (pers.comm. S. Jackson
and pers. comm. J. Petrini and R. Fisher).
The alternative mechanism for repair of DSBs is the NHEJ pathway, which does
not require a homologous chromosome (Figure 1.3) 143,145. NHEJ can therefore function
throughout the cell cycle, although it has been suggested that it is most active in G1,
when resection at DSBs is limited 60,62. NHEJ involves direct ligation of the two DNA
ends in a manner that might lead to nucleotide loss (typically, 1-10 nt) or untemplated
nucleotide addition (typically, 0-3 nt) at the rejoining site. Because of its imprecision,
NHEJ is potentially mutagenic.
The first step of NHEJ is the binding of the Ku70/Ku80 heterodimer to the two
DNA ends (Figure 1.3) 146,147, where it promotes the synapsis of DNA ends and facilitates
the recruitment of other NHEJ factors. The Ku complex can bind to DNA due to its
toroidal structure, which has a 20 Å hole through the center that permits it to thread like a
ring onto DNA ends 148. In addition, Ku interacts with and can recruit to DSBs multiple
NHEJ factors, including the nuclease Artemis 149,150; the kinase DNA-PKcs 151; the
polymerases µ and λ 152-154; and the ligase complex Cernunnos(XLF)-XRCC4-DNA
ligase IV 155,156. The second step of NHEJ occurs at a subset of DSBs, at which the two
broken ends are incompatible and require further processing. End-processing of
overhangs can be mediated by the nuclease activity of Artemis complexed with DNA-
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PKcs. DNA-PKcs is a PIKK that acquires serine/threonine protein kinase activity when
bound to a DNA end, and phosphorylates itself and Artemis. In vitro Artemis has a weak
5’-3’ exonuclease activity on its own but as part of the Artemis-DNA-PKcs activated
complex, it acquires an endonuclease activity towards both 3’ and 5’ overhangs of
variable length. In addition to resection, end-processing may also involve the activities of
the X-pol family polymerases to promote template-dependent fill-in synthesis at gaps.
The final step of NHEJ is the direct ligation of the two ends by the Cernunnos(XLF)XRCC4-DNA ligase IV complex (reviewed in 157).
The ligase complex Cernunnos(XLF)-XRCC4-DNA ligase IV plays a critical role
in the NHEJ pathway. Studies of human patients who harbor hypomorphic mutations, as
well as analysis of mice that carry conditional alleles, have indicated that
Cernunnos(XLF), XRCC4, and DNA ligase IV are core components of the NHEJ
pathway. When the function of these factors is impaired in human patients, or when the
genes are conditionally deleted in a specific cellular compartment in genetically modified
mice, the consequences are striking. The marked failure to repair DSBs leads to genetic
instability, developmental delay, and immunodeficiency 155,156,158,159. On the other hand,
analyses of several other factors involved in NHEJ have revealed that they do not play an
essential role. Ku70, Artemis, and DNA-PK-deficient mice exhibit reduced but not
abolished proficiency to perform V(D)J recombination, an established read-out for ability
to execute NHEJ repair (see below)149,150,160,161.
It has been speculated that rather than being essential components, Ku, Artemis,
and DNA-PKcs might contribute to the efficiency of the NHEJ process. For instance, as
described above, the Artemis-DNA-PKcs complex may only be required for the repair of
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a subset of DSBs that contain incompatible DNA ends 150. Ku, on the other hand, has
been implicated to contribute to NHEJ by maintaining close proximity between the two
DNA ends. The synapsis role of Ku has been demonstrated in an experiment where a
unique I-SceI endonuclease site, flanked by a TetO array on one side and a LacO array on
the other side, was introduced into mouse cells 162. Upon I-SceI-mediated introduction of
a single DSB, the dynamic behavior of the two DNA ends was monitored over time in
living cells by imaging the movement of fluorescently-labeled TetR and LacR. Whereas
in wild-type cells, the two DNA ends exhibited positional stability and remained in close
proximity for extended periods of time, in cells with reduced Ku protein levels, the two
ends often moved apart. Thus, the local mobility of broken ends is prevented in the
presence of Ku, extending into living cells the hypothesis, based on structural
observations, that Ku forms an asymmetric ring around the two broken ends and
functions to align broken chromosome termini at the site of repair 148.
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Figure 1.3. Schematic representation of the NHEJ pathway
Ku70/Ku80 complex has been implicated in promoting the positional stability of the two DNA
ends of a DSB, induced by various factors. Incompatible DNA ends further are processed by the
Artemis-DNA-PKcs complex, which removes 5’ and trims long 3’ overhangs. Based on the
presence of microhomologies, the two ends are brought together and polymerases from the X-pol
family perform template-dependent synthesis to fill in remaining gaps. In the last step of NHEJ,
the ligation reaction is executed by the Cernunnos(XLF)-XRCC4-DNA ligase IV complex.
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Different NHEJ model systems reveal conflicting roles of IRIF factors
Irradiation-induced DSBs
The contribution of IRIF factors to the regulation of NHEJ has been addressed in several
model systems. As mentioned above, the persistence of IRIFs is tightly correlated with
the presence of un-repaired DSBs following exposure to γ-irradiation. In addition,
H2AX-, MDC1-, and 53BP1-deficient cells are radiosensitive. Given the minor
contribution of these factors to DNA damage signaling, the accumulation of
chromosomal abnormalities following exposure to DSB-inducing agents strongly
suggests a role in DNA repair. However, standard experimental techniques such as
Comet assay and FAR pulse-field gel analysis have failed to assign a role to H2AX,
MDC1, or 53BP1 in the repair of γ-irradiation-induced DSBs 100,136,163. The shortcoming
of these techniques is that they examine gross chromosomal repair and therefore require
very high doses of γ-irradiation (20-80 Gy). This disadvantage would preclude
identification of factors involved in subtle, regulatory aspects of the NHEJ pathway.

I-SceI cut
Rare-cutting endonucleases, such as I-SceI, allow the introduction of one or a few DSBs
into complex genomes. Similar to γ-irradiation-induced DSBs, the accumulation of IRIF
factors at an I-SceI cut can be monitored by immunofluorescence, but chromatin
immunoprecipitation studies can also take advantage of the site specificity. Importantly,
depending on the sequences surrounding an I-SceI cut, successful repair through NHEJ or
HDR pathways can be measured by the expression of a fluorescent marker whose reading
frame is re-established only if a correct NHEJ or HDR repair reaction has taken place.
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NHEJ repair requires little or no homology but frequently results in small deletions or
insertions. HDR, on the other hand, re-establishes the correct reading frame through
recombination-dependent repair involving a homologous gene.
This technique has been instrumental in establishing a role for Ku in maintaining
positional stability of the two ends of a DSB (described above). In contrast, detailed
analysis of the roles of MDC1 and 53BP1 in promoting repair using HDR- and NHEJspecific I-SceI assays has revealed conflicting results 115,164. On one hand, Xie et al.
observed that MDC1 contributed primarily to HDR and sister chromatid recombination,
in a manner strictly dependent upon its ability to bind γ-H2AX, whereas 53BP1 appeared
to be involved exclusively in NHEJ 115. 53BP1’s function, in these assays, depended on
its interaction with H4-K20diMe, and was largely independent of γ-H2AX 115. Based on
these data, it has been proposed that MDC1 and 53BP1 function to promote different
repair pathways, HDR and NHEJ, respectively 115. On the other hand, a previous study
had demonstrated a role for MDC1 in NHEJ 163, whereas a different study had identified
no role for 53BP1 in NHEJ 136. This controversial set of data suggests that under certain
circumstances IRIF factors may contribute to repair. Curiously, a direct interaction
between MDC1 and DNA-PKcs has been reported, which appears to promote the
autophosphorylation and therefore activation of DNA-PKcs 163. Similarly, the HDR
factor RAD51 was found to interact with MDC1 164. It is not clear whether these
interactions have any functional significance.
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V(D)J recombination
The contribution of IRIF factors to NHEJ has also been examined in the context of V(D)J
recombination, which rearranges the immune locus in B- and T-cells in the process of
antigenic receptor diversification. The V(D)J recombination process assembles the
Variable (V), Diversity (D), and Joining (J) encoding gene segments through a
specialized somatic DNA rearrangement mechanism. The locus is rearranged in two
steps; first one D and one J gene segments are joined, followed by the addition of one V
gene segment to the (D)J product to form the final rearranged V(D)J locus. The reaction
is initiated by the lymphoid-specific factors RAG1 and RAG2, which recognize
recombination signal sequences in the immunoglobulin locus of a B- or a T-cell and
introduce two DSBs at specific locations. The DNA ends to be joined, called the coding
and the signal ends, are maintained in close proximity by the RAG complex while repair
takes place. The two coding ends, whose joining gives rise to the rearranged locus, are
characterized by terminal hairpins that require removal by the Artemis-DNA-PKcs
complex prior to the ligation event. The two ends of the intervening sequence, called
signal ends, are blunt, and they are also ligated to release an extrachromosomal circle.
The joining is accomplished by the classical NHEJ repair machinery. As mentioned
above, the ligase complex components Cernunnos(XLF), XRCC4, and DNA ligase IV
are essential for V(D)J recombination, whereas the factors Ku, Artemis, and DNA-PKcs
have been implicated in promoting the V(D)J process.
Analysis of V(D)J recombination in MRN- 165,166, H2AX- 100, MDC1- 114, and
53BP1- 136 deficient mice has not revealed any obvious defects.
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Class switch recombination
On the other hand, NBS1-, H2AX-, MDC1-, and 53BP1-null mice have prominent
defects in CSR 100,106,134-137,167. Similarly to V(D)J recombination, CSR is a programmed
pathway in the immune system that requires NHEJ-mediated repair of DSBs 168. During
the terminal maturation of B-lymphocytes, which occurs upon antigen recognition,
immunoglobulin genes undergo an additional molecular processing step called CSR,
whose purpose is to increase the efficiency of the humoral response. During class
switching, the constant region of the immunoglobulin heavy chain is exchanged while the
variable region stays the same. This allows daughter cells from the same activated B cell
to produce antibodies with the same antigen specificity but of different isotypes or
subtypes.
CSR is initiated by the B-cell specific enzyme AID (activation-induced cytidine
deaminase), which, in a transcription dependent manner, deaminates cytidine residues in
the constant regions to generate uridines. The U/G mismatches are recognized by the
enzyme UNG (uracil-N-glycosylase) and removed to create abasic sites. In turn, the
abasic sites are most likely cleaved by a specific endonuclease, such as Ape1, thus
creating DNA nicks. DNA nicks generated on the two DNA strands lead to staggered
DNA DSBs that can be modified by nucleases and/or polymerases in the process of
repair. The free DNA ends are rejoined by NHEJ in a manner that specifies a new
constant region of the heavy chain of the antibody. The intervening DNA is
concomitantly deleted from the chromosome, removing the unwanted heavy chain
constant region exons. The distance between the old and the new constant regions can be
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as much as 100 Kb. A specific factor that would promote the synapsis of these distant
regions, similarly to the RAG complex in V(D)J, has not been identified.
The role of NHEJ factors in CSR cannot be easily analyzed in knockout mice as
they lack a mature immune system. Several independent approaches have been used to
circumvent this problem. In one experiment, a monoclonal mature B-cell compartment
was reconstituted in mice deficient for NHEJ factors. In this setting, Ku70- and Ku80deficiency impaired CSR, but this defect could result from a reduced proliferation or
increased apoptosis of B cells rather than a CSR defect per se 169,170. In another
experimental approach, to overcome the embryonic lethality associated with DNA ligase
IV-deficiency, a conditional allele that can be specifically removed in mature B-cells was
introduced 171. Surprisingly, although reduced by more than 50%, CSR still occurred in
absence of XRCC4 and DNA ligase IV, suggesting the existence of an ‘alternative’
NHEJ repair pathway. Indeed, two recent reports have demonstrated that in the absence
of essential NHEJ factors, both CSR and V(D)J recombination may rely on an alternative
end-joining pathway 172,173. However, the ‘classical’ NHEJ pathway is most likely
dominant in the case of CSR, as it is for V(D)J recombination. Consistent with this
conclusion, two studies reported that both CSR and V(D)J recombination occur in G1
stage of the cell cycle, when NHEJ is thought to be active 174,175.
CSR is promoted by a number of upstream DNA damage response factors, ATM,
γ-H2AX, MDC1, the MRN complex, and 53BP1, all of which are known to localize at
AID-induced DSBs 175. Among these factors, 53BP1 deficiency gives the strongest CSR
defect 134,136. For instance, comparison of experimental data from several reports reveals
that 53BP1 loss reduces the frequency of the IgG1 isotype by about 15-fold, whereas
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absence of ATM, NBS1, or H2AX causes a 2-6-fold decrease 100,136,137. Furthermore, in
the absence of 53BP1, DSBs in different switch regions fail to join successfully, resulting
in a predominance of intra-switch recombination events 135. As a consequence of the
impaired repair of AID-induced DBSs, activated B-cells isolated from H2AX-, MDC1-,
and 53BP1-null mice accumulate chromosome breaks and translocations 106. To explain
the extensive contribution of IRIF factors to CSR, it has been proposed that IRIF factors,
in particular 53BP1, might either facilitate the synapsis of DNA ends or ‘shepherd’ NHEJ
factors to the break 135.

Dysfunctional telomeres as a model system to study the regulation of NHEJ
In sum, previous analysis of the contribution of IRIF factors to NHEJ has implicated a
potential involvement but also yielded conflicting results and failed to provide a unifying
mechanism that would explain the phenotypical variability under different circumstances.
We have developed dysfunctional telomeres as an alternative model system to
study novel aspects of the regulation of NHEJ. In part II of this chapter, the components
of the telomeric nucleo-protein complex are introduced and insight is provided into how
telomeres protect chromosome ends from recognition as DSBs. In this context, it is
described how we can disrupt telomere function in order to generate DSBs at specific
locations – at the ends of chromosomes. This background is the basis for the techniques
used in this thesis work to genetically dissect the contribution of IRIF factors to the
regulation of the NHEJ repair pathway.
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PART II: TELOMERE STRUCTURE AND FUNCTION
In the 1940s the special qualities of ‘natural’ ends of linear chromosomes were first
recognized 176. Barbara McClintock observed that in contrast to ‘broken’ ends, which
tended to fuse and create dicentric chromosomes, ‘natural’ chromosome ends were stably
maintained 177. We now know that chromosome ends are stable because they are capped
by telomeres, dynamic and complex nucleoprotein machineries that protect the integrity
of chromosomes and are essential for cellular survival.
The telomeric DNA is comprised of a long array of double-stranded TTAGGG
repeats that extend into a single-stranded overhang on the G-rich strand 178,179. The
shelterin complex, composed of six telomere-specific factors, TRF1 (Telomere repeat
binding factor 1), TRF2 (Telomere repeat binding factor 2), POT1 (Protection of
telomeres 1), RAP1, TIN2 (TRF1-interacting nuclear factor 2) and TPP1, specifically
coats the telomeric DNA and is essential for the prevention of detrimental genome
instability.
In this chapter we discuss the abilities of shelterin to remodel the telomeric DNA
into a protected structure and to locally inhibit the activation of the DNA damage
response machinery (Figure 1.4a). Although not a focus of this thesis work, gradual
telomere loss limits the replicative potential of human somatic cells. Hence it has been
proposed that telomeres play an important role as a tumor suppressor mechanism. In this
regard, shelterin plays a critical role in determining telomere length by suppressing
excessive nuclease activity at the chromosome terminus and by regulating telomerase, the
enzyme that elongates telomeres by adding TTAGGG repeats to the 3’end (Figure 1.4b).
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Figure 1.4. Overview of the multiple roles of shelterin at telomeres.
a, Shelterin protects chromosome ends. Telomeric DNA consists of 2-30 Kb dsTTAGGG repeats
in human cells and 20-150 Kb in mouse cells with a 50-300 nt ssTTAGGG overhang on the 3’
strand. Shelterin complex specifically coats both the ds portion of the telomere and the ss
extension. The presence of shelterin at telomeres promotes the formation of a protective structure
at chromosome ends and also suppresses the activation of DNA damage signaling and repair
pathways.
b, Shelterin regulates telomere length. Telomere ends are subject to degradation by unknown 5’3’ nuclease(s) that resects the 5’-strand in order to generate the telomere overhang. Shelterin
regulates the activity and/or recruitment of this nuclease and thereby prevents excessive nuclease
degradation and telomere shortening. At the same time, telomerase can elongate telomeres by
adding TTAGGG repeats to the 3’ end, an activity that is positively and negatively regulated by
shelterin.
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Telomere-binding proteins in mammalian cells
The shelterin complex
The first two shelterin factors, TRF1 and TRF2, bind to the double-stranded portion of
the telomere and are essential for the recruitment and stabilization of the other shelterin
members (Figure 1.5) 180-182. The high specificity of TRF1 and TRF2 for telomeric DNA
is achieved by two complementary mechanisms. In the first place, both proteins contain
homologous carboxy-terminal DNA-binding (SANT/Myb-type) domains that recognize
5’-YTAGGGTTR-3’ sequence in double-standed DNA with high specificity 183-185. In
addition, both TRF1 and TRF2 contain structurally similar dimerization (TRFH) domains
and exist as homodimers in solution, with TRF2 having a propensity to form higher-order
oligomers 182,186,187. Both TRF1 and TRF2 are essential for cell viability, since deletion of
either genes leads to early lethality in mouse embryonic development 188-190.
TRF1 and TRF2 are bridged by another shelterin factor, TIN2, which plays a core
role in the shelterin complex (Figure 1.5). TIN2 can interact simultaneously with TRF1
and TRF2, and, in turn, can recruit to the telomere two other shelterin components, TPP1
and its binding partner POT1 191-195. The main function of TPP1 is to link TIN2 and
POT1 193,195,196. Interestingly, although POT1 contains two
oligonucleotide/oligosaccharide-binding (OB) folds that are highly specific for the singlestranded telomeric sequence 5’-(T)TAGGGTTAG-3’, its recruitment to chromosome
ends is not dependent on its ability to bind to the 3’telomeric overhang. Instead, the
association of POT1 with telomeres is mediated through its interaction with TPP1 (Figure
1.5). Indeed, it has been shown that in the absence of TPP1, POT1 is not recruited to
chromosome ends and the phenotypes mirror POT1 loss.
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Whereas human cells contain one POT1 gene, mouse cells have two POT1 genes
– POT1a and POT1b 197,198. Both proteins associate with telomeres and share similar
sequences and domain structures. However, they are not functionally redundant. While
POT1a is an essential gene, as its deletion leads to early embryonic lethality, POT1bdeficient mice are viable 197.
The sixth shelterin component, RAP1, is a binding partner of TRF2 (Figure 1.5)
199

. The interaction between the two factors is required for the recruitment of RAP1 to

telomeric DNA and is essential for the stability of RAP1 protein levels 190,199.
Taken as a whole, the intricate interconnections between the different members of
shelterin ensure that the complex has high affinity and specificity for telomeric DNA.
Indeed, shelterin is highly abundant exclusively at telomeres and its known functions are
restricted to telomere maintenance.
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Figure 1.5. Shelterin.
The shelterin complex consists of six subunits. TRF1 and TRF2 are dimers that specifically
recognize and bind to ds telomeric DNA with their Myb domains. The binding site for each TRF1
or TRF2 dimer can be overlapping or separate sequences as indicated. RAP1 is a TRF2 binding
partner. TIN2 can interact with both TRF1 and TRF2 and recruits TPP1 and POT1 to the ds
portion of the telomere. The ability of TIN2 to bind to both TRF1 and TRF2, independently or
simultaneously, creates the possibility for different shelterin subcomplexes as shown. The
TRF1/TIN2, TRF2/TIN2 and TRF1/TRF2/TIN2 shelterin subcomplexes could all potentially play
roles in the enrichment of TPP1/POT1 at ssDNA. The POT1 binding sequence at ssDNA can be
located at an internal site or at the 3’ end as indicated.

Telomere-associated proteins
In addition to shelterin, a number of other proteins have been detected at human
telomeres. Most of these factors are DNA damage signaling and repair molecules that
have been implicated to associate transiently with telomeres and to perform essential
accessory functions in telomere maintenance. However, all of these proteins have
primary functions that are independent from telomere biology. Examples of such factors
include the MRN complex 200; XPF/ERCC1 201, a component of the nucleotide-excision
repair pathway; Apollo 202,203, a putative 5’ exonuclease; DNA-PKcs 204,205; Ku70/80
204,206,207

; BLM and WRN RecQ helicases 208-211, implicated in branch migration of
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recombination structures; Rad51D 212, a factor with a potential role in homologous
recombination; and others. Deficiencies in some of these factors lead to abnormalities in
telomere structure and function and have been implicated in human diseases.
As described below, the main protective functions of shelterin are to mask
telomeres from recognition by the ATM and ATR signaling pathways and to prevent the
processing of chromosome ends by the HDR and NHEJ machineries. Therefore, it seems
paradoxical that factors involved in these pathways are specifically recruited to
telomeres. It is possible that their function is tailored in the context of shelterin to service
telomeres without activating their respective signaling and repair pathways.

Shelterin shapes telomeric DNA into a protected structure
3’ telomeric overhang
An important requirement for telomere protection is the generation of a 3’ overhang,
which POT1 binds to and which is an essential element of t-loop formation. Telomeric
overhangs arise from degradation of the terminal RNA primer laid down during lagging
strand synthesis as well as from additional resection of the C-rich strand 179,213. In most
human cells, the average length of the telomeric overhang is 50-300 nucleotides 214,215.
The nuclease responsible for telomere end resection has so far eluded identification.
Studies of POT1 genes in mouse and human cells suggested that POT1 function
might be required to regulate the resection activities of this nuclease(s). Strikingly,
deletion of mouse POT1b, but not POT1a, leads to extreme overhang elongation,
observed both in MEFs isolated from POT1b-deficient embryos and in liver samples
taken from adult POT1b-deficient mice 197. The increase in single-stranded TTAGGG
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repeats is attributed to excessive 5’-3’ nucleolytic activity and the resulting degradation
of the C-rich 5’ strand. Although POT1b-deficient mice are viable, the excessive loss at
the 5’ strand leads to progressive telomere shortening 216. Therefore, mouse POT1b, by
an unknown mechanism, functions to prevent de-regulated resection at the chromosome
terminus.
It has been speculated that human POT1 is also involved in regulating endprocessing events, since the precise 5’ end on the resected strand of human telomeres
(CCAATC-5’) is randomized upon downregulation of POT1 protein levels by RNAi
217,218

. These studies documented that human POT1 sets the 5’ end sequence, and,

similarly to mouse POT1b, implicated human POT1 in the regulation of nuclease(s)
activity at chromosome ends. The mechanism of overhang generation and maintenance
would be further clarified if the identity of the nuclease(s) responsible for the generation
of the 3’ telomeric overhang were known.

T-loop formation
Once the overhang is generated, the next step in telomere protection is thought to be the
formation of a lariat structure at the chromosome terminus, referred to as telomeric loop
(t-loop). In the t-loop configuration, the single-stranded telomeric DNA invades the
double-stranded portion of the telomere, displaces the G-rich strand, and base pairs with
the complementary strand. The predicted role of t-loops is to effectively shield the
chromosome end from nucleolytic attack and from recognition by DNA damage factors.
T-loops can be visualized directly by electron microscopy if the telomeric DNA
has been cross-linked to maintain the strand invasion 219. Analysis of the structural
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features confirms a strand invasion event, including the presence of the displaced singlestranded G-rich strand, which forms a displacement loop (D loop). The size range of tloops is heterogeneous and roughly correlates with the total telomere length, suggesting
that the strand invasion takes place at a random site along the telomere duplex array 219.
Recently, electron microscopy analysis of whole telomere chromatin isolated from
chicken erythrocytes and mouse splenocytes further revealed the presence of intact
nucleosome arrays along the t-loop structures 220. The current model argues that t-loops
are probably present at all chromosome ends, throughout the cell cycle, except perhaps
temporarily during S-phase when the passage of the replication machinery would release
the invading strand, thereby revealing a naked or POT1-bound single-stranded DNA end.
Both TRF1 and TRF2 have been implicated in t-loop formation. In vitro data
suggest that TRF2 has the ability to remodel DNA 219,221 and biochemical analysis further
suggests that TRF2 has the ability to modify DNA topology and more specifically, to
induce untwisting of neighboring DNA, thereby promoting strand invasion 222. TRF1 also
has in vitro DNA remodeling capacity including ability to bend, loop and pair distant
regions containing telomeric repeats 183,186,187. It is also likely that some of the telomereassociated factors described above may also participate in t-loop assembly. In particular,
the MRN complex and BLM helicase have the functional requirements to promote t-loop
formation and/or resolution but experimental evidence in support of this hypothesis is
lacking.
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Suppression of the ATR-dependent DNA damage response at telomeres
Stretches of single-stranded DNA are recognized as sites of damage by the ATR
pathway. The ATRIP/ATR complex is recruited to RPA-coated single-stranded DNA
with the help of TOPBP1, the 9-1-1 complex, Rad17, and RFC 223-226. The ATR kinase
induces cell cycle arrest through the phosphorylation and activation of the downstream
checkpoint kinase Chk1 227.
Telomeres also contain stretches of single-stranded DNA even when the 3’
overhang is base-paired as in the t-loop configuration because the D-loop is exposed and
can potentially recruit RPA and activate the ATR pathway 219. Recent data in mouse and
human cells have established that telomeres can indeed activate ATR signaling and that
POT1 is the shelterin component that prevents the activation of the ATR pathway at
telomeres (Figure 1.6) 228. Conditional deletion of POT1a in MEFs, knockdown of its
recruiter, TPP1, or downregulation of human POT1 by RNAi lead to acute activation of
the DNA damage response at chromosome termini 197,198,229. This response is
characterized by activation of the ATR-dependent signaling pathway, as evidenced by
Chk1 phosphorylation, which is not observed in absence of ATR. In addition, ATR
mediates the accumulation of DNA damage response factors, including γ-H2AX, MDC1,
MRN, and 53BP1, in telomeric foci, called telomere dysfunction-induced foci (TIFs)
197,198,228

. These findings suggest that POT1 protects chromosome ends from recognition

by the ATR-dependent DNA damage response pathway. One possibility is that POT1,
which binds to single-stranded telomeric DNA with high specificity and affinity, can
prevent the activation of DNA damage by displacing the single-stranded DNA sensor in
the ATR pathway, RPA, from telomeric sequences.
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Suppression of the ATM-dependent DNA damage response at telomeres
TRF2, on the other hand, is responsible for the suppression of the ATM pathway (Figure
1.6) 228. ATM kinase, as discussed in part I of this chapter, responds primarily to the
presence of DSBs and its principal downstream effector is the Chk2 kinase 30. When
TRF2 is deleted from MEFs bearing one null and one conditional allele of TRF2
(TRF2F/-), the protective function of telomeres is lost and chromosome ends are
recognized as DSBs. Mounting evidence indicates that the consequences of TRF2 loss
are identical to the events activated in response to DSBs. They involve the dramatic
accumulation of a number of DNA damage response factors, including γ-H2AX, MDC1,
53BP1, and the MRN complex, at chromosome ends to form TIFs 190. In addition, loss of
TRF2 leads to activation of ATM-dependent checkpoint signaling as evidenced by the
detection of ATM, autophosphorylated at S1981, and by the phosphorylation and
activation of Chk2 kinase. The response to telomere dysfunction in cells lacking TRF2 is
entirely dependent on ATM function. Dysfunctional telomeres in TRF2- and ATM-null
cells are not associated with TIFs and do not trigger a checkpoint response 228. These data
establish that the ATM pathway is uniquely positioned to recognize and respond to loss
of TRF2 function.
Telomere dysfunction can also be induced in human cells when the function of
human TRF2 is suppressed as a result of the overexpression of a dominant negative allele
of TRF2, which lacks the amino-terminal basic and the carboxy-terminal Myb domains
(TRF2-DN) 230. TRF2-DN dimerizes with the endogenous protein but since it lacks the
DNA binding domain, the resulting heterodimer does not localize to telomeres. In
addition to activating the DNA damage response 83 as described above, overexpression of
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TRF2-DN results in p53-dependent cell cycle arrest or apoptosis, depending on the cell
type 231,232. In human cells, however, the response to TRF2-DN-induced telomere
dysfunction is not entirely dependent on ATM kinase, as a reduced number of TIFs can
still form in A-T cells. One possible explanation for the inconsistency between mouse
and human cells is that complete loss of TRF2 and inhibition of TRF2 function through a
dominant negative allele may have different impacts on telomere structure.
There are several models for how TRF2 prevents the activation of ATM kinase at
functional telomeres. One possibility is that TRF2 is required to maintain the terminal tloop structure, which the ATM sensor, MRN, may not be able to recognize as a DSB. A
complementary model suggests that TRF2 directly inhibits the activation of ATM by
binding to ATM in a region that contains S1981 233. Presumably, since TRF2 is
exclusively enriched at chromosome termini and not elsewhere in the cell, ATM
activation would be specifically dampened in the vicinity of telomeres. Therefore, even if
telomeres present DNA structures that would normally signal to the ATM pathway,
TRF2 might locally suppress any downstream propagation.

Prevention of inappropriate NHEJ and HDR repair at chromosome ends
In addition to suppressing the activation of ATR and ATM signaling, shelterin efficiently
prevents inappropriate repair reactions at chromosome ends (Figure 1.6). The
consequences of aberrant repair processing of telomeres in human cells can be
deleterious. In particular, fused chromosomes, which have been joined end-to-end, are
dicentric and cannot properly segregate in mitosis. Instead, they propagate the bridge-
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breakage-fusion cycle 234, which can lead to extensive genomic instability as
chromosomes are broken and re-joined at random places during each cell division.
The role of shelterin in suppressing inappropriate repair at telomeres can be best
appreciated in the setting when loss of TRF2 function leads to uncapping of chromosome
ends. Upon inhibition of TRF2 – both in the TRF2 conditional knockout MEFs and upon
overexpression of the TRF2-DN allele in human cell – telomere-mediated protection is
lost and chromosome ends undergo extensive repair processing 190,230. The consequences
are striking. Metaphase spreads collected five days after deletion of TRF2 reveal that
many chromosomes have fused to one another, creating long trains, with the telomeric
DNA retained at the sites of fusion 190. Evidence for the involvement of the NHEJ
pathway came from genetic experiments, which showed that DNA ligase IV is required
for this process 190,235. In DNA ligase IV-deficient MEFs, the rate of NHEJ of TRF2depleted dysfunctional telomeres is reduced 100-fold compared to the rate of fusion of
dysfunctional telomeres observed in control cells. On the other hand, the requirement for
another NHEJ factor, Ku70, appears less stringent, since in the absence of Ku70 the rate
of NHEJ is reduced only 12-fold 236. Recently, it has been shown that the ATM kinase
also promotes the efficienty of NHEJ of dysfunctional telomeres 228.
NHEJ of dysfunctional telomeres in absence of TRF2 takes place preferentially
during the G1 stage of the cell cycle 237. Prior to or simultaneously with the fusion step,
the 3’ telomere overhangs are removed in a reaction stimulated by the XPF/ERCC1
endonuclease complex 201. Interestingly, in mouse cells overhang cleavage and endjoining are coupled 190, whereas in human cells, the two processes can occur
independently 230.
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Two models reason how TRF2 might prevent NHEJ-mediated processing of
telomeres. Overhang loss is a prerequisite for the execution of the NHEJ reaction and
therefore, one possibility is that TRF2 prevents inappropriate repair by hiding the
overhang into the t-loop structure. The circular configuration of t-loops would be
expected to prevent the first step of NHEJ – loading of the Ku70/80 complex – by
masking the free DNA end. Alternatively, it is possible that TRF2 prevents NHEJ repair
by suppressing ATM-mediated DNA damage signaling. Although DNA damage
signaling and repair have been viewed as largely separate processes, loss of TRF2 in
ATM-deficient MEFs does not lead to NHEJ 228. Therefore, TRF2 might repress NHEJ
by preventing the activation of ATM, which in turn is required for efficient NHEJ of
dysfunctional telomeres.
Interestingly, TRF2 plays a role in the repression of the HDR pathway as well. As
described above, dysfunctional telomeres resulting from TRF2 loss are repaired primarily
through the NHEJ pathway. However, in the absence of Ku70, deletion of TRF2 leads to
reduced overhang loss and diminished frequency of telomere fusion events. Instead,
extensive HDR between sister telomeres takes place, leading to numerous telomeric
sister-chromatid exchanges (T-SCEs) 236. It is important to note that increased HDR at
chromosome ends in this setting is not due to lack of NHEJ-processing, since T-SCEs are
not observed as a phenotype of TRF2 deletion from DNA-ligase IV-deficient cells. One
interpretation of these data is that, at functional telomeres, TRF2 together with Ku
actively suppresses T-SCEs in order to prevent drastic telomere length changes that
would be an inevitable consequence of unequal exchanges.
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Figure 1.6. Shelterin protects chromosome ends from recognition by the DNA damage
signaling and repair machineries.
TRF2 complex inhibits the activation of the ATM pathway and prevents NHEJ of telomeres
(left). In the absence of TRF2, ATM is activated and phosphorylates Chk2 kinase, which in turn
promotes the p53/p21 pathway, leading to senescence or apoptosis, depending on the cell type.
Active ATM kinase also leads to the accumulation of multiple TIF factors at chromosome ends.
The overhang is cleaved in a reaction dependent on the XPF/ERCC1 endonuclease, the Ku70/80
complex is loaded on the DNA ends to promote DNA ligase IV-executed fusion reaction.
Chromosome end-to-end fusions can be deleterious as they lead to the formation of dicentric
chromosomes that cannot be segregated properly during mitosis. On the other hand, POT1 (bound
along the overhang or on the D loop) suppresses the ATR signaling pathway (right). Upon loss of
POT1, ATR is activated and in turn phosphorylates and activates the downstream Chk1 kinase. In
the absence of TRF2, ATM and POT1 in mouse cells, ATR activation also promotes the NHEJ
pathway.
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Advantages of dysfunctional telomeres as a model for NHEJ
In the studies described in this thesis work, we use telomere dysfunction, experimentally
induced by the deletion of the telomere protective factor TRF2, as a model system to
study the regulation of the NHEJ pathway by DNA damage response factors. We focus
on the roles of the MRN complex (Chapter 2), γ-H2AX/MDC1 (Chapter 3), and 53BP1
(Chapters 4 and 5).
Dysfunctional telomeres exhibit multiple features that make them an
advantageous model for the study of DNA repair. In the first place, damage signaling and
repair occur in a largely synchronized fashion following Cre-mediated deletion of TRF2
from TRF2F/-p53-/- MEFs 190. TIF formation and activation of checkpoint factors can be
detected 48-72 hours after Cre expression, whereas progressive repair of dysfunctional
telomeres can be monitored 72-120 hours after Cre-mediated TRF2 deletion. The absence
of p53 or SV40-LT-mediated inhibition of p53 function prevent the activation of the
G1/S checkpoint 232, allowing analysis of the consequences of telomere dysfunction over
several cell divisions.
In the second place, loss of TRF2 induces DNA damage response at all
chromosome ends 190. These sites feature known molecular markers both in the presence
and in the absence of TRF2 function, namely the repetitive TTAGGG DNA and other
shelterin components, such as TRF1. This allows immunofluorescence (IF), live-cell
imaging, FISH (fluorescent in situ hybridization), and ChIP (chromatin
immunoprecipitation) analysis of the molecular events at the same sites before and after
the induction of damage.
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In the third place, TRF2 deletion activates specifically the ATM pathway,
allowing investigation into the identity of the sensor in this pathway 228.
In the fourth place, NHEJ of dysfunctional telomeres takes place gradually, over
several days, so that its rate can be reproducibly measured. In addition, NHEJ-mediated
repair of dysfunctional telomeres occurs primarily during the G1 stage of the cell cycle
237

. Therefore, the determinants for this cell cycle specificity can be addressed.
Finally, the response to dysfunctional telomeres is indistinguishable from the

response to chromosome-internal DSBs, arguing that a novel mechanism found to
contribute to NHEJ repair of dysfunctional telomeres may also play a part in the repair of
chromosome-internal DSBs 83,190,230,231,235,236.
In this thesis, I define the relative involvement of the MRN complex, γ-H2AX,
MDC1, and 53BP1 in the NHEJ pathway at dysfunctional telomeres and propose a
unifying mechanism for their role in repair.
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CHAPTER 2: DISSECTING THE ROLE OF
MRE11/RAD50/NBS1 COMPLEX AT FUNCTIONAL AND
DYSFUNCTIONAL TELOMERES
Introduction
The MRN complex has been implicated in multiple aspects of telomere function and in
the first part of this chapter we explore the role of MRN at functional telomeres. An
association between MRN and the TRF2 complex has been well-documented 200,
although the mechanism and the functional importance of this interaction have remained
unclear. Recent studies have implicated NBS1 as an accessory component for telomerasemediated telomere extension 238 and suggested a role for the MRN complex in overhang
maintenance in telomerase-positive cells 239. Given the role of MRN complex in HDR, it
has further been proposed that MRN might play a role in the generation of the telomeric
overhang and/or promote t-loop formation 240. On the other hand, as described in the
introduction, MRN most likely functions as the DSB sensor in the ATM pathway. An
association, therefore, between MRN and functional telomeres seems counterintuitive,
since the primary goal of telomeres is to prevent the DNA damage response at natural
chromosome ends.
In order to address these functional questions, we aimed at understanding the
mechanism of MRN recruitment to functional telomeres. We tested a potential model for
the interaction between NBS1 and TRF2, and in the beginning of this chapter we describe
some of the experimental limitations we encountered. We also report evidence that the
MRN complex might play a regulatory role in overhang generation/maintenance but is
not otherwise required for the function and structure of mouse telomeres.
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The MRN complex also localizes to telomeres rendered dysfunctional through
depletion of TRF2 from chromosome ends 83,190,190. In the second part of this chapter, we
asked whether MRN is required for the activation of the ATM-dependent DNA damage
response at deprotected telomeres. Previous data on the response to telomere dysfunction
in human cells have already hinted that the MRN complex might be the sensor.
Treatment with the PIKK inhibitor caffeine, which effectively disrupts the recruitment of
53BP1 to TIFs, does not prevent the accumulation of Mre11 at TRF2-depleted telomeres
83

, arguing that the recruitment of MRN is kinase-independent. However, in human cells,

the response to telomere dysfunction induced by a dominant negative allele of TRF2,
TRF2-DN, is not entirely dependent on ATM since in A-T cells the TIF response is only
mildly reduced 83. The redundancy of the kinase, which signals telomere dysfunction in
human cells, complicates the analysis of MRN’s contribution. Here, we focus on mouse
cells, in which the requirement for ATM kinase in the response to telomere dysfunction
elicited by loss of TRF2 has been genetically established 228. We undertook several
independent approaches in order to dissect the role of the MRN complex, including
chemical inhibition, RNAi to MRN and to factors closely associated with MRN, as well
as genetic knockout of the MRN component, NBS1. Ultimately, the main conclusions
came from the genetic analysis, which exposed key roles for MRN in signaling as well as
in repair of dysfunctional telomeres.
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The interaction between MRN and TRF2 is enhanced in the absence of a
phosphorylation event
The interaction between endogenous MRN and TRF2 complexes can be weakly but
reproducibly detected by immunoprecipitation of nuclear extracts isolated from human
cells 200. With this technique, roughly 1-5% of total TRF2 can be recovered with an
Mre11-specific antibody. We asked whether phosphorylation plays a role in promoting
this association by adding phosphatase inhibitors to the nuclear extract. We saw the
opposite result by immunoblot – TRF2 was absent from the Mre11 immunoprecipitate in
the presence of the phosphatase inhibitors NaF and β-glycerophosphate (Figure 2.1a),
suggesting that a phosphorylation event strongly inhibits the association.
Recently, the structural basis for the interaction between TRF2 and a telomereassociated nuclease Apollo has been determined 241. The crystal structure reveals a close
contact between a loop located in the TRFH domain of TRF2 and a Y-x-L-x-P motif in
Apollo (Figure 2.1b). Indeed, a mutant of Apollo in which this motif is changed to Y-xE-x-A no longer associates with TRF2, and vice versa, mutation of the critical residue in
TRF2 (F120) abolishes the Apollo-TRF2 interaction. As NBS1 contains a Y-x-L-x-P
motif at amino acid position 429 242, we asked whether it might be a point of contact
between the MRN complex and TRF2. In NBS1, this motif contains a serine residue, Yx-L-S-P, creating a potential CDK phosphorylation site. Structural modeling predicts that
phosphorylation at this site (S432 in human; S433 in mouse NBS1) would lead to a steric
clash with the TRFH domain, consistent with our findings above that phosphorylation
inhibits the MRN-TRF2 interaction.
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Unpublished data from two groups (S. Jackson, pers. comm. and J. Petrini and R.
Fisher, pers. comm.) have identified S432 of human NBS1 (S433 in mouse NBS1) as a
CDK2 target that is preferentially phophorylated during the S and G2 stages of the cell
cycle. Moreover, phosphorylation at that particular residue has been implicated in
promoting resection during HDR-mediated repair of DSBs. Interestingly, while Mre11
and Rad50 remain associated at human telomeres throughout the cell cycle, NBS1 is
preferentially recruited to telomeres only in S phase. If NBS1 indeed binds to TRF2
through the Y-x-L-S-P motif, such an interaction can only occur in absence of S432
phosphorylation, suggesting a potential model for how TRF2 might be regulating the
DNA damage response function of MRN. In this model, NBS1 bound to TRF2 would be
kept in an inactive, de-phosphorylated form, preventing ATM activation as well as
unwanted resection at chromosome termini. At the same time, MRN might be employed
in promoting a different aspect of telomere function.
In order to test this model, we wished to study the interaction of TRF2 with
various versions of human and mouse NBS1, bearing relevant mutation at S432/S433.
However, we were unable to perform any functional analysis because the expression
levels of tagged NBS1 transiently transfected into 293T cells were very low (at least 100fold below endogenous levels). We could not overexpress human or mouse NBS1 in
293T cells even when the other members of the complex, Mre11 and Rad50, were cotransfected. Since the presence of an N-terminal tag might affect expression levels, we
tried a C-terminal tag or no tag at all, but did not observe a higher level of expression. We
also cloned NBS1 into a vector that contained a chimeric intron, pCi, in case transcription
was splice-dependent, without any success in bolstering protein levels. Finally,
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expression levels of exogenously introduced NBS1 remained low even in Cre-treated
NBS1F/- cells that lacked endogenous NBS1 (Figure 2.1c), arguing against a model in
which the total levels of NBS1 within a cell are strictly regulated. Because of low protein
levels, even in the case of exogenously introduced wild-type NBS1, we could neither
detect an association with telomeric proteins by co-IP nor recover telomeric DNA by
ChIP (Figure 2.1d), precluding further analysis of mutants.
Successful expression of exogenous human NBS1 in cells derived from NBS
patients has been previously shown on immunoblots 243. However, it is not excluded that
the reported expression of NBS1 in human NBS cells failed to reach wild type expression
since these experiments lacked the internal control for normal NBS1 levels. As shown
here (Figure 2.1c), the expression of NBS1 protein was also detectable in immunoblots of
Cre-treated NBS1F/- mouse cells but the NBS1 levels were substantially reduced
compared to the endogenous protein. Importantly, although we could detect protein
expression, it was not enough for functional analysis by ChIP. In addition, expression of
exogenous NBS1 was lost over time and thus we could not stably rescue Cre-treated
NBS1F/- cells. Recently, several groups have used fluorescently tagged NBS1 in live-cell
imaging experiments 109. These constructs seem expressed at normal levels, and
importantly, appear to be functional at least in terms of localization to DSBs. It is
therefore prudent to test whether the presence of a fluorescent protein tag stabilizes NBS1
protein and enhances its expression levels so that the planned experiments can be done.
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Figure 2.1. Mechanistic insight into the interaction between MRN and TRF2 complexes
a, Immunoblot of IPs from HeLa1.2.11 nuclear extracts, incubated with pre-immune serum,
human Mre11- (874), or human TRF2 (647)-specific rabbit Abs, in the presence or absence of the
phosphatase inhibitors 10 mM NaF and 50 mM β-glycerophosphate. 1% cell extract was loaded
as control for input. TRF2 IP was used as a positive control for the efficiency of the IP. The blot
was probed with a mouse monoclonal Ab raised against human TRF2.
b, Schematic representation of the TRF2 complex, highlighting the critical F120 residue in the
TRFH domain of TRF2, which mediates the interaction with the Y-x-L-x-P motif in Apollo and,
potentially, with the same motif in NBS1 from the MRN complex.
c, Immunoblot of whole cell lysates prepared from NBS1F/- MEFs or NBS1F/- MEFs, stably
expressing the following N-terminally FH2-tagged constructs from pLPC-puro expression vector:
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NBS1-WT (wild type), NBS1-S433A, or NBS1-S433E, retrovirally infected with pWzl-hygro
vector or pWzl-hygro-Cre, and harvested after 6 days of hygromycin selection. The blot was
probed with a mouse NBS1-specific Ab (93’6). A non-specific band from the same blot was used
a loading control.
d, Dot blot of telomeric DNA ChIP of nuclei prepared from NBS1F/- cells rescued with WT,
S433A, or S433E NBS1 and treated with pWzl-hygro-Cre to delete the endogenous protein, as
shown in (c). The following Abs were used for ChIP: pre-immune, HA (11), FLAG (M2), NBS1
(93’6), and TRF2 crude serum (647). Telomeric DNA was detected by hybridization to a
TTAGGG repeat-specific, radioactively labeled probe. 25% input labeled as Total.

MRN complex plays a regulatory role in overhang processing
Next we asked whether MRN plays a structural and functional role at mouse telomeres.
We analyzed SV40-LT transformed, NBS1 conditional knockout MEFs (NBS1F/-) 137,244.
Although NBS1 is an essential gene, SV40 transformed cells can survive up to 10 days
after deletion of NBS1 with Cre, allowing the long-term analysis of NBS1 loss. At early
(3-4 days post Cre) as well as at late (8-10 days post Cre) time points, we did not find any
evidence for telomere dysfunction in absence of NBS1. We did not detect TIFs at
chromosome ends in more than 200 cells examined by immunofluorescence and we did
not observe enrichment for end-to-end fusions or T-SCEs on metaphase spreads.
Previously published data examining the effect of MRN RNAi in human cells
reported transient shortening of G-overhang upon knockdown of MRN components 239.
This effect, however, was only observed in telomerase expressing cells, arguing for a role
of MRN in telomerase-mediated overhang regulation rather than in overhang
maintenance per se. We examined the effect of NBS1 loss on overhang structure in
NBS1F/- MEFs harvested at consecutive time-points after Cre-mediated deletion of the
conditional allele and analyzed by overhang assay. In this assay, the 3’ telomeric
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overhang is detected in-gel, under native conditions, with a telomere-specific probe. The
single-stranded signal is then normalized to the total telomeric DNA signal quantified on
the same gel after denaturation. The relative value represents the change in overhang
signal compared to control. While in one overhang assay, we saw a progressive increase
in relative overhang signal in the absence of NBS1 (Figure 2.2a), in an independent
experiment, we saw no significant change in the relative overhang signal up to 10 days
after deletion of NBS1 from NBS1F/- MEFs (Figure 2.2b). The latter result was confirmed
in a subsequent experiment (Figure 2.2c), indicating that the MRN complex is not
essential for overhang maintenance.
Loss of NBS1, on the other hand, appeared to diminish the overhang increase
associated with inhibition of POT1b function. As described in the introduction, POT1b
protects chromosome termini from nuclease-dependent degradation 197,216. To test
whether NBS1 plays a role in the pathway triggered in absence of POT1b, we used a
dominant-negative allele of POT1b function as a tool to induce aberrant overhang
elongation 245. POT1-HA is a chimeric protein that is composed of the N-terminal half of
human POT1 and the C-terminal half of mouse POT1a. The resulting fusion protein acts
as a dominant-negative allele because it localizes at mouse telomeres but lacks a segment
from POT1b that is required to prevent excessive nuclease activity 245. We introduced
POT1-HA into NBS1F/- MEFs and assayed for overhang signal with or without Cremediated NBS1 deletion (Figure 2.2c). NBS1 loss by itself did not affect overhang length
in this experiment. As an additional control, overexpression of POT1-HA led to a 3-fold
increase in overhang signal in NBS1-proficient cells, confirming its role as a dominantnegative allele. In NBS1-deficient cells, on the other hand, we observed only a 2-fold
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increase in the intensity of the relative overhang signal upon POT1-HA overexpression.
The 30% reduction in overhang signal in the absence of NBS1 establishes a potential
regulatory role for NBS1 in overhang processing. On the other hand, the incomplete
reversal of the dominant negative effect implies the presence of redundant pathway(s).
The identity of the nuclease(s) that resect telomeric DNA upon POT1b inhibition
is not known, and it might or might not be the nuclease that is also responsible for
overhang generation under normal circumstances. The data presented here suggested that
NBS1, as part of the MRN complex, might be involved in regulating this nuclease
activity. An obvious potential candidate for such nuclease is CtIP, which has been
demonstrated to function in conjunction with the MRN complex.
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Figure 2.2. Role of NBS1 in the maintenance of the telomeric 3’ overhang

60

Figure 2.2. Role of NBS1 in the maintenance of the telomeric 3’ overhang
a-c, In-gel detection of telomeric DNA from cells, described below. DNA in agarose plugs was
separated on agarose gel by pulse-field gel electophoresis and hybridized in-gel to a radioactively
labeled (CCCTAA)4 probe (native). The DNA was denatured in situ and rehybridized to the same
probe (denatured). In each lane, the ssTTAGGG signal quantified under native condition was
normalized to the total TTAGGG signal, detected after denaturation.
a, NBS1F/- cells were harvested 4, 5, 6, and 7 days after introduction of pWzl-hygro vector or
pWzl-hygro-Cre introduced by 4 retroviral infections, delivered at 12 hour intervals and followed
by hygromycin selection. The relative overhang signal represents the normalized ssTTAGGG
signal in Cre-treated cells (in red), compared to control, vector-treated cells (set at 100%, in
black) at each time point.
b, same as in (a) but cells were collected 2, 4, 6, 8, and 10 days after Cre infection.
c, NBS1F/- cells were infected with pWzl-hygro vector or pWzl-hygro-Cre introduced via 3
retroviral infections at 12 hour intervals, followed by retroviral infections with vector or POT1HA dominant negative allele, composed from N-terminal half of human POT1 and the C-terminal
half of mouse POT1a 245, expressed from pWzl-hygro, introduced via 3 consecutive retroviral
infections. At that point cell were placed under hygromycin selection. Cells were harvested 4 or 6
days after the second round of infections. The overhang signals are normalized to vector-treated,
NBS1-proficient controls at each time point. The numbers in red below the arrows indicate the
effect of NBS1 deficiency on POT1-HA-induced overhang signal increase.
* NBS1 deletion was not complete at the indicated time points in (b) and (c).
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No evidence for a role of CtIP in overhang processing and in the repair of
dysfunctional telomeres
As described in the introduction, CtIP, the human homolog of Sae2, is a putative nuclease
that, as a part of the MRN complex, promotes the initial resection step in HDR of
DSBs 63,144,246. This resection step is regulated by CDK activity and displays cell cycle
specificity for the S and G2 stages of the cell cycle 58. We were interested in the potential
roles CtIP nuclease might play in overhang generation at functional telomeres and in the
repair of dysfunctional telomeres.
We tested whether CtIP is the nuclease responsible for overhang generation at
functional telomeres. We assayed the telomeric overhang signals at 6 and 8 days after the
introduction of two CtIP-specific shRNAs144. Both shRNAs reduced CtIP protein levels
efficiently, as evidenced by diminished CtIP signals in immunoblots (Figure 2.3a).
Downregulation of CtIP, however, did not affect the relative overhang signal at
functional telomeres (Figure 2.3b), arguing against CtIP as the only nuclease required for
overhang generation. A genetic knockout would be required to further substantiate this
conclusion.
We next asked whether CtIP played a role in the processing of dysfunctional
telomeres. We based our analysis on experimental evidence obtained from analysis of
chromosome internal DSBs, where it has been proposed that CtIP, together with the
MRN complex, promotes resection in the S and G2 stages of the cell cycle and stimulates
HDR. Interestingly, in experiments designed to address the proficiency of fission yeast
cells lacking Ctp1 (S. pombe homolog of Sae2/CtIP) to execute HDR and NHEJ, the
former repair pathway was found to be impaired, while the efficiency of the latter
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appeared enhanced 60. These results led Takeda and colleagues to propose a model where
HDR is stimulated in S/G2 by increased resection at DSBs 60. NHEJ, on the other hand, is
limited to G1, because in G2 high levels of CDK activity promote end-processing. A
prediction of this model is that if resection were artificially inhibited through CtIP or
MRN downregulation, NHEJ could be potentially activated in G2.
We were interested in testing this model at TRF2-depleted mouse dysfunctional
telomeres, which are known to be subject to NHEJ repair preferentially in G1 237.
Interestingly, G2 fusion events of dysfunctional telomeres can be promoted by CDK
inhibition with roscovitine 237. This experimental evidence supported a model where
NHEJ could in principle occur in G2, but is suppressed by CDK activity. Analysis of the
interplay between HDR and NHEJ pathways at dysfunctional telomeres is, however,
complicated by the initial presence of 3’ telomeric G-overhangs, which are removed by
an endonuclease cut prior to or concomitant with the NHEJ-mediated fusion. The
removal of the telomeric overhang is thought to occur in G1, since overhang loss and
end-joining reactions are coupled in mouse cells Therefore, the 3’ overhang is most likely
present in S/G2, when NHEJ is normally suppressed. Mechanistically, it is not clear what
prevents HDR from engaging dysfunctional telomeres containing 3’ overhangs during
S/G2, but it has been previously established that this is not the case. To avoid these
complications, in our analysis we only focused on whether the cell cycle specificity of
NHEJ of dysfunctional telomeres is determined by CtIP without addressing the role of
CtIP in HDR and resection.
To address whether CtIP function regulated the cell cycle specificity of NHEJ of
TRF2-depleted mouse dysfunctional telomeres, we introduced two independent CtIP-
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specific shRNAs into TRF2F/-p53-/- MEFs and analyzed metaphase spreads 84 hours post
adenoviral Cre infection (Figure 2.3c). We scored for G1 and G2 fusions of dysfunctional
telomeres. G1 fusions appear as chromosome-type fusions on metaphase spreads (see
schematic in Figure 2.3d). Because they occurred prior to replication, both of the arms
from one chromosome are fused to the sister telomeres on another. In contrast, chromatid
fusions, where one of the sister chromatids fuses to the arm of a different chromosome,
and sister fusions, where both sisters fuse intrachromosomally, (see schematic in Figure
2.3d) are indicative of post-replicative, G2 NHEJ events. As mentioned above, G1
fusions are predominant upon TRF2 deletion, whereas G2 fusions are less frequent. Both
in control and in CtIP shRNA-treated cells, there were 35-39% chromosome type-fusion
events per chromosome end and a significantly smaller fraction of the chromosome ends,
3-5%, were engaged in chromatid- and sister-type fusions (Figure 2.3d). These results
argued against a role for CtIP in determining the cell cycle specificity of NHEJ-mediated
repair of dysfunctional telomeres. In addition, CtIP downregulation did not affect the loss
of the telomeric G-overhang (Figure 2.3b), which is another major consequence of TRF2
deletion that precedes or coincides with the fusion reaction, further establishing that CtIP
does not play a role in NHEJ of dysfunctional telomeres. It is possible that analysis of
CtIP knockout cells may be required to detect a functional phenotype.
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Figure 2.3 Effect of CtIP downregulation on functional and dysfunctional telomeres
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Figure 2.3 Effect of CtIP downregulation on functional and dysfunctional telomeres
a, Immunoblots of whole cell lysates, prepared from TRF2F/-p53-/- MEFs expressing vector or
mouse CtIP-specific shRNA, sh1 or sh2, from pSuperior retroviral expression vector. Cells were
harvested 4 or 6 days after shRNA infections (Left) or 60 hours post mock or adenoviral Cre
infections delivered 4 days after the shRNA infections (Right). The blots were probed with Abs
raised against human CtIP (H-300) and human TRF2 (647). Astericks indicate non-specific bands
in the CtIP immunoblot. A non-specific band from the TRF2 blot was used as a loading control.
b, In-gel detection of telomeric DNA from cells, treated as in (a). DNA in agarose plugs was
separated on agarose gel by pulse-field gel electophoresis and hybridized in-gel to a radioactively
labeled (CCCTAA)4 probe (native). The DNA was denatured in situ and rehybridized to the same
probe (denatured). In each lane, the ssTTAGGG signal quantified under native condition was
normalized to the total TTAGGG signal, detected after denaturation. The relative overhang signal
in red represents the overhang signal in shRNA-treated cells, compared to control, vector-treated
cells (set at 100%, in black) at each time point, indicating the effect of CtIP knockdown on 3’
overhang at functional telomeres. The relative overhang signal in green represents the overhang
signal in Cre-treated cells, compared to mock-treated cells (set at 100%, in black) at each time
point. These values demonstrate the effect of CtIP knockdown on overhang loss following TRF2deletion.
c, Metaphase spreads of TRF2F/-p53-/- cells expressing vector or CtIP-specific shRNA, sh1 or
sh2, harvested 84 hours after adenoviral Cre infection and processed for FISH with telomerespecific FITC-OO-(AATCCC)3 oligonucleotide (green); DNA is counterstained with DAPI (red).
d, Table summarizing the percentage of chromosome- and chromatid-type fusions scored per
chromosome end (n≥1000) in metaphases in (c). Schematic diagrams provide visual descriptions
for each type of fusion and desribes the scoring method.
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Testing MRN function at telomeres with a small molecule inhibitor, mirin
Since inhibition of individual components of the MRN pathway did not reveal a possible
role for this complex in telomere function, we sought a more general way of inhibiting
the MRN complex. Mirin is a small molecule that was isolated from a chemical screen
for inhibitors of the ATM pathway 247. Instead of affecting ATM kinase activity, mirin
was found to inhibit the MRN-dependent activation of ATM. As a consequence,
mammalian cells treated with mirin exhibit impaired G2/M checkpoint response and
homology-dependent repair defects. In vitro, mirin was found to inhibit the nuclease
activity of the MRN complex but the relevance of this inhibition to the ATM pathway has
not been established 247.
In our experiments, treatment with mirin led to a profound defect in cell growth
(after 6 days in culture mirin-treated cells had undergone 5.2 population doublings versus
9.9 population doublings for the control cells). Impaired growth, however, was not due to
telomere dysfunction. Treatment with mirin did not induce TIFs, and did not lead to
detectable abnormalities in telomere structure on metaphase spreads or in overhang
assays. The integrity of telomeres in the presence of mirin indicated that the function of
the MRN complex that is affected by mirin does not play a major role at telomeres.
We also tested whether mirin affected the response to telomere dysfunction by
introducing mirin into Cre-treated TRF2F/-p53-/- MEFs. As the response to TRF2 loss is
entirely ATM-dependent, we expected a significant effect. Mirin, however, did not affect
the accumulation of γ-H2AX and 53BP1 at dysfunctional telomeres (Figure 2.4a). In
contrast, the association of NBS1 with dysfunctional telomeres seemed to be stabilized in
the presence of mirin (Figure 2.4a), which is consistent with previous data showing that
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mirin stimulates MRN-dependent DNA tethering in vitro 247. The functional basis for this
increased association is not clear, but it has been suggested that in the presence of mirin,
the MRN complex cannot dissociate from DNA 247.
We also noted a slight effect of mirin on NHEJ of dysfunctional telomeres (Figure
2.4b). While control cells lost 40% of their telomeric G-overhang at 72 hours post Cremediated TRF2 deletion, mirin-treated cells lost a comparable amount of overhang signal
(33%) with a delay of 24 hours, at 96 hours post Cre infection. Furthermore, there
appeared to be fewer fusions on metaphase spreads prepared from mirin-treated cells
compared to control cells (Figure 2.4c). However, due to the growth defect associated
with mirin treatment, there were not enough metaphases to score the number of fusions
reliably.
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Figure 2.4. Effect of MRN inhibitor, mirin, on the response to telomere dysfunction
a, Bar graph presenting percentage of cells (n≥100), which contained 10 or more IF signals that
co-localized with the TTAGGG-repeat specific FISH probe. TRF2F/-p53-/- MEFs, infected with
Hit&Run Cre retrovirus and grown in the absence or in the presence of 50 µM mirin, added to the
medium 12 hours after the last infection, were fixed 72 hours post Cre and processed for IF-FISH.
IF was performed with Abs raised against γ-H2AX, 53BP1 (100-304), or NBS1 (93’6). Telomeric
DNA was detected in FISH with a telomere-specific FITC-OO-(AATCCC)3 probe.
b, In-gel detection of telomeric DNA from cells, described below. DNA in agarose plugs was
separated on agarose gel by pulse-field gel electophoresis and hybridized in-gel to a radioactively
labeled (CCCTAA)4 probe (native). The DNA was denatured in situ and rehybridized to the same
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probe (denatured). In each lane, the ssTTAGGG signal quantified under native condition was
normalized to the total TTAGGG signal, detected after denaturation. Lane 1-6 (-Cre): TRF2F/p53-/- MEFs were mock treated or incubated with 50 µM mirin for 3, 6 or 9 days to analyze the
effect of mirin on overhang signal at functional telomeres. The relative overhang signal (in red)
represents the overhang signal in mirin-treated cells, compared to control, mock-treated cells (in
black) at each time point. Lane 7-10 (+Cre): To assay for the role of MRN in the processing of
dysfunctional telomeres, TRF2F/-p53-/- MEFs were treated with Cre for 72 or 96 hours in the
presence or absence of 50 µM mirin. The overhang signal at 72 and 96 hours post Cre is
normalized to the signal in –Cre cells collected at day 3 post mock or mirin treatment.
c, Examples of metaphase spreads of TRF2F/-p53-/- cells, treated or untreated with 50 µM mirin,
harvested 72 or 96 hours after Hit&Run Cre infections and processed for FISH with telomerespecific FITC-OO-(AATCCC)3 oligonucleotide (green); DNA was stained with DAPI (red).

NBS1 is required for ATM-dependent response to telomere dysfunction
Since the experiments with mirin-mediated MRN inhibition led to inconclusive results,
we decided to address genetically the role of the MRN complex in the response to
telomere dysfunction. We crossed TRF2F/F mice 190 with NBS1F/- mice 137,244 to generate
TRF2F/+NBS1F/+ and TRF2F/+NBS1+/- progeny. These were crossed again to obtain
TRF2F/FNBS1F/- and TRF2F/FNBS1F/+ litters. Crosses of these mice generated E13.5
mouse embryos, from which we isolated MEFs with TRF2F/FNBS1F/- and
TRF2F/FNBS1F/+ genotypes. MEFs were immortalized at passage 2 with SV40-LT to
abrogate the ability of these MEFs to arrest in G1/S after telomere deprotection 232.
Western blotting confirmed that treatment with Cre recombinase in TRF2F/FNBS1F/- led
to deletion of the NBS1 gene and, at the same time, resulted in TRF2 loss (Figure 2.5e).
In the control, TRF2F/FNBS1F/+ MEFs, Cre infection induced TRF2 deletion in the
presence of functional MRN complex (Figure 2.5e).
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As described in the introduction, the major consequence of TRF2 deletion is the
recognition of all chromosome ends as sites of DSBs by the ATM signaling machinery
228

. Using this system, we could, therefore, directly address whether or not NBS1 is

required for the activation of ATM kinase. First, we determined whether NBS1 behaves
as a sensor for DNA damage by scoring TIFs in TRF2F/FNBS1F/- and TRF2F/FNBS1F/+
cells 72 hours post Cre treatment (Figure 2.5a-c). We found that NBS1 is indeed required
for the activation of the DNA damage response machinery. In the presence of NBS1,
~90% of the cells scored positive for γ-H2AX, MDC1 and 53BP1 TIFs, whereas in cells
lacking NBS1, less than 1% contained damage foci at telomeres (Figure 2.5d). The
phenotype of NBS1 loss is more severe compared to observations made in MDC1deficient cells (see Chapter 3), in which γ-H2AX TIF formation was not significantly
affected. The difference demonstrates that unlike MDC1, which is involved in
amplification of the damage signal, NBS1 is required for its activation.
In addition to the effect on TIF formation, absence of NBS1 also resulted in
complete abrogation of checkpoint signaling. While in NBS1-proficient cells, we
detected robust Chk2 phosphorylation following Cre-mediated induction of telomere
deprotection; in NBS1-deficient cells, we failed to observe Chk2 activation even upon
efficient TRF2 deletion (Figure 2.5e). This phenotype is identical to observations made in
ATM-deficient cells 228 and establishes a critical role for NBS1 in the ATM signaling
pathway. On the other hand, there was no difference in cell proliferation between Cretreated TRF2F/FNBS1F/- and TRF2F/FNBS1F+ (Figure 2.5f), demonstrating that the
absence of DNA damage response and lack of checkpoint activation in NBS1-deficient
MEFs was not due to defects in cell cycle progression. In sum, the complete lack of Chk2
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activation and TIF formation in NBS1-deficient cells support the conclusion that the
MRN complex is the only sensor in the ATM pathway.
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Figure 2.5. Analysis of the contribution of NBS1 to the ATM pathway activated in response
to telomere dysfunction
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Figure 2.5. Analysis of the contribution of NBS1 to the ATM pathway activated in response
to telomere dysfunction
a-d, Representative examples of TRF2F/FNBS1F/- and TRF2F/FNBS1F/+, fixed 72 hours post
Hit&Run Cre retroviral infections and processed for IF-FISH. IF (in green) was performed with
Abs specific to γ-H2AX, mouse MDC1, and 53BP1 (100-304). Telomeric DNA was detected by
FISH (in red) with a TTAGGG-repeat specific FISH probe. DNA (in blue) was counterstained
with DAPI. Images were merged and enlarged.
d, Bar graph summarizing the average percentage of cells (n≥100), which contained 10 or more
53BP1 IF signals co-localizing with TTAGGG-specific FISH probe. IF-FISH was performed as
in (c) in TRF2F/FNBS1F/- and TRF2F/FNBS1F/+ MEFs, fixed 72 hours post mock or Hit&Run Cre
infections. Meand and s.d. from three independent experiments is indicated.
e, Immunoblots of whole cell lysates prepared from TRF2F/FNBS1F/- and TRF2F/FNBS1F/+ MEFs
harvested 72 hours post mock or Hit&Run Cre infections. Blots were probed with Abs raised
against mouse NBS1 (93’6), mouse TRF2 (1254), Chk2, and γ- tubulin (clone GTU; as loading
control).
f, Total cell numbers of TRF2F/FNBS1F/- and TRF2F/FNBS1F/+ MEFs, plated at 24 hours post
mock or 2 independent Hit&Run Cre retroviral infections and counted at 72, 96, and 120 hours
post Cre.
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NBS1 promotes NHEJ of dysfunctional telomeres
Previous data have indicated that ATM is required for NHEJ of TRF2-depleted
dysfunctional telomeres 228. Since our results demonstrate that NBS1 is in turn necessary
for ATM activation, we asked whether NBS1 is also an essential component of the NHEJ
process at dysfunctional telomeres. For these experiments, we scored and compared the
number of fusions per chromosome end detected in metaphase spreads from TRF2F/F
NBS1F/- and TRF2F/F NBS1F+ MEFs in the presence or absence of Cre (Figure 2.6a, b).
Indeed, whereas control MEFs displayed the expected frequency of fusion events after
Cre treatment, in TRF2F/FNBS1F/- cells, there were hardly any fusions at 96 hours post
Cre, and at the late, 120-hour time-point we observed a 5-fold reduction in the frequency
of fused chromosome ends (Figure 2.6a-c). At the same time growth rates were
comparable when TRF2 was deleted in the presence or absence of NBS1 (Figure 2.5f).
Therefore, in NBS1-deficient cells, telomere fusions occurred inefficiently and with
delayed kinetics compared to control cells and this was not due to an obvious change in
cell cycle progression.
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Figure 2.6. Effect of NBS1 deficiency on NHEJ of dysfunctional telomeres
a, Examples of metaphase spreads of TRF2F/FNBS1F/-and TRF2F/FNBS1F/+MEFs collected 96 or
120 hours after mock or Hit&Run Cre infections, and processed for telomere-specific FISH with
FITC-OO-(AATCCC)3 probe (green). DNA was stained with DAPI (red).
b, Schematic description of the method used to determine the frequency of fused ends in
metaphase spreads containing chromosome-type, chromatid-type, and sister telomere fusion
events.
c, Bar graph informing on the percentage of chromosome- and chromatid-type fusions detected
per chromosome end in metaphases prepared as in (a) in the indicated cell lines and scored as in
(b). Error bars represent s.d. from three independent experiments.
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Occurrence of chromatid-type fusions in the absence of TRF2 and NBS1
We noted, however, that in Cre-treated TRF2F/FNBS1F/- cells, the type of fusions differed
from the type of fusions normally observed as a consequence of TRF2 loss. The repair of
TRF2-depleted telomeres takes place mostly in G1, leading to chromosome-type fusions
in metaphase spreads that had occurred prior to replication. In accordance, we found that
more than 90% of the NHEJ events detected in metaphase spreads of control cells were
chromosome-type fusions (Figure 2.6a, c). In contrast, 60-80% of the fusion events
scored in TRF2F/FNBS1F/- cells at 96 and 120 hours post Cre were chromatid-type,
indicative of post-replicative repair that had occurred in S/G2 (Figure 2.6a, c). Although
we detected a low frequency of chromosome-type fusions in this setting (Figure 2.6c), we
argue that these fusions most likely did not arise as a consequence of G1 telomere fusion
events but represent chromatid-type fusions that have undergone an additional round of
replication prior to harvesting. In particular, short arm fusions of mouse chromosomes are
known to segregate stably during mitosis.
These data argue that NBS1 is in fact an essential component of the NHEJ
pathway in G1. In addition, the increased incidence of chromatid-type fusions only when
both TRF2 and NBS1 were absent suggests a novel redundant function for TRF2 and
NBS1 in the protection of telomeres after replication.

MRN deficiency does not affect overhang loss upon TRF2 deletion
We next asked whether NBS1 deficiency affected the removal of the telomeric 3’
overhang, a step that, as mentioned previously, occurs simultaneously with the joining of
dysfunctional telomeres. Over time, we observed a decrease of the overhang signal in
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NBS1-deficient cells upon TRF2 deletion, but it occurred with a delay compared to
NBS1-proficient cells (Figure 2.7a, b). This is consistent with previous data in Ku70- and
DNA ligase IV-deficient cells, where a strict coupling between overhang removal and
fusion of dysfunctional telomeres has been documented 190,236. In addition, the
appearance of high molecular weight signals on the denatured gel, which are indicative of
end-to-end telomere fusions following TRF2 deletion, was reduced but not abolished in
the absence of NBS1 (Figure 2.7a). Most likely, these are consequent to the postreplicative fusion events that occur in TRF2- and NBS1-deficient cells.

Figure 2.7. Effect of NBS1 deficiency on the rate of overhang loss induced by TRF2 deletion
a, In-gel detection of telomeric DNA from TRF2F/FNBS1F/- and TRF2F/FNBS1F/+MEFs collected
at 96 or 120 hours after mock or Hit&Run Cre infections. DNA in agarose plugs was separated on
agarose gel by pulse-field gel electophoresis and hybridized in-gel to a radioactively labeled
(CCCTAA)4 probe (native). The DNA was denatured in situ and rehybridized to the same probe
(denatured). In each lane, the ssTTAGGG signal quantified under native condition was
normalized to the total TTAGGG signal, detected after denaturation. The relative overhang signal
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represents the overhang signal in Cre-treated cells (in red), compared to control, mock-treated
cells (set at 100%, in black) for each cell line.
b, Quantification of the results in 5 indepenent experiments. Error bars indicate s.d. from the
average.

TRF2-DN allele revisited
Chromatid-type telomere fusions have previously been described in human cells as a
prominent outcome of telomere dysfunction, induced by the overexpression of TRF2-DN.
As described in the introduction, this allele, which lacks the DNA binding domain, acts
by binding to endogenous TRF2 and sequestering it away from chromosome ends.
However, since TRF2-DN retains the interaction with the MRN complex, overexpression
of this dominant-negative allele also prevents the association of MRN with chromosome
ends200. Therefore, the chromatid-type fusions, incurred by TRF2-DN overexpression, are
likely due to the combined absence of both TRF2 and MRN from telomeres, similarly to
the situation described in this study.
Consistently, in a previous experiment, downregulation of Mre11 and NBS1 by
shRNA in human cells (Figure 2.8a), treated with control β-gal or TRF2-DN adenovirus
to induce telomere dysfunction, did not affect the frequency of fusions (Figure 2.8b, c).
This negative result stands in contrast to the data obtained from Cre-expressing NBS1and TRF2-conditional knockout MEFs, but can be explained through a double-dominant
effect of TRF2-DN on TRF2 and the MRN complex.
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Figure 2.8. Effect of Mre11/NBS1 downregulation by shRNA on NHEJ of dysfunctional
telomeres
a, Immunoblots performed with Abs raised against human Mre11 (874) and anti-myc (9E10) with
whole cell lysates prepared from HeLa1.3 cells, expressing control luciferase or Mre11-specific
shRNAs, sh5 or sh6, from pSuperior retroviral expression vector, harvested 48 hours postinfection with adenovirus expressing myc-tagged TRF2 dominant negative allele (TRF2-DN).
b, Representative metaphase spreads stained with DAPI (red) of HeLa1.3 cells expressing
luciferase or Mre11-specific shRNA, sh6, fixed 48 hours post β-gal or TRF2-DN adenoviral
infection.
c, Bar graph presenting the relative number of fusions per chromosome end scored in metaphase
spreads prepared as in (b).
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Summary of findings in Chapter 2
In this chapter we dissected the function of the MRN complex at natural as well as at
deprotected chromosome ends. We were unable to prove our hypothesis that a direct
contact exists between the TRFH domain of TRF2 and the Y-x-L-S-P motif in NBS1.
However, we found some evidence that NBS1 might be redundantly involved in the
regulation of the nuclease(s) that aberrantly resects telomeric DNA in the absence of
POT1b function.
Whether or not the MRN complex is the only sensor in the ATM pathway has
been an open question, despite mounting evidence in support of this model 248. To test
this hypothesis, we examined the contribution of NBS1 in the response to TRF2 loss
which activates exclusively the ATM kinase 228. When we examined the response to
telomere dysfunction in TRF2-deficient cells that also lacked NBS1, we observed that
chromosome ends were no longer recognized as sites of DNA damage. H2AX at
telomeric chromatin was not phosphorylated and TIFs did not form. Additionally, Chk2
phosphorylation, as read-out for the activation of checkpoint signaling, did not occur.
These findings indicate that NBS1, and hence a functional MRN complex, is required to
activate the ATM pathway. Our conclusions have been confirmed in a recent report 54,
which examined the role of Mre11 in the response to telomere dysfunction induced by the
overexpression of a dominant negative allele of TPP1. TPP1 ΔRD causes activation of
the ATM pathway by an unknown mechanism. The report revealed that in cells lacking
Mre11, expression of TPP1 ΔRD does not lead to ATM autophosphorylation and does
not induce TIF formation, establishing that the MRN complex is required to activate
ATM in this setting. Together, our data and the report by Buis et al. provide
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uncontestable evidence in support of the long-standing hypothesis that the MRN complex
is the only sensor of DSBs that can activate ATM kinase.
In addition, we showed that in the absence of NBS1, dysfunctional telomeres are
not repaired in G1, indicating an essential requirement for the MRN complex in G1
NHEJ. We also found compelling evidence that TRF2 and the MRN/ATM pathway act in
concert to protect telomeres from NHEJ after replication. We observed that combined
deficiency in TRF2 and MRN gives rise to a novel type of post-replicative telomere
fusions at approximately 10% of chromosome ends that were not detected as a
consequence of TRF2 or NBS1 deletion alone. Based on these findings, we speculated
that simultaneous loss of TRF2 and the MRN/ATM pathway causes the specific
deprotection of telomeres after replication.
To reconcile the data that only combined loss of TRF2 and MRN uncovers a
defect at post-replicative chromosome ends, we argue that telomere protection after
replication is enacted through two redundant pathways, one directly dependent on TRF2
and one mediated through the MRN/ATM pathway. We envision that the function of
MRN/ATM can be carried out at functional telomeres, possibly under the control of
TRF2, which can recruit both MRN and ATM to chromosome ends. The MRN/ATM
pathway, however, can also execute this role at dysfunctional telomeres in TRF2depleted cells. In this case, the MRN complex senses the presence of telomere damage
and locally activates the ATM kinase. Further studies are necessary to dissect the
mechanism of how TRF2 and the MRN complex protect telomeres after replication.
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CHAPTER 3: THE CONTRIBUTION OF γ-H2AX/MDC1 TO
NHEJ OF DYSFUNCTIONAL TELOMERES
Introduction
In the previous chapter we uncovered important roles for the MRN complex in activating
the response to telomere dysfunction and in regulating the cell-cycle specificity of NHEJ.
Here, we investigate the role of another DNA damage response factor, MDC1, at
functional and dysfunctional telomeres. We show that MDC1 localizes to telomeres only
in response to telomere dysfunction. Using RNAi to knock down MDC1 protein levels,
we dissect the role of MDC1 in the DNA damage response pathway at deprotected
telomeres and explore its contribution to NHEJ. At the end of the chapter, we confirm our
findings in a genetic setting.

MDC1 is not detectable at functional telomeres
MDC1 interacts with NBS1 and is required for the stable accumulation of the MRN
complex at DSBs 69-73. In view of that model and given that the molecular basis of the
TRF2-MRN interaction is not known, we asked whether MDC1 is involved in the
association of MRN with functional telomeres.
Previous reports have demonstrated a weak but reproducible association of the
MRN complex with functional telomeres, which can be detected by IP 200 and ChIP 249
analysis. Although we could reproduce those data in our study, we found no evidence for
MDC1 at chromosome ends. For instance, we analyzed the recovery of telomeric DNA in
ChIP of nuclei prepared from immortalized human fibroblasts (BJ-hTERT) expressing
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vector or FLAG-tagged MDC1 (Figure 3.1a). Although we could detect the expected
fractions of shelterin components and Mre11 associated with telomeric DNA, ChIP with
anti-FLAG antibody did not lead to significant recovery of telomeric DNA (Figure 3.1b).
Furthermore, endogenous MDC1 was not recovered in TRF2 immunoprecipitate in
transformed human cells (HeLa1.2.11), whereas the TRF2 interacting partner, Rap1, was
immunoprecipitated efficiently. Similar results were obtained in co-IP experiments with
293T cells where transiently overexpressed FLAG-MDC1 was not recovered in anti-myc
immunoprecipitates of transiently transfected myc-tagged TRF1, TRF2 or Rap1 (Figure
3.1d). In addition, we did not observe co-localization of MDC1 with the shelterin
components TRF1 or TRF2 by IF analysis of either in primary (IMR90 and BJ) and
transformed (HeLa1.2.11) human cells (Figure 3.2a) or in MEFs (Figure 3.2b). For each
cell line, we examined more than 100 cells to exclude the possibility that MDC1,
analogous to its interacting partner NBS1, transiently associates with telomeres in S
phase. Importantly, downregulation of MDC1 with RNAi (Figure 3.1e) did not affect the
interaction of MRN with TRF2 as evidenced by equal levels of endogenous TRF2 present
in Mre11 immunoprecipitates in HeLa1.2.11 cells expressing control luciferase- or
MDC1-specific siRNA.
These data strongly argue that MDC1 is not localized at functional telomeres,
does not interact with telomeric proteins, and is not required for the recruitment of the
MRN complex to functional telomeres. Although our initial hypothesis that MDC1
facilitates the recruitment of MRN complex to functional telomeres was not
substantiated, our data are consistent with the established role of shelterin to actively
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suppress the DNA damage response at natural chromosome ends and to prevent the
accumulation of DNA damage factors, such as γ-H2AX and MDC1, at telomeres.

Figure 3.1. MDC1 is not at functional telomeres and is not required for the recruitment of
Mre11 to TRF2 complex at telomeres
a, Immunoblot of whole cell lysates from BJ-hTERT cells with or without pLPC-puro-FLAGMDC1 introduced by retroviral infections. Blot was probed with anti-FLAG (M2) Ab.
b, Dot blot of telomeric DNA ChIP of nuclei prepared from cells described in (a). The following
crude sera were used for ChIP: pre-immune, FLAG (M2), TRF1 (371), TRF2 (647), Rap1 (765),
Tin2 (864), Mre11 (874), and Pot1 (1048). Telomeric DNA was detected by hybridization to a
TTAGGG repeat-specific, radioactively labeled probe. 25% input labeled as Total. % telomeric
DNA for each IP was calculated based on the signal relative to the corresponding total DNA
c, Immunoblots of IPs from HeLa1.2.11 nuclear extracts incubated with beads, pre-immune
serum, or human TRF2-specific mouse Ab. Blots were probed with Abs specific to human MDC1
and human Rap1 (765). 1 and 5% input of cell extract loaded as indicated.
d, Immunoblots of myc co-IPs from 293T cells transiently transfected with FLAG-MDC1 and
myc-tagged TRF1, TRF2, or Rap1. Blots were probed with FLAG (M2) and myc (9E10) Abs. 5%
input loaded in indicated lanes.
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e, Immunoblots of whole cell lysates from HeLa1.2.11 cells transfected with luciferase- or
MDC1-specific siRNA and probed with Abs specific to human MDC1 and human Mre11 (as
loading control).
f, Immunoblot detected with human TRF2-specific mouse Ab of IPs from cells described in (e).
IPs were performed in the presence of beads only, pre-immune serum, or rabbit Abs specific to
human Mre11 (874) or human TRF2 (647). 1 and 5% input loaded in indicated lanes.

MDC1 localizes to dysfunctional telomeres
Whereas MDC1 was not observed at functional telomeres, it accumulated at chromosome
ends when telomere function was compromised by the adenoviral introduction of TRF2DN, a dominant negative allele of TRF2 that inhibits the endogenous protein in human
cells. Upon TRF2-DN overexpression, MDC1 formed large foci that co-localized with
telomeres detected with the telomere marker TRF1, which remains associated at
telomeres upon TRF2-DN overexpression 230 (Figure 3.2a). Similarly, MDC1 formed
TIFs in TRF2F/-lig4-/-p53-/- MEFs upon Cre-mediated deletion of TRF2. We used lig4deficient cells for this analysis, because in the absence of DNA ligase IV-mediated repair
of deprotected telomeres, TIFs persist longer 190,250. Furthermore, the cells lacked a
functional p53 pathway, abrogating their ability to arrest at G1/S after telomere
deprotection 232. Upon deletion of TRF2 from such TRF2F/-lig4-/-p53-/- cells, MDC1
formed TIFs that co-localized with telomeres detected with a FISH probe and coincided
with 53BP1 foci detected by IF (Figure 3.2b). Thus, MDC1 localizes to telomeres that are
dysfunctional as a consequence of TRF2 loss.
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Figure 3.2. Nuclear localization of MDC1 in cells with functional and dysfunctional
telomeres
a, Examples of HeLa1.2.11 cells, infected with control β-gal or TRF2-DN adenovirus for 48
hours, and processed for IF with a rabbit Ab specific to human MDC1 (ab11169) (green) and a
mouse Ab specific to human TRF1 (red). Images were merged and enlarged.
b, Representative images of TRF2F/-lig4-/-p53-/- MEFs, untreated or treated for 72 hours with
retroviral Hit&Run Cre recombinase and processed for IF or IF-FISH. IF was performed with a
mouse Ab raised against mouse MDC1 (green) co-stained with mouse TRF2-specific rabbit Ab
(1254) (red) or with 53BP1-specific rabbit Ab (100-304) (red). IF-FISH was performed with
mouse Ab raised against mouse MDC1 (green). Telomeric DNA was detected by FISH (red) with
a TTAGGG-specific FISH probe. DNA (blue) was counterstained with DAPI. Images were
merged and enlarged.
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Efficient downregulation of MDC1 by RNAi
To examine the role of MDC1 in the telomere damage response, we targeted mouse
MDC1 with shRNAs expressed from pSuperior retroviral expression vector. IF indicated
a significant reduction in mouse MDC1 protein levels after treatment with two
independent shRNAs, sh4 and sh5 (Figure 3.3a) and RT-PCR indicated a 75-90%
decrease in MDC1 mRNA levels (Figure 3.3b). We also designed 3 independent shRNAs
specific to human MDC1, sh1, sh2 and sh3, which efficiently downregulated human
MDC1 protein levels in primary and transformed human cells (Figures 3.5a, 3.10b, and
3.11a).
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Figure 3.3. RNAi mediated inhibition of mouse MDC1
a, IF for MDC1 in TRF2F/-lig4-/-p53-/- MEFs, infected with pSuperior retroviral construct
expressing luciferase- or two mouse MDC1-specific shRNAs, sh4 or sh5, and treated with
Hit&Run Cre for 72 hours to induce telomere dysfunction. IF was performed with anti-mouse
MDC1 Ab (green) co-stained with a TTAGGG-specific FISH probe (red). DNA was
counterstained with DAPI (blue). Images were merged.
b, RT-PCR monitoring mouse MDC1 mRNA levels in TRF2F/-p53-/- and TRF2F/+p53-/- MEFs
treated with luciferease- or two mouse MDC1-specific shRNAs, sh4 or sh5. GAPDH-specific
RT-PCR was used as control. RT-PCR products were detected by ethidium bromide staining after
agarose gel-electropheresis.
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MDC1 downregulation affects TIF formation
We used these shRNAs to address the role of MDC1 in the response to telomere
dysfunction. As expected from its role in promoting the persistence of DNA damage
factors in IRIFs, 118, MDC1 also played a central role in TIF formation. Knockdown of
mouse MDC1 abrogated the recruitment of 53BP1 and ATM-S1981-P to dysfunctional
mouse telomeres in Cre-treated TRF2F/-lig4-/-p53-/- MEFs. While in 40% of cells,
expressing luciferase shRNA and Cre recombinase, 53BP1 and ATM-S1981-P localized
to deprotected telomeres and formed bright foci, in MDC1 shRNA-treated Creexpressing cells, the staining of both factors remained diffuse and homogenous (Figure
3.4a, b). Quantification of the frequency of cells with more than five 53BP1 or ATMS1981-P foci at dysfunctional telomeres indicated that MDC1 knockdown reduced the
TIF response to background levels (Figure 3.4d).
TIF formation by γ-H2AX, on the other hand, was affected to a lesser extent by
MDC1 knockdown (Figure 3.4c). Reliable scoring of γ-H2AX TIFs is complicated by the
presence of multiple γ-H2AX foci in S-phase. Fortuitous overlap of these foci with
telomeres gives rise to a high background in control samples (~10% of –Cre cells contain
more than 5 telomeric γ-H2AX foci (Figure 3.4d)). In luciferase-treated TRF2F/-lig4-/-p53/-

MEFs, fixed 72 hours after Cre infections, we observed 5 or more γ-H2AX TIFs in 60%

of the cells. Cells treated with MDC1 sh4 showed a partial reduction (from ~60% to
~40%) in the fraction of cells that were γ-H2AX TIF positive, whereas downregulation of
MDC1 with sh5 led to a less significant reduction in the fraction of γ-H2AX TIF positive
cells (Figure 3.4d). The relative reduction in γ-H2AX TIF positive cells we observe upon
MDC1 downregulation is consistent with a role for MDC1 in signal amplification as
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proposed by Jackson and colleagues 118. On the other hand, the minor reduction is in
conflict with evidence obtained from MDC1-/- MEFs, where γ-H2AX IRIF formation is
not affected by MDC1 absence 114. This issue was clarified later in this chapter in a
genetic setting.
Therefore, it is parsimonious to assume that the role of MDC1 at dysfunctional
telomeres is similar (if not identical) to its function at DSBs.
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Figure 3.4. Effect of MDC1 RNAi on TIF formation in mouse cells
a-c, Representative fluorescent microscopic images of TRF2F/-lig4-/-p53-/- MEFs, expressing
luciferase- or mouse MDC1-specific shRNA, sh4, fixed 72 hours post mock or Hit&Run Cre
retroviral infections and processed for IF-FISH to monitor the effect of MDC1 knockdown on
TIF formation in response to deletion of TRF2. FISH (red) with a probe specific to TTAGGG
repeats was performed in combination with IF (green) with Abs specific to (a) 53BP1(100-304),
(b) ATM-S1981-P, and (c) γ-H2AX. DNA was counterstained with DAPI (blue). Images were
merged and enlarged.
d, Quantification of the data shown in (a-c). Bars show the fraction of cells containing 5 or more
IF signals for the indicated factors that co-localize with TTAGGG-specific FISH. At least 100
cells were scored in each experiment. Error bars display s.d. derived from three independent
experiments.
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A similar result was obtained in human cells, in which overexpression of the
TRF2-DN allele described above was used to induce telomere deprotection. MDC1
knockdown in these cells (Figure 3.5a) completely abrogated TIF formation by several
DNA damage factors we examined. We analyzed by IF-FISH more than 100 cells treated
with MDC1 sh1 and observed that upon introduction of TRF2-DN the nuclear staining of
53BP1, ATM-S1981-P, and Nbs1-S343-P remained homogenous, whereas these factors
localized to TIFs in luciferase-treated cells (Figure 3.5b, c). In this setting MDC1 knock
down by sh1 did not result in a quantitative difference in the fraction of cells containing
γ-H2AX TIFs (Figure 3.5b, c). These results reporting on the contribution of human
MDC1 to TIF formation are consistent with our analysis on the role of mouse MDC1
described above.
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Figure 3.5. Effect of MDC1 RNAi on TIF formation in human cells
a, Immunoblot of whole cell lysates from HeLa1.2.11 cells, expressing empty vector or MDC1specific shRNA, sh1, from pSuperior retroviral expression vector, harvested 48 hours after
adenoviral infection with control β-gal or TRF2-DN to induce telomere dysfunction. Blots were
probed with Abs specific to human MDC1, myc (9E10, which reports on the expression levels of
myc-tagged TRF2-DN allele), and γ-tubulin (clone GTU, loading control).
b-c, Representative images of cells processed for IF with rabbit Ab raised against human TRF1
(371)(red) co-stained with mouse Abs raised against 53BP1, ATM-S1981-P, γ-H2AX (green), or
for IF with rabbit Ab raised against NBS1-S343-P (green) performed in combination with
telomere-specific FISH (red). HeLa1.2.11 cells with (c) or without (b) MDC1 sh1 were infected
for 48 hours with control β-gal or TRF2-DN adenovirus. Images were merged and enlarged.
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These results were further confirmed through inhibition of MDC1 with a
dominant negative allele, MDC1-FHA (MDC1, aa 1-394; see Figure 3.6a for schematic.
While MDC1-FHA does not directly associate with sites of DNA damage, previous
experiments have shown that its overexpression inhibits MDC1, 53BP1 and MRN
complex IRIF formation 107,251. The N-terminal FHA domain of MDC1 was initially
implicated in promoting multiple protein-protein interactions, including an association
with itself as well as with the MRN complex. Subsequently, it has been determined that
MDC1 interacts with NBS1 in the MRN complex through its S-T-D-rich domain 69-71.
Thus, the FHA domain does not play a role in this association. It is possible that in earlier
experiments endogenous MDC1 bridged the recovery of MRN complex from MDC1FHA-specific immunoprecipitates. The most likely explanation for the dominant negative
effect of MDC1-FHA, therefore, seems to be its ability to interact with endogenous
protein and to sequester it away from sites of damage.
We asked whether MDC1-FHA acted as a dominant negative allele with respect
to TIF formation induced by treatment with the TRF2-DN allele. We overexpressed
MDC1-FHA in immortalized human fibroblasts (BJ-hTERT) treated with TRF2-DN and
analyzed TIF formation by IF (Figure 3.6b). We observed complete absence of 53BP1
TIFs in more than 100 cells examined, confirming the dominant negative effect of
MDC1-FHA.
Next we addressed whether MDC1 functioned downstream of ATM or ATR
kinases by testing whether the dominant negative effect of MDC1-FHA at TRF2-depleted
telomeres could be observed in cells lacking ATM or functional ATR. We examined
primary human ATM-deficient cells (A-T, derived from patient #504405) or
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immortalized cells, which are hypomorphic for the ATR kinase (Seckel-hTERT, derived
from Seckel syndrome patient, F02-98 252). In both cell types, introduction of TRF2-DN
allele leads to 53BP1 TIF formation (Figure 3.6b, c and 83), which was completely
prevented by the overexpression of MDC1-FHA (Figure 3.6c, d). In each instance, more
that 100 cells were examined by IF. These results demonstrated that TRF2-DN-induced,
MDC1-mediated TIF formation was likely promoted by redundant kinase activities. The
contribution of MDC1 to ATM, ATR, and, potentially, DNA-PKcs pathways can be
explained by the ability of these kinases to phosphorylate H2AX, the recruiter of MDC1
to sites of DNA damage.
The presence of TIFs in A-T cells treated with TRF2-DN suggests that ATR
and/or DNA-PKcs are also involved in the response to telomere dysfunction in human
fibroblasts. This contrasts the TIF response induced by TRF2 deletion in mouse cells,
which is entirely dependent on the ATM kinase. This discrepancy could be explained if
the TRF2-DN allele, in addition to removing endogenous TRF2 from telomeres, also
sequesters POT1 from chromosome ends. The interacting partner of TRF2, TIN2, binds
to TPP1, which in turn binds to and recruits POT1 to telomeres (see Introduction for
more detail and references). Therefore, it is possible that overexpressed TRF2-DN, which
retains the TIN2 interaction domain, could remove TPP1 and POT1 from telomeres.
Depletion of POT1 from telomeres has previously been shown to activate the ATRdependent DNA damage response pathway 228, providing an explanation for the
involvement of ATR in TRF2-DN-induced TIF formation.
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Figure 3.6. Effect of MDC1-FHA on 53BP1 TIF formation in BJ-hTERT, A-T and SeckelhTERT cells.
a, Schematic representation of the domain structure of MDC1, indicating the location of the
MDC1-FHA dominant negative allele.
b-d, Panels present typical images of (b) BJ-hTERT, (c) A-T (ATM-deficient; #504405), and (d)
Seckel-hTERT (ATR-hypomorphic; F02-98) cells, with or without MDC1-FHA expressed from
pLPC-puro retroviral delivery vector, fixed 48 hours after treatment with TRF2-DN adenovirus to
induce telomere dysfunction and processed for IF. IF was performed with mouse Ab raised
against human 53BP1 (green) co-stained with rabbit Ab raised against human TRF1 (371).
Images were merged and enlarged.
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Collectively, these data indicate that MDC1 promotes the formation of foci
containing ATM-S1981-P, 53BP1, and Nbs1-S343-P at dysfunctional telomeres as it
does at DSBs. In addition, the close parallels between the DNA damage responses at
dysfunctional telomeres and at DSBs validate our model system. The similarities further
underscore that insights gained from analysis of deprotected telomeres may lead to more
detailed understanding of the response to DSBs.

MDC1 and γ -H2AX play an essential role in promoting the physiological pace of
NHEJ at dysfunctional telomeres
Since knockdown of MDC1 inhibited the localization of MRN complex at dysfunctional
telomeres, we asked whether similarly to NBS1, MDC1 also plays a role in NHEJ. We
scored fusions in metaphases of control or MDC1 shRNA-treated TRF2F/- p53-/- MEFs
collected at 72 hours after TRF2 deletion (Figure 3.7a). As expected, in control cells we
observed 10-15% fusions per deprotected chromosome end, while in cells with lowered
MDC1 levels we noted that only a small fraction of the metaphases showed fusions.
Quantitative analysis revealed a 4-5 fold decrease in telomere fusions in cells with
reduced MDC1 protein levels (Figure 3.7b). The effect of MDC1 inhibition was most
prominent at the early timepoints of telomere deprotection (60-72 hours post Cre
infection). At later timepoints, most chromosomes fused into long trains both in control
and in MDC1 shRNA-treated cells.
Similar results were observed in human HeLa1.3 cells, where MDC1 was
downregulated with two MDC1-specific shRNAs. We analyzed metaphase spreads of
control or MDC1 shRNA-treated cells at 48 hours after TRF2-DN-induced telomere
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dysfunction (Figure 3.7c) and recorded a 3-4 fold decrease in telomere fusion events in
cells with reduced levels of MDC1 (Figure 3.7d).
The complimentary results in mouse and human cells established that MDC1
contributes to the NHEJ pathway. However, the appearance of delayed fusions argued
against an essential role for MDC1 in NHEJ of dysfunctional telomeres. Instead, MDC1
seemed most likely involved in promoting the efficiency of the repair reaction or in
regulating a step in NHEJ.
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Figure 3.7. MDC1 stimulates NHEJ of dysfunctional telomeres.
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Figure 3.7. MDC1 stimulates NHEJ of dysfunctional telomeres.
a, Metaphase spreads of TRF2F/-p53-/- and TRF2F/+p53-/- MEFs expressing luciferase- or mouse
MDC1-specific shRNA, sh4, collected 60 hours after Hit&Run Cre infections and processed for
telomere-specific FISH with FITC-OO-(AATCCC)3 probe (green). DNA was stained with DAPI
(red).
b, Bar graph summarizing the effect of MDC1 knockdown on the relative frequency of fused
chromosome ends detected on metaphase spreads of TRF2F/-p53-/- MEFs untreated or 60 hours
after Hit&Run Cre infections and processed as in (a).
c, Metaphase spreads of HeLa1.3 cells treated with control or human MDC1-specific shRNA,
sh2, delivered from pSuperior retroviral expression vector, harvested 48 hours post-infection with
control β-gal or TRF2-DN adenovirus. Telomere-specific FISH was performed as in (a)
d, Bar graph presenting the relative frequency of chromosome end fusions in human HeLa1.3
cells, expressing control or 2 human MDC1-specific shRNAs, sh1 and sh2, treated with
control β-gal or TRF2-DN adenovirus and processed as in (c).
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NHEJ-mediated repair of dysfunctional telomeres was also affected when the
recruitment of MDC1 to chromatin was blocked by lowering the amount of its binding
partner, γ-H2AX, with shRNA to H2AX. This shRNA 109 causes efficient knockdown of
H2AX, which we confirmed in human HeLa1.3 cells by Western blotting and IF (Figure
3.8a, b). As expected from γ-H2AX recruiting MDC1, cells with lowered H2AX protein
levels did not contain MDC1 foci upon TRF2-DN treatment (Figure 3.8b) and the overall
fraction of cells that contained MDC1 foci at dysfunctional telomeres was reduced 4
times (Figure 3.8c). Reduction of H2AX and MDC1 localization at dysfunctional
telomeres impacted the rate of NHEJ. At 48 hours post infection with Ad-TRF2-DN,
these cells showed a 3-fold reduction in telomere fusion frequencies on metaphase
spreads, which is similar to the effect of MDC1 knockdown. These results indicated that
γ-H2AX mediated-recruitment of MDC1 to chromatin accelerates the rate by which
dysfunctional telomeres are repaired by NHEJ.
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Figure 3.8. Effect of H2AX knockdown on the recruitment of MDC1 to dysfunctional
telomeres and on the efficiency of NHEJ of dysfunctional telomeres.
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Figure 3.8. Effect of H2AX knockdown on the recruitment of MDC1 to dysfunctional
telomeres and on the efficiency of NHEJ of dysfunctional telomeres.
a, Immunoblot of whole cell lysates from HeLa1.3 cells expressing luciferase- or H2AX-specific
shRNA, sh3, from pSuperior retroviral delivery vector. Blot was probed with H2AX-specific Ab
(ab11175); non-specific bands from the same immunoblot were used as loading control.
b, Representative IF images of HeLa1.3 cells expressing luciferase- or H2AX-specific shRNA,
sh3, fixed 48 hours post infection with control β-gal or TRF2-DN adenovirus and processed for
IF with a rabbit Ab raised against γ-H2AX (green) co-stained with a mouse Ab raised against
mouse MDC1 (red). DNA counterstained with DAPI (blue). Images were merged and enlarged.
c, Bar graph summarizing data from IF-FISH analysis of cell described in (b). IF was performed
with a mouse Ab raised against mouse MDC1 in combination with FISH performed with a OOFITC-(TTAGGG)3 telomere repeat-specific probe. Bars show the fraction of cells (n>100), which
contained 5 or more IF signals for MDC1 co-localizing with TTAGGG-specific FISH. Error bars
show s.d. derived from triplicate experiments
d, Metaphase spreads of HeLa1.3 cells, stably expressing luciferase- or H2AX-specific sh,
sh3,harvested 48 hours post infection with control β-gal or TRF2-DN adenovirus. Telomerespecific FISH was performed with FITC-OO-(AATCCC)3 probe (green). DNA was stained with
DAPI (red).
e, Bar graph quantifying the effect of H2AX downregulation on the frequency of telomere fusions
on metaphase spreads prepared as in (d). Error bars indicated s.d. derived from 3 independent
experiments.
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In-gel overhang analysis of control and shRNA-treated cells provided
independent support for the role of MDC1 in NHEJ of dysfunctional telomere. Prior data
has shown that the 3’ overhang of dysfunctional telomers is retained when the NHEJ
pathway is blocked by Ku70 or DNA ligase IV deficiency 190,236. In fact, when TRF2 is
deleted from Ku70- or DNA ligase IV-deficient MEFs, the overhang signals increase
slightly, presumably due to degradation of the deprotected C-rich telomeric DNA strand.
A similar increase in the overhang signal occurred when TRF2 was deleted from TRF2F/p53-/- MEFs with reduced MDC1 levels (Figure 3.9a, b). This effect was most
pronounced at 72 hours after Cre-mediated TRF2 deletion and coincided with the
inhibition of NHEJ by MDC1 knockdown. At later time points, 96 and 120 hour post Cre,
the overhang signal decreased as expected from the occurrence of fusions at these stages
(Figure 3.9a, b). Thus, MDC1 knockdown affected the initial rate of both overhang loss
and fusions in mouse cells, as would be expected from the previously reported, tight
coupling between NHEJ and overhang processing. We could not address in this
experimental system whether MDC1 promoted the overhang processing step or regulated
the end-to-end joining reaction.
Further insight on that issue was obtained in human cells. Previous work had
shown that in human cells, overhang processing can occur before the actual joining of the
telomeres, leading to the detection of telomeres with diminished overhangs that had not
(yet) been joined 230. Thus, in human cells, overhang processing is not strictly coupled to
NHEJ as it is in mouse cells. This slight difference in the telomere fusion pathway in
human and mouse cells allowed us to ask whether MDC1 affected the overhang
processing step itself. Although MDC1 loss clearly delayed telomere fusion in
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transformed human cells (Figure 3.7c, d), there was no effect on overhang processing
(Figure 3.9c, d). We noted the same reduction in overhang signal (~40%) both in MDC1
knockdown and control cells analyzed 48 hours after introduction of TRF2-DN into
HeLa1.3 cells. This result argues against a role for MDC1 in overhang processing per se
and suggests that MDC1 promotes NHEJ of dysfunctional telomeres through another
step.
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Figure 3.9. Effect of MDC1 knockdown on overhang processing of dysfunctional telomeres
in mouse and human cells.
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Figure 3.9. Effect of MDC1 knockdown on overhang processing of dysfunctional telomeres
in mouse and human cells.
a, In-gel detection of telomeric DNA from TRF2F/-p53-/- MEFs expressing luciferase- or mouse
MDC1-specific shRNAs, sh4 or sh5, harvested at 72 hours post mock or Hit&Run Cre retroviral
infections. DNA in agarose plugs was separated on agarose gel by pulse-field gel electophoresis
and hybridized in-gel to a radioactively labeled (CCCTAA)4 probe (native). The DNA was
denatured in situ and rehybridized to the same probe (denatured). In each lane, the ssTTAGGG
signal quantified under native condition was normalized to the total TTAGGG signal, detected
after denaturation. The relative overhang signal represents the normalized ssTTAGGG signal in
Cre-treated cells, compared to mock-treated cells (set at 100%) at each time point for each cell
line.
b, Graph showing the effect of MDC1 knock down on overhang processing in cells described in
(a), untreated or treated with Hit&Run Cre retrovirus for 72, 96 and 120 hours and processed by
in-gel overhang assay as in (a). The relative overhang signal at different time points after Cre
infection is calculated as a percentage of the overhang signal in the absence of Cre for each cell
line. Error bars indicate the s.d. derived from three independent experiments.
c, In-gel detection of telomeric DNA isolated from HeLa1.3 cells expressing control or human
MDC1-specific shRNAs, sh1 or sh2, harvested 48 hours post infection control β-gal or TRF2-DN
adenovirus. Telomeric DNA was separated by agarose gel-electophoresis and hybridized in-gel to
a radioactively labeled (CCCTAA)4 probe (native). The DNA was denatured in situ and
rehybridized to the same probe (denatured). In each lane, the ssTTAGGG signal quantified under
native condition was normalized to the total TTAGGG signal, detected after denaturation. The
relative overhang signal represents the normalized ssTTAGGG signal in TRF2-DN-treated cells,
compared to control β-gal cells (set at 100%) for each cell line.
d, Bar graph quantifying the effect of MDC1 knock down on overhang processing in cells
described in (c), treated with control β-gal adenovirus for 48 hours or with TRF2-DN adenovirus
for 24 or 48 hours, and processed by in-gel overhang assay as in (c). For each cell line, the
relative overhang signal at different time points after TRF2-DN infection is normalized to the
overhang signal after control β-gal treatment. Error bars indicate the s.d. derived from triplicate
experiments.
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MDC1 is not required for checkpoint signaling in response to telomere dysfunction
Several reports have presented conflicting evidence as to whether or not MDC1 is
required for checkpoint activation in response to DSBs induced by γ-irradiation. The
current model, which reconciles these contradictory data, suggests that MDC1 is
preferentially required to amplify the signal in response to low doses of γ-irradiation (1-2
Gy), whereas at higher levels of DNA damage (>5 Gy), activation of checkpoint effectors
is MDC1-independent 118. We asked whether signaling at dysfunctional telomeres could
be placed in the first or second category with regard to requirement for MDC1 function.
This question was also relevant to the potential role of MDC1 in facilitating NHEJ of
dysfunctional telomeres. It was possible that in the absence of MDC1 impaired NHEJ
was a consequence of a checkpoint-signaling defect. For instance, since TRF2-depleted
mouse telomeres join preferentially in G1 237, changes in the progression from G1 into S
phase could affect the rate of NHEJ. Therefore, we examined the effect of MDC1
knockdown on relevant cell cycle effectors that mediate the G1/S arrest after telomere
dysfunction. In contrast to NBS1-deficiency, immunoblotting indicated that MDC1 status
affected neither the autophosphorylation of ATM nor the phosphorylation of Chk2 after
TRF2 deletion from mouse cells (Figure 3.10a). Furthermore, in primary human
fibroblasts (IMR90) the increase in p53 and p21 protein in response to TRF2-DN was
unaltered by MDC1 knockdown (Figure 3.10b) and the cells senesced within a week after
TRF2 inhibition regardless of the level of MDC1. Moreover, the TRF2-DN-induced
senescence was associated with dramatic alterations in morphology regardless of MDC1
status. Both control and MDC1 shRNA-treated senescent cells appeared flatter compared
to dividing fibroblasts, increased in size, often contained two or more nuclei, and stained
109

positive for senescence associated β-galactosidase activity (Figure 3.10c). These data
indicate that reduced levels of MDC1 did not affect checkpoint signaling.
The results obtained with MDC1 knockdown in TRF2F/-p53-/- mouse cells also
argued against the possibility that MDC1 affects NHEJ in a manner that involves cell
cycle progression. As these cells lack a functional p53 pathway, they fail to trigger the
G1/S checkpoint in response to TRF2-deletion, although their growth was impaired
significantly in the presence of telomere dysfunction. Downregulation of MDC1 in Cretreated TRF2F/-p53-/- did not additionally alter their proliferation rates, as shown by
growth curves, which compare the total number of cells up to 120 hours after deletion of
TRF2. In addition, we evaluated the fraction of cells that incorporated the thymidine
analogue, BrdU, in 1 hour, as an indication for the portion of cells in S-phase during the
labeling period. Again, there was no detectable difference between luciferase- and
MDC1- shRNA treated cells, both in the presence and in the absence of Cre-induced
telomere dysfunction.
Collectively, these data indicate that the activation of the G1/S checkpoint does
not require the accumulation of MDC1, 53BP1, ATM-S1981-P, or Nbs1-S343-P at the
sites of telomere damage. Most likely, the ATM kinase is activated and retains the ability
to phosphorylate its targets in the nucleoplasm despite the lack of detectable association
of ATM with the dysfunctional telomeres. Importantly, these results also argue against a
model claiming that the contribution of MDC1 to NHEJ might be mediated through
alteration of checkpoint signaling or cell cycle progression. Instead, we concluded that
MDC1 regulates an aspect of the NHEJ pathway directly.
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Figure 3.10. MDC1 knockdown does not affect checkpoint signaling in response to telomere
dysfunction.
a, Immunoblots of whole cell lysates prepared from TRF2F/-p53-/- MEFs, expressing luciferase- or
mouse MDC1-specific shRNAs, sh4 or sh5, harvested 72 hours post mock or Hit&Run Cre
retroviral infections. Blots were probed with Abs specific to TRF2 (647), mouse Rap1 (1252),
ATM-S1981-P, Chk2, and γ- tubulin (clone GTU; as loading control).
b, Immunoblots of whole cell lysates prepared from primary human fibroblasts, IMR90,
expressing vector- or human MDC1-specific shRNAs, sh1 or sh2, harvested 48 hours post control
β-gal or TRF2-DN retroviral infections. Blots were probed for the induction of p53 (DO-1) and
p21 (F-5) after inhibition of TRF2. Control blots were probed with Abs raised against human
MDC1 (ab11169), myc (9E10, to detect myc-tagged TRF2-DN), and γ- tubulin (clone GTU; as
loading control).
c, Light microscopyx photographs of IMR90 cells, expressing vector or MDC1 shRNA, sh1,
infected with empty vector control or TRF2-DN retrovirus, delivered from pWzl-hygro
expression vector, stained for SA-β-galactosidase activity at 12 days after infection.
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d, Graph indicating the effect of MDC1 knockdown on cell growth. TRF2F/-p53-/- MEFs,
expressing luciferase- or mouse MDC1-specific shRNAs, sh4 or sh5, were plated 48 hours after
Hit&Run Cre retroviral infections, and counted at 72, 96, and 120 hours post Cre.
Inset table presenting the percentage of cells with BrdU-specific IF signals. TRF2F/-p53-/- MEFs,
expressing luciferase- or mouse MDC1-specific shRNAs, sh4 or sh5, were grown for 1 hour in
medium containing BrdU at 72 hours post mock or Hit&Run Cre retroviral infections. Cells were
fixed and processed for IF with a fluorophore-conjugated anti-BrdU Ab. The fraction of cells
exhibiting BrdU incorporation was determined by microscope analysis.

An MDC1-“specific” shRNA with a critical off-target effect
We noted that upon more prolonged culturing (>2 weeks), primary human fibroblasts
expressing MDC1 shRNAs sh1 or sh2 started proliferating more slowly than the controls
cells and attained a senescence phenotype (Figure 3.11a), even in absence of TRF2-DN.
A senescence response to MDC1 knockdown, likely due to accumulation of unrepaired
DSBs, is consistent with the diminished proliferation and senescent phenotype of MDC1
knockout MEFs 114. However, a third human MDC1 shRNA, sh3, which downregulated
MDC1 efficiently (Figure 3.11b), and has been used in previous studies 109,110,113,116, did
not have this senescence phenotype (Figure 3.11a). Unexpectedly, we found that this
shRNA (sh3) has extensive sequence identity to the mRNA for the ATM kinase (Figure
3.11c) and induced a significant reduction in ATM protein levels (Figure 3.11d). Thus,
MDC1 sh3 has a remarkably pathway-specific off-target effect whereby it affects both
MDC1 itself and ATM, the main kinase responsible for the generation of MDC1 binding
sites in damaged chromatin.
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Figure 3.11. ATM-specific off-target effect of MDC1 shRNA, sh3.
a, Light microscopic photographs of IMR90 cells, stained for SA-β-galactosidase activity at 14
days after infection with vector or human MDC1-specific shRNA, sh2 or sh3, delivered by
retroviral infections from pSuperior retroviral expression vector.
b, Immunoblot of whole cell lysates prepared from cells described in (a). Blot was probed with
Ab raised against human MDC1 (ab11169). Non-specific band from the same blot was used as
loading control.
c, Schematic diagram of MDC1 sh3 sequence and its target sites in MDC1 and ATM.
d, Immunoblots detecting ATM protein levels in whole cell lysates prepared from IMR90 and BJ
cells treated with vector or sh3. Blots were probed with Abs raised against human ATM (MAT3)
and human TRF2 (647, as loading control).
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Genetic deletion of MDC1 in the context of the TRF2 conditional knockout confirms
shRNA studies
These RNAi studies suggested that whereas MDC1 promoted the repair of dysfunctional
telomeres, it was not required for this process to occur. It was possible, however, that the
partial inhibition of NHEJ was due to incomplete knockdown of MDC1. In order to
address this caveat genetically, we obtained MDC1 knockout mice 114 and bred MDC1+/mice to TRF2F/F mice to generate TRF2F/FMDC1+/- progeny. Crosses of TRF2F/FMDC1+/generated E13.5 embryos of TRF2F/FMDC1-/- and TRF2F/FMDC1+/+ genotypes. MEFs
isolated from these embryos were immortalized at passage 2 with SV40-LT. Western
blotting confirmed the absence of MDC1 and successful deletion of TRF2 in
TRF2F/FMDC1-/- MEFs, analyzed 72 hours after introduction of Hit&Run Cre
recombinase. Absence of MDC1 abolished TIF formation by MRN complex and 53BP1
in all cells (n>200) that lacked TRF2 but did not affect the extent of γ-H2AX
phosphorylation at dysfunctional telomeres (Figure 3.12b).

114

Figure 3.12. Effect of MDC1 deletion on TIF formation
a, Immunoblots of whole cell extracts prepared from TRF2F/FMDC1+/+ and TRF2F/FMDC1-/- cells,
untreated or treated with Hit&Run Cre retrovirus for 72 hours and probed with Abs raised against
mouse MDC1 (300-757A) and human TRF2 (647). A non-specific band from the TRF2 blot was
used as loading control.
b, Representative examples of TRF2F/FMDC1+/+ and TRF2F/FMDC1-/- cells, fixed 72 h post mock
or Hit&Run Cre retroviral infections, and processed for IF-FISH. IF (in red) was performed with
Abs specific to γ−H2AX, 53BP1 (100-304), and NSB1 (93’6). Telomeric DNA was detected by
FISH (in green) with a telomere repeat-specific FISH probe. DNA (in blue) was counterstained
with DAPI. Images were merged and enlarged.
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Next we compared the frequency of end-to-end fusions and the rate of overhang
loss in TRF2F/FMDC1-/- and TRF2F/FMDC1+/+ MEFs, treated with Cre to remove TRF2.
The results confirmed the shRNA studies. Fusions occurred at a slower pace in MDC1deficient MEFs compared to control cells. Metaphase spreads from MDC1-proficient
cells contained 24±4% fusions per chromosome end at 96 hours post Cre. This frequency
further increased to 33±2% at 120 hours post Cre. In contast, in absence of MDC1, we
observed only 0.6±0.4% fusions per chromosome end at 96 hours post Cre and the
percentage of fused chromosome ends increased only slightly to 14±5% at the latest
timepoint. The overhang signal also diminished more slowly in TRF2F/F MDC1-/- MEFs
compared to MEFs generated from a TRF2F/F MDC1+/+ littermate, indicating a delay in
the NHEJ reaction. We conclude that MDC1 is not essential for the NHEJ pathway but
significantly promotes the efficiency of this process at dysfunctional telomeres.
The phenotype of MDC1 loss with regard to NHEJ of dysfunctional telomeres
thus recapitulates the delayed fusion phenotype observed for ATM- or NBS1-deficient
MEFs (Chapter 2 and 228). In all cases, repair events occurred with delayed kinetics so
that there was absence of NHEJ at early time points and a 2-4 fold decrease in fusion
frequencies at later time points. The similarity between ATM, NBS1, and MDC1deficient cells is consistent with the well-established model, which places MDC1 in the
same pathway as the MRN complex and the ATM kinase. On the other hand, the residual
fusions in MDC1-deficient cells were predominantly chromosome-type, establishing that,
unlike ATM and NBS1 whose absence increased the frequency of chromatid-type
fusions, MDC1 does not affect the occurrence of G2 telomere fusion events.
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Figure 3.13. Effect of MDC1 deficiency on end-joining and overhang processing of
dysfunctional telomeres
a, Detection of telomere fusions in metaphase spreads of TRF2F/FMDC1+/+ and TRF2F/FMDC1-/MEFs collected at 72, 96, or 120 hours after Hit&Run Cre retroviral infections. Telomeric signals
(in green) were detected by TTAGGG-repeat specific probe. DNA was stained with DAPI and
false colored in red. Numbers in each panel indicate the fraction of chromosome ends fused at
that time point based on analysis of ≥ 350 metaphase chromosomes. s.d. from 3 independent
experiments is given.
b, In-gel detection of telomeric DNA from TRF2F/FMDC1+/+ and TRF2F/FMDC1-/- MEFs,
harvested post 72 hours mock infection or 72, 96 or 120 hours post Hit&Run Cre retroviral
infections. DNA in agarose plugs was separated on agarose gel by pulse-field gel electophoresis
and hybridized in-gel to a radioactively labeled (CCCTAA)4 probe (native). The DNA was
denatured in situ and rehybridized to the same probe (denatured). In each lane, the ssTTAGGG
signal quantified under native condition was normalized to the total TTAGGG signal, detected
after denaturation. The relative overhang signal at each time point represents the normalized
ssTTAGGG signal in Cre-treated cells, compared to mock-treated cells (set at 100%) for each cell
line. Fused telomeres are indicated by dashed line.
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Testing the role of MDC1 in the repair of non-telomeric DSBs
The evidence presented in this chapter argues that MDC1 is required to support the
physiological pace of NHEJ of dysfunctional telomeres. These data raise the question
whether MDC1 also contributes to other instances of NHEJ reactions or whether its role
is limited to dysfunctional telomeres. We tested whether MDC1 was required for efficient
repair of IR-induced chromosome-internal DSBs in FAR (Fraction of activity released)
assay. In this assay, genomic DNA from cells, irradiated with a high dose of γ-irradiation
(20-80 Gy), is separated on agarose gel by pulse-field gel electrophoresis. Genomic DNA
from non-irradiated or from repair-proficient cells remains in the wells due to its size,
whereas genomic DNA, fragmented by γ-irradiation in cells, harvested immediately after
irratiation or in cells that are deficient for repair factors, is resolved in the lane. Therefore,
one can monitor the ratio of unrepaired genomic DNA resolved in each lane to total
genomic DNA (lane + well) (referred to as FAR ratio) as a measure for the progress of
gross chromosomal repair at consecutive time points after IR. The FAR assay has
previously been used to show that repair is impaired by wortmannin and caffeine, which
inhibit the major kinase in the NHEJ pathway, DNA-PKcs. Although we were able to
replicate these experiments (Figure 3.14a), we did not observe any difference in the FAR
ratios of irradiated human and mouse cells containing wild-type or reduced MDC1
protein levels (Figure 3.14b, c). These data suggest that either MDC1 is not required for
the repair of chromosome-internal DSBs, or the FAR assay, which generates ~10 times
more sites of DNA damage than are created through inhibition of TRF2, probes for DSBs
repair in a range of DNA damage that is less dependent on MDC1.
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Figure 3.14. Effect of MDC1 downregulation on FAR ratio as a measure for the efficiency of
gross chromosomal repair.
a, FAR assay on HeLa204 cells, irradiated with 20 Gy and harvested immediately after IR or after
recovery for 60 or 120 minutes, in the presence of no drug, 50 µM wortmannin, or 10 mM
caffeine. Genomic DNA in agarose plugs was resolved by pulse-field gel electrophoresis and
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Southern blotting was performed using Alu-repeat specific radioactively-labeled probe. Graph
presenting the ratio of the signal detected in each lane to the signal quantified in lane+well in
cells treated as indicated and collected at the indicated time points after IR.
b, Graph presenting the results from FAR assay performed as in (a) on HeLa204 cells expressing
control or human MDC1-specific shRNAs, sh1 or sh2, harvested 0, 30, 60, or 120 minutes after
irradiation with 20 Gy.
c, Graph presenting the results of FAR assay performed as in (a) on TRF2F/+p53-/- MEFs
expressing control or mouse MDC1-specific shRNAs, sh4 or sh5, harvested 0, 30, 60, or 120
minutes after irradiation with 20 Gy.
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Summary of findings in Chapter 3
In this chapter we established that MDC1 accumulates at chromosome ends only in the
presence of telomere dysfunction. We showed that MDC1 requires γ-H2AX in order to
localize to dysfunctional telomeres, and that, in turn, MDC1 promotes the accumulation
of a number of DNA damage response factors, including 53BP1, ATM-S1981-P, and
NBS1, at dysfunctional telomeres. These results draw a model for TIF formation that is
identical to the currently established model for IRIF formation, and therefore, suggest a
parallel between dysfunctional telomeres and chromosome-internal DSBs in terms of
their association with DNA damage response factors.
Next, we used dysfunctional telomeres as a model system to dissect the relative
contribution of MDC1 to the signaling and repair pathways activated by inhibition of
TRF2 function. We found that MDC1 and the modified histone it binds to, γ-H2AX, are
required for the physiological pace of NHEJ of dysfunctional telomeres. The delay in
NHEJ that we observed in cells that lacked or contained diminished levels of MDC1 was
not a consequence of either altered checkpoint signaling or reduced proliferation rates.
We also tested whether MDC1 promoted the repair of chromosome-internal
DSBs. Despite the negative result in FAR assay, we have no reason to assume that the
role of MDC1 in NHEJ is specific for telomere dysfunction. In fact, as described in the
next, the differences between end-joining of dysfunctional telomeres and NHEJ-mediated
repair of IR-induced DSBs might inform us on the function that MDC1 and its associated
factors play in NHEJ.
Our conclusions on the involvement of MDC1 in the regulation of NHEJ are
consistent with the lower rate of plasmid transfection in cells overexpressing a dominant
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negative allele of MDC1 112, the modest class switch defect of MDC1-/- mice, and their
hypersensitivity to DSBs 114. In contrast, MDC1-/- mice have no overt defect in V(D)J
recombination 114, an established measure of NHEJ. Therefore, it was unclear whether
MDC1 promotes DSB repair through an effect on NHEJ or through its effect on cell
cycle progression. This issue is clarified by our study since MDC1 affected NHEJ
without affecting the cell cycle effectors of the ATM signaling pathway or cell cycle
progression.
Therefore, we conclude that MDC1 affects NHEJ of dysfunctional telomeres
directly. It has been reported that MDC1 interacts with DNA-PKcs/Ku 163 and this might
be related to its ability to accelerate NHEJ. MDC1 also interacts with the HR protein
Rad51 164, but the functional relevance these interactions remains to be established.
However, we favor an alternative explanation. We propose that the ability of MDC1 to
stabilize the association of other DNA damage response factors at dysfunctional
telomeres and its capacity to enhance the extended domains of altered chromatin is
pertinent to its role in NHEJ. We have confirmed this model in the next chapter, where
we present direct evidence that 53BP1, a factor that requires MDC1 for its prolonged
association in TIFs, is an essential component of the NHEJ pathway.
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CHAPTER 4: THE CONTRIBUTION OF 53BP1 TO NHEJ
OF DYSFUNCTIONAL TELOMERES
Introduction
In this chapter, we focus on 53BP1, a DNA damage response factor, which similarly to
MDC1, accumulates at DSBs and at deprotected telomeres. As described in the
introduction, the interaction of 53BP1 with chromatin near DSBs is mediated in part
through the binding of its Tudor domain to H4-K20diMe and through a poorly
understood γ-H2AX/MDC1-dependent interaction of 53BP1 with ubiquitilated
chromatin. Unlike MDC1, however, 53BP1 does not play a role in the amplification of
the DNA damage signal at DSBs 132, a result we confirmed here in the context of
telomere dysfunction. On the other hand, experimental evidence has linked 53BP1 to
certain aspects of NHEJ. While 53BP1 is not strictly required for NHEJ during V(D)J
recombination, the repair of AID-induced DSBs in CSR is severely affected by 53BP1
deficiency134,136. Hence, we tested the role of 53BP1 in NHEJ of dysfunctional telomeres
and investigated the mechanism by which 53BP1 promotes DNA repair.

Generation of 53BP1-deficient, TRF2-conditional knockout MEFs
In order to address the genetic contribution of 53BP1 to the response to telomere
dysfunction, we bred 53BP1-/- mice 132 with TRF2F/- mice 190 to generate TRF2F/-53BP1+/and TRF2F/+53BP1+/- progeny. These were crossed and MEFs from E13.5 embryos with
TRF2F/-53BP1-/-, TRF2F/-53BP1+/-, and TRF2F/+53BP1-/- genotypes were isolated. MEFs
were transformed at passage 2 with SV40-LT, abrogating the G1/S checkpoint, which is
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activated in response to telomere dysfunction 232. The presence or absence of 53BP1
protein in these cells was confirmed by immunoblotting (Figure 4.1a) and by IF (Figure
4.1b) using 53BP1-specific antibodies. To induce telomere dysfunction, the conditional
allele of TRF2 was removed by Hit&Run Cre retroviral infection. Immunoblotting for
TRF2 confirmed efficient deletion of TRF2 at 72 hours post Cre expression in TRF2F/but not in TRF2F/+ MEFs (Figure 4.1a).

Figure 4.1. Characterization of TRF2F/-53BP1+/-, TRF2F/-53BP1-/-, and TRF2F/+53BP1-/MEFs.
a, Immunoblots of whole cell lysates from TRF2F/-53BP1-/-, TRF2F/-53BP1+/-, and
TRF2F/+53BP1-/- MEFs harvested 72 hours post Hit&Run Cre retroviral infections. Blots were
probed with Abs specific to 53BP1 (100-305) and TRF2 (647). A non-specific band from the
TRF2 blot was used as loading control.
b, IF for 53BP1 (red), performed with anti-53BP1 Ab (100-304) in TRF2F/- 53BP1+/- and
TRF2F/- 53BP1-/- MEFs, fixed 72 hours post Hit&Run Cre infections. Images were merged with
DNA counterstained with DAPI (blue).
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53BP1 is required for NHEJ of dysfunctional telomeres
Using these MEFs, we determined the contribution of 53BP1 to NHEJ by scoring the
frequency of telomere fusions on metaphase spreads. Deletion of TRF2 from
TRF2F/-53BP1+/- MEFs caused the expected level of telomere fusions: on average 33% of
chromosome ends fused at 120 hours post Cre infections (equivalent to 4 population
doublings) (Figure 4.2a, b). The frequency of chromosome end fusions was scored in
parallel on metaphase spreads from TRF2F/-53BP1-/- MEFs, collected at the same time
point after Cre-mediated TRF2 deletion. Surprisingly, in the absence of 53BP1, we
observed at least a 50-fold reduction in the frequency of NHEJ events (Figure 4.2a, b).
This phenotype was significantly more severe than the 3-5 fold reduction in fusion
frequency in NBS1- and MDC1-deficient MEFs (Chapters 2 and 3). In fact, the
consequence of 53BP1 deficiency was comparable to observations previously reported in
cells lacking DNA ligase IV 190. Similarly to DNA ligase IV, 53BP1 thus appeared to be
an essential component of the NHEJ pathway at dysfunctional telomeres.
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Figure 4.2. NHEJ repair of dysfunctional telomeres in 53BP1-proficient and 53BP1deficient cells
a, Representative metaphase chromosomes from TRF2F/-53BP1+/- and TRF2F/-53BP1-/- cells,
harvested 120 hours after Hit&Run Cre infections. Images of telomeric DNA, detected with a
telomere-specific FITC-OO-(AATCCC)3 probe (in green) merged with total DNA, stained with
DAPI (in red).
b, Table summarizing the frequency of fusion events, scored per chromosome end, in metaphase
spreads prepared from cells described in (a). The total number of chromosomes scored in each
instance is indicated in parenthesis. The median±s.d. derived from 3 independent experiments is
given.
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Previous experiments using RNAi to stably downregulate 53BP1 in human
HeLa1.3 cells did not result in impaired NHEJ of dysfunctional telomeres (Figure 4.3a,
b), although by immunoblotting, 53BP1 protein appeared significantly reduced (Figure
4.3a). The conflicting results could be explained if fusions induced by the overexpression
of TRF2-DN are not dependent on 53BP1. The alternative possibility that we favor is that
a trace amount of 53BP1 protein is sufficient to promote NHEJ, emphasizing the
advantage of using a genetic knockout over shRNA knockdown.

Figure 4.3. Effect of 53BP1 RNAi on telomere NHEJ in the presence of TRF2-DN
a, HeLa1.3 cells expressing luciferase- or 53BP1-specific shRNAs, sh1 or sh2, delivered from
pSuperior retroviral vector, were harvested 48 hours post infection with control β-gal or myctagged TRF2-DN adenovirus. Immunoblots of whole cell lysates from these cells were probed
with anti-53BP1 (100-305) and anti-myc (9E10) Abs.
(b) Bar graph indicating the average relative frequency of chromosome fusions scored in 2
independent experiments on metaphase spreads from cells in (a) stained with DAPI.
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To confirm that 53BP1 is required for the repair of dysfunctional telomeres upon
TRF2 deletion with an independent method, we monitored the fusion reaction by an ingel hybridization assay. We harvested TRF2F/-53BP1+/- and TRF2F/-53BP1-/- cells at 72,
96, and 120 hours post Cre-mediated TRF2 deletion, and analyzed the progressive
disappearance of the telomeric G-rich overhang as well as the concurrent appearance of
high molecular weight fusion products on the denatured gel (Figure 4.4a). Both reactions,
which are well-established measures for the process of NHEJ at TRF2-depleted
telomeres, were impaired in 53BP1-deficient cells (Figure 4.4a, b). In fact, instead of
overhang loss, we observed a 2-3 fold increase in the overhang signal upon TRF2
deletion from 53BP1-deficient cells (Figure 4.4b). A similar increase in overhang signal
has been reported in Ku70- and DNA Ligase IV-deficient cells 190,236, where the fusion
step is blocked, and we observed the same phenomenon in MDC1-deficient cells (Figure
3.9a), where NHEJ is delayed. Most likely, it represents progressive resection at
deprotected chromosome termini in the absence of a functional NHEJ pathway.
The presence of long single-stranded DNA at DSBs is potentially inhibitory to the
NHEJ pathway. Therefore, it is possible that the contribution of 53BP1 to NHEJ may be
to prevent resection at DNA ends. That would explain why in absence of 53BP1 we
observed inhibition of NHEJ, concomitant with the presence of elongated 3’ G-rich tails.
Such model, however, is unlikely because 53BP1 also localizes to chromosome ends in
POT1a/POT1b double knockout cells but fails to prevent extensive 5’ end resection in
that setting 197.
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Figure 4.4. Analysis of overhang processing of dysfunctional telomeres in 53BP1-proficient
and 53BP1-deficient cells.
a, In-gel detection of telomeric DNA from TRF2F/-53BP1-/- and TRF2F/-53BP1+/- MEFs, harvested
96 hours post mock infection or 96 and120 hours post Hit&Run Cre retroviral infections. DNA in
agarose plugs was separated on agarose gel by pulse-field gel electophoresis and hybridized ingel to a radioactively labeled (CCCTAA)4 probe (native). The DNA was denatured in situ and
rehybridized to the same probe (denatured).
b, Bar graph quantifying the effect of 53BP1 deficiency on overhang processing in cells
described in (a), mock treated or treated with Hit&Run Cre retrovirus for 72, 96, or 120 hours,
and processed by in-gel overhang assay as in (a). In each lane, the ssTTAGGG signal quantified
under native condition was normalized to the total TTAGGG signal, detected after denaturation.
The relative overhang signal at each time point represents the normalized ssTTAGGG signal in
Cre-treated cells, compared to mock-treated cells (set at 100%) for each cell line. Error bars
indicate s.d. from the mean in three independent experiments.
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53BP1 deficiency does not affect checkpoint signaling or TIF formation
Whereas the NHEJ of dysfunctional telomeres was severely impaired in TRF2F/-53BP1-/cells, the DNA damage signaling pathway was not affected by the absence of 53BP1.
Analysis of Western blots indicated that ATM and its downstream target Chk2 were
phosphorylated to an equal extent in 53BP1-proficient and 53BP1-deficient MEFs
following telomere deprotection (Figure 4.5a). Additionally, the number of cumulative
population doublings of TRF2F/-53BP1+/- and TRF2F/-53BP1-/- MEFs at 72 and 120 hours
after Hit&Run Cre infections indicated that these cells underwent a comparable number
of cell divisions regardless of their 53BP1 status (Figure 4.5b). Moreover, the S-phase
index of Cre-treated TRF2F/-53BP1+/- and TRF2F/-53BP1-/- MEFs, calculated as the
percentage of cells that incorporated the thymidine analogue BrdU in 1 hour, was also not
affected by 53BP1 deficiency (Figure 4.5c). Collectively, these important controls
confirmed that, as previously established, 53BP1 does not play a significant role in
checkpoint signaling. Moreover, these data ensured that the inhibitory effects of 53BP1deficiency on NHEJ were not due to changes in cell cycle progression.
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Figure 4.5. Effects of 53BP1 status on checkpoint signaling and proliferation rates
a, Immunoblots of whole cell lysates from TRF2F/-53BP1+/- and TRF2F/-53BP1-/- MEFs harvested
72 hours post mock or Hit&Run Cre retroviral infections. Blots were probed with Abs raised
against Chk2, ATM-S1981-P, total ATM (MAT3), and TRF2 (1254). A non-specific band from
the TRF2 Western was used as a loading control.
b, Growth curve of cumulative population doublings of TRF2F/-53BP1+/- and TRF2F/-53BP1-/MEFs plated at 24 hours after Hit&Run Cre retroviral infections and counted at 72 and 120 hours
post Cre. Error bars indicate s.d. in triplicate experiments.
c, Table presenting the percentage of cells with BrdU-specific IF signal. TRF2F/-53BP1+/- and
TRF2F/-53BP1-/- MEFs were grown for 1 hour in medium containing BrdU at 96 and 120 hours
post mock or Hit&Run Cre retroviral infections. Cells were fixed and processed for IF with a
fluorophore-conjugated anti-BrdU Ab. The fraction of cells exhibiting BrdU incorporation was
determined by fluorescent microscope analysis.
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We also examined how absence of 53BP1 affected the accumulation of the DNA
damage site markers γ-H2AX, MDC1, and NBS1 in TIFs. We found that at least 68% of
both 53BP1-deficient and 53BP1-proficient cells contained γ-H2AX, MDC1, and NBS1
foci at telomeres (Figure 4.6a, b). This result is entirely consistent with previous
experiments 132, which have not attributed any role to 53BP1 in the accumulation of these
factors in IRIFs. In sum, 53BP1 was not involved in either checkpoint response or
amplification of the DNA damage signal. We hypothesized that the main role of 53BP1
may be in promoting DNA repair.

132

Figure 4.6. Effect of 53BP1 status on TIF formation
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Figure 4.6. Effect of 53BP1 status on TIF formation
a, Representative examples of fluorescent microscopic images of TRF2F/- 53BP1-/- and TRF2F/53BP1+/- MEFs, fixed 72 hours after mock or Hit&Run Cre retroviral infections and processed for
IF-FISH. IF (in red) was performed with Abs raised against γ-H2AX, mouse MDC1, and mouse
NSB1 (93’6). Telomeric DNA was detected by FISH (in green) performed with a TTAGGG
repeat-specific FISH probe. DNA (in blue) was counterstained with DAPI. Images were merged.
b, Table summarizing the effects of 53BP1 status on TIF formation. The frequency of cells
(n>100) containing more than 10 IF signals for the indicated DNA damage response factors colocalizing with the telomere-specific FISH probe were scored in IF-FISH analysis performed in
(a).

The interactions of 53BP1 with modified chromatin contribute to its role in NHEJ
MDC1 is required for the stable accumulation of 53BP1 at chromatin surrounding sites of
DNA damage, including dysfunctional telomeres (Figures 3.4, 3.5 and 3.12) and DSBs
120,121

. Therefore, the delayed repair phenotype we reported in Chapter 3 in MDC1-

deficient cells was likely due to inefficient recruitment of 53BP1 to TIFs. Surprisingly,
53BP1 deletion caused a more severe repair defect than MDC1 absence (comparison
between Figures 3.13 and 4.2). This can only be explained if 53BP1 is involved in a
parallel, MDC1-independent pathway that contributes to its repair function. An obvious
candidate is the association of 53BP1 with dimethylated H4-K20 (H4-K20diMe), which
is required for the initial recruitment of 53BP1 to sites of DNA damage 138. X-ray
analysis has implicated D1521 located in the Tudor domain of 53BP1 to be required for
binding to H4-K20diMe. Accordingly, 53BP1-D1521A mutant fails to bind H4-K20diMe
and is characterized by impaired recruitment to IRIFs 138.
To test whether the Tudor domain-mediated recognition of H4-K20diMe
contributed to the role of 53BP1 in NHEJ, we complemented TRF2F/-53BP1-/- cells with
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wild-type human 53BP1 or mutant 53BP1-D1521A allele (see schematic in Figure 4.7a).
Previous work has established that expression of human 53BP1 can reconstitute 53BP1
function in 53BP1-/- MEFs 253. The two forms of 53BP1 were expressed equally at levels
comparable to endogenous 53BP1 as indicated by immunoblotting (Figure 4.7b).
Immunofluorescence analysis showed that, as expected, the recruitment of 53BP1D1521A to deprotected chromosome ends was diminished compared to exogenously
expressed wild type 53BP1, which formed large TIFs upon deletion of TRF2 (Figure
4.7c).
Next, we analyzed how the D1521A mutation in 53BP1 affected NHEJ. In this
experiment, as shown above, metaphase spreads of the control (vector) TRF2F/-53BP1-/cells showed no telomere fusions even at 120 hours after deletion of TRF2 (Figure 4.7d,
e). As an additional control, cells complemented with wild type 53BP1 exhibited
increasing frequency of telomere fusions at 96 and 120 hours post Cre expression. In
contrast, TRF2F/-53BP1-/- cells complemented with the 53BP1-D1521A mutant showed
no telomere fusions at the 96 hour time point, and at 120 hours post-Cre, the frequency of
fusions was 2-3 fold reduced compared to cells complemented with wild type 53BP1
(Figure 4.7d, e). Therefore, the Tudor domain-mediated interaction of 53BP1 with H4K20diMe contributed to the timely execution of NHEJ at dysfunctional telomeres.
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Figure 4.7. Analysis of 53BP1-D1521A mutant and its proficiency for NHEJ
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Figure 4.7. Analysis of 53BP1-D1521A mutant and its proficiency for NHEJ
a, Schematic of the domain structure of 53BP1 highlights the N-terminal cluster of S/TQ
ATM/ATR phosphorylation target sites, γ-H2AX interaction domain, Tudor domains, and Cterminal BRCT repeats. The critical Tudor domain D1521 residue is also indicated, as well as the
location of the BP1-2 allele.
b, Immunoblots of whole cell lysates from TRF2F/- 53BP1-/- cells, complemented with Nterminally myc-tagged vector, wild type 53BP1 (53BP1-WT), or 53BP1 D1521A mutant,
expressed from pLPC-puro retroviral delivery vector. Blots were probed with Abs specific to myc
(9E10) and γ-tubulin (clone GTU) as loading control.
c, Fluorescent microscopic images of cells described in (b), fixed 72 hours after mock or
Hit&Run Cre retroviral infections, and processed for IF (in red), performed with Ab raised
against 53BP1 (100-304), co-stained with TTAGGG-repeat specific FISH probe (in green). DNA
(in blue) was counterstained with DAPI. Images were merged
d, Metaphase spreads of cells described in (b), fixed untreated or 96 and 120 hours after Hit&Run
Cre retroviral infections. Telomeric DNA (in green) was detected with TTAGGG-repeat specific
FISH probe. DNA (in red) was stained with DAPI.
c, Bar graph summarizing the effect of Tudor domain mutation on NHEJ of dysfunctional
telomeres. The frequency of chromosome end fusions was scored on metaphase spreads prepared
as described in (d). More than 500 chromosomes were examined in each instance. Error bars
indicated s.d. from median in triplicate experiments.
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The finding that the Tudor domain mutation in 53BP1 did not abrogate NHEJ
argued that γ-H2AX/MDC1-mediated interaction of 53BP1 with chromatin also
contributed to NHEJ. This was already expected based on our analysis of
TRF2F/FMDC1-/- MEFs, where the rate of fusion of dysfunctional telomeres was reduced.
However, to test this model, we downregulated MDC1 by two independent shRNAs in
TRF2F/-53BP1-/- cells expressing the 53BP1-D1521A mutant allele. Efficient knockdown
of MDC1 in these cells was confirmed by immunoblotting (Figure 4.8a). Although cells
rescued with 53BP1-D1521A already showed impaired ability to carry out NHEJ, MDC1
downregulation led to further decrease in the frequency of fusion events detected upon
telomere deprotection (Figure 4.8b, c). The combination of Tudor domain 53BP1 mutant
and MDC1 downregulation phenotypically resembled complete absence of 53BP1. These
results demonstrated that efficient NHEJ of dysfunctional telomeres requires stable
association of 53BP1 at TIFs, which in turn can be promoted by the additive functions of
H4-K20diMe and γ-H2AX/MDC1.
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Figure 4.8. Role of MDC1-mediated recruitment of 53BP1 to chromatin in promoting NHEJ
a, Immunoblots of whole cell lysates from TRF2F/- 53BP1-/- MEFs, complemented with 53BP1D1521A, and treated with vector or MDC1-specific shRNAs, sh4 or sh5, delivered by pSuperior
retroviral vector. Cells were harvested 120 hours after mock or Hit&Run Cre retroviral infections.
Blots were probed with Abs specific to mouse MDC1 (300-757A), mouse TRF2 (1254), and γtubulin (clone GTU) as a loading control.
b, Representative examples of metaphase spreads of cells described in (a) fixed 120 hours after
Hit&Run Cre infections. Telomeric DNA (in green) was detected with TTAGGG-repeat specific
FISH probe. DNA (in red) was stained with DAPI.
c, Bar graph indicating the median frequency of chromosome end fusions scored in metaphases
prepared as described in (b). More than 500 chromosomes were examined in each instance. Error
bars represent s.d. in triplicate experiments.
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Hypothesis: 53BP1 preferentially affects NHEJ of distant DNA ends
Our analysis established an indispensable role for 53BP1 in promoting NHEJ of
dysfunctional telomeres. On one hand, the extensive requirement for 53BP1 in repair
appeared puzzling since 53BP1 does not have any domains that would suggest DNA
processing activities and 53BP1 is not required for NHEJ in the context of V(D)J
recombination. On the other hand, 53BP1 protein contains several protein-protein
interaction domains, at least one of which (the tandem Tudor domain) is known to
associate with a specific chromatin modification and to contribute to the repair function
of 53BP1. Hence, we tested whether 53BP1 might be involved in promoting NHEJ
directly by influencing the behavior of damaged DNA ends.
Previous data have indicated that 53BP1 contributes to NHEJ in CSR. In contrast,
53BP1 is not required for NHEJ in the context of most V(D)J recombination or random
chromosome-internal DSBs. It has been argued that the crucial difference between these
processes might be the distance between the DNA ends involved in the end-joining
reaction 135. Whereas the two ends generated by RAG1/2 or chromosome-internal DNA
damage are close together, the DNA ends generated by AID in CSR are often far apart as
are dysfunctional telomeres, which are processed by NHEJ in G1 when chromosome
ends are dispersed throughout the nucleus.
We considered two models for the mechanism by which 53BP1 might promote
NHEJ at distant sites. In one model, originally proposed by Nussenzweig and colleagues,
53BP1 would promote synapsis, providing a molecular ‘glue’ that holds the ends together
135

. In another, non-exclusive, model, we proposed that 53BP1 would endow damaged
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ends with higher mobility within the nucleus, thereby increasing the chance of their
juxtaposition.

Figure 4.9. Schematic of the live-cell imaging experiments
a, Schematic diagram of the fluorescently-labeled markers used in live-cell imaging studies.
b, eGFP-TRF1 to mark telomeres and mCherry-BP1-2 to mark dysfunctional telomeres were
introduced into TRF2F/- 53BP1-/- and TRF2F/-53BP1+/- MEFs. Time-lapse microscopy was
performed 72-84 hours after Hit&Run Cre-mediated deletion of TRF2. Individual dysfunctional
telomeres were tracked and the dynamic properties of their traces were analyzed.
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Time-lapse microscopy setup
We turned to time-lapse microscopy to address whether 53BP1 altered the synapsis
and/or dynamics of deprotected telomeres (Figure 4.9a, b). To detect telomeres, we
introduced an eGFP-tagged version of the shelterin component TRF1 into
TRF2F/- 53BP1-/- and TRF2F/-53BP1+/- cells (Figure 4.9a). TRF1 is known to remain
associated with telomeres when TRF2 is removed thereby providing a reliable marker for
both functional and dysfunctional telomeres. Overexpression of this and other forms of
TRF1 does not affect the protective function of telomeres 254. As expected, eGFP-TRF1
fluorescent signals exhibited a nuclear pattern of discrete localization sites, which
coincided with TRF2 signals (Figure 4.10a). The pattern of eGFP-TRF1 remained
unchanged upon TRF2 deletion (Figure 4.10b).
In order to mark dysfunctional telomeres, we introduced an mCherry labeled,
functionally impaired, allele of 53BP1 (mCherry-BP1-2, comprising aa 1220-1711; see
Figure 4.7a for schematic, Figure 4.9a) that localizes to chromatin near DSBs and
deprotected telomeres but lacks the N-terminal S/T-Q ATM/ATR target sites, most of the
γ-H2AX binding region, and the C-terminal BRCT domains. Fluorescence microscopic
analysis confirmed that in the absence of telomere dysfunction, mCherry-BP1-2 was
homogeneously distributed throughout the nucleus, whereas upon deletion of TRF2,
mCherry-BP1-2 localized to telomeric sites containing eGFP-TRF1 both in 53BP1proficient and 53BP1-deficient cells (Figure 4.10b). Therefore, mCherry-BP1-2 was a
good marker for telomere dysfunction.
Immunoblots verified that both fluorescently-labeled markers were expressed at
equal levels in TRF2F/-53BP1-/- and TRF2F/-53BP1+/- cells (Figure 4.10c). Additionally,
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for each imaging experiment, we confirmed by immunoblotting that Hit&Run Cre
expression in these cells resulted in efficient deletion of TRF2, thereby inducing telomere
dysfunction (Figure 4.10c).

Figure 4.10. Expression and localization of fluorescent markers
a, Representative images of TRF2F/- 53BP1-/- and TRF2F/-53BP1+/- cells expressing eGFP-TRF1
from pWzl-hygro retroviral expression vector, processed for IF with Ab specific to mouse TRF2
(1254) (in red). eGFP signal (in green) was detected by fluorescence microscope. DNA (in blue)
was stained with DAPI.
b, Microscopic images of eGFP (in green) and mCherry (in red) fluorescence signals in TRF2F/53BP1-/- and TRF2F/-53BP1+/- MEFs, expressing eGFP-TRF1 from pWzl-hygro and mCherry-
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BP1-2 from pLPC-puro retroviral expression vectors. Cells were fixed untreated or 72 hours after
Hit&Run Cre retroviral infections. Images were merged and enlarged.
c, Immunoblots of whole cell lysates prepared from cells in (b). Blots were probed with the
following Abs: anti-mouse TRF1, anti-53BP1 (100-305), and anti-TRF2 (647). TRF2F/-53BP1+/cells not expressing fluorescent markers and untreated with Cre were used as control. Nonspecific band from the TRF2 blot was used as a loading control.

We also verified that the DNA damage marker mCherry-BP1-2 did not restore
53BP1 function in 53BP1-deficient cells and did not act as a strong dominant negative
allele in 53BP1 wild type setting. Metaphase spreads from TRF2F/-53BP1-/- cells
expressing eGFP-TRF1/mCherry-BP1-2 did not contain fusions at 120 hours after
deletion of TRF2, while metaphase spreads from TRF2F/-53BP1+/- cells expressing eGFPTRF1/mCherry-BP1-2 showed that ~15% of the chromosome ends had become fused at
the same time point (Figure 4.11). These results established that the mCherry-BP1-2
marker might weakly, but not significantly, inhibit the NHEJ pathway. We also repeated
key imaging experiments in cells lacking the 53BP1 fragment with the same outcome
(see below) further establishing mCherry-BP1-2 as a neutral marker for DNA damage in
this context.
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Figure 4.11. Validation of mCherry-BP1-2 as a neutral DNA damage marker
Detection of telomere fusions in metaphase spreads of TRF2F/- 53BP1+/- and TRF2F/-53BP1-/MEFs, expressing eGFP-TRF1 and mCherry-BP1-2, fixed untreated or at 120 hours after
Hit&Run Cre retroviral infections. Telomeric DNA (in green) was detected with a TTAGGGrepeat specific FISH probe. Total DNA (in red) was stained with DAPI. Numbers in the bottom
two panels indicate the frequency of chromosome end fusions scored in 2 independent
experiments. At least 330 chromosomes were scored in each instance.
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Live-cell imaging of dysfunctional telomeres in the presence and absence of 53BP1
To analyze the movement of dysfunctional telomeres in the presence and in the absence
of 53BP1, time-lapse microscopy was performed on TRF2F/-53BP1+/- and
TRF2F/-53BP1-/- cells, expressing eGFP-TRF1 and mCherry-BP1-2 markers, at 72-84
hours after introduction of Cre. At this early stage after deletion of TRF2, DNA damage
foci had formed at telomeres but telomere fusions were not yet prominent so that most
TRF1-marked sites represented free chromosome ends. Cells were monitored using a
DeltaVision RT microscope installed with an environmental chamber that maintained the
temperature at 37°C. Three-dimensional stacks of eGFP and mCherry signals
encompassing a 5 µm Z-distance were acquired every 30 seconds. Images were
subsequently digitally deconvolved and projected in two dimensions.
Originally, we had intended to analyze the relative behavior of telomeres over
long periods of time (~6 hours). We wanted to address the frequency of synapsis between
dysfunctional telomeres in the absence of 53BP1 and ask whether such associations
persisted over time, giving rise to productive repair events, or dissociated prematurely.
Such analysis was geared towards testing the ‘glue’ model for 53BP1 function. However,
it was not possible to image MEFs under high magnification for prolonged periods of
time due to their mobility. Instead, we settled for 20-minute imaging sessions, when cell
motility was not a significant factor but fusion events were rarely observed. Nevertheless,
at this stage, we could still obtain information on the dynamic behavior of individual
dysfunctional telomeres.
Initial analysis of 20-minute movies indicated that in TRF2F/-53BP1+/- cells, the
telomeres exhibited a greater mobility after TRF2 deletion whereas the dysfunctional
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telomeres in TRF2F/-53BP1-/- cells appeared more static (Video 3-8). We observed
occasional apparent fusion events (two telomeres joining and staying together during the
imaging session) in 53BP1-proficient cells lacking TRF2 (Video 1). In contrast, no
potential fusions were observed in 53BP1 deficient cells even for telomeres that were
closely apposed at the beginning of the imaging session (Video 2). These crude
observations suggested that there might be quantitative difference in the mobility of
dysfunctional telomeres in 53BP1-proficient and 53BP1-deficient cells.

Videos 1-2. Potential fusion events in TRF2F/-53BP1+/- but not in TRF2F/-53BP1-/- cells
The movies highlight telomeres undergoing a potential fusion reaction in a TRF2F/-53BP1+/- cell
(Video 1) or a group of closely apposed, but static telomeres in a TRF2F/-53BP1-/- cell (Video 2).
TRF2F/-53BP1+/- and TRF2F/-53BP1-/- cells were imaged 72 h after Hit&Run Cre infection. Zstacks of eGFP-TRF1 [green] and mCherry-BP1-2 [red] signals were acquired every 30 sec over
20 min. Videos constructed from deconvolved and projected frames are supplemented in a DVD.
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Videos 3-8. Dynamic movement of dysfunctional telomeres in 53BP1-proficient and 53BP1deficient cells
Representative TRF2F/-53BP1+/- (Videos 3-5) and TRF2F/-53BP1-/- (Videos 6-8) cells imaged 72 h
after Hit&Run Cre infection. Z-stacks of eGFP-TRF1 [green] and mCherry-BP1-2 [red] signals
were acquired every 30 sec over 20 min. Videos constructed from deconvolved and projected
frames are supplemented in a DVD.
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Quantitative analysis of the movement of dysfunctional telomeres
To obtain a quantitative measure of telomere mobility, we tracked individual eGFPTRF1-labeled dysfunctional telomeres that contained mCherry-BP1-2 within projected
images using ImageJ software. Figure 4.12 shows telomeres tracked in representative
nuclei of TRF2F/-53BP1+/- and TRF2F/-53BP1-/- cells, imaged 72 hours after Cre-mediated
TRF2 deletion. As a control, eGFP-TRF1-marked functional telomeres in cells not
treated with Cre were also examined. From each genotype and treatment, we chose at
least 10 cells for analysis, and per cell, we focused on 5 representative telomeres. Only
telomeres, which were continuously tracked for at least 18 out of 20 minutes were
considered. The x and y coordinates were extracted for each telomere, at each time frame,
and used to calculate two parameters – the cumulative distance traveled in 20 minutes
and the maximal displacement from starting point recorded during the 20-minute imaging
session. In order to correct for cell mobility, cells were registered using software that
offset translational and rotational movements. To further manually correct for finer cell
movements, the average x and y positions of all analyzed telomeres in a given cell were
used as a reference point in the calculations (in literature also referred to as weight
center). Telomeres that showed obvious aberrant synchronous movement due to local
repositioning of part of the nucleus (see Figure 4.12b for example) were excluded from
analysis.
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Figure 4.12 Tracking of individual dysfunctional telomeres in whole nuclei of 53BP1proficient and 53BP1-deficient cells
a, (Left) Traces (multicolored) of individual eGFP signals (in green) tracked in a representative
TRF2F/-53BP1+/- cell, expressing eGFP-TRF1 and mCherry-BP1-2, imaged 72 hours after
Hit&Run Cre retroviral infections. Snapshot is at t=20 minutes. (Right) Overlay of the eGFP (in
green) and mCherry (in red) signals. Boxes indicate 5 eGFP-marked telomeres, which were
chosen for further analysis based on two criteria. They co-localized with mCherry signals and
were tracked for at least 18 minutes.
b, A representative TRF2F/- 53BP1-/- cell, presented as in (a). Circle highlights telomeres that
would be excluded from analysis due to aberrant movement of part of the nucleus.
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53BP1 is required for increased mobility of deprotected telomeres
Detailed examination of tracks of individual functional and dysfunctional telomeres from
TRF2F/-53BP1+/- and TRF2F/-53BP1-/- MEFs, imaged for 20 minutes (Figure 4.12)
revealed two striking phenotypes. In the first place, we noted that in the 53BP1-proficient
setting, dysfunctional telomeres were more dynamic than functional telomeres. This
conclusion was made based on comparative visual analysis of telomere tracks (Figure
4.13a, top), which appeared to cover a greater territory in Cre-treated compared to
untreated cells. In addition, there was a marked difference in the slopes of curves, which
portrayed the cumulative distance travelled by individual telomeres as a function of time
(Figure 4.13b, top). The slopes of curves derived from analysis of dysfunctional
telomeres were steeper in comparison to the ones corresponding to functional telomeres,
indicating faster movement. Second, we noticed that in 53BP1-deficient cells, the
mobility of functional and dysfunctional telomeres differed less. Telomere tracks
appeared similar in the absence and in the presence of telomere dysfunction in TRF2F/53BP1-/- MEFs (Figure 4.13a, bottom). Moreover, the slopes of curves, plotting
cumulative distance traveled as a function of time, for representative functional and
dysfunctional telomeres, were also indistinguishable in 53BP1-deficient cells (Figure
4.13b, bottom). These observations suggested that, in response to telomere dysfunction,
chromosome ends become more mobile, and that this increase in dynamic behavior is
dependent on 53BP1.
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Figure 4.13. Tracking of individual telomeres
a, Representative traces (in yellow) of eGFP signals (in green) that also co-localized with
mCherry in TRF2F/-53BP1+/- and TRF2F/-53BP1-/- MEFs, expressing eGFP-TRF1 and mCherryBP1-2, imaged untreated or 72 hours post Hit&Run Cre retroviral infections. Snapshots were
taken at indicated time points during a 20-minute imaging session.
b, Graphs of cumulative distance traveled by individual eGFP-marked telomeres, described in (a)
plotted as a function of time.

These initial observations, made on individual telomeres, were confirmed when
we analyzed statistically significant populations of functional and dysfunctional
telomeres in cells of each genotype. The p-values were calculated using a two-tailed
Mann-Whitney test (also referred to as rank sum test), which compares two unpaired
groups without assuming Gaussian distribution.
We found that the behavior of functional telomeres in 53BP1-proficient and
53BP1-deficient cells was similar. Both traveled in a random walk over a total path of
approximately 3.7-3.9 µm in a 20-minute imaging session (Figures 4.14a-c). The
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calculated median speed, 180-190 nm/min-1, is comparable to movement of human
telomeres previously reported in 255. In contrast, dysfunctional telomeres in Cre-treated
TRF2F/-53BP1+/- were significantly more mobile, traveling at a speed of
270-360 nm/min-1, over a median cumulative distance ranging from 5.4 to 7.2 µm
(Figures 4.14a, c). As expected from the visual observations above, the increased
mobility associated with telomere dysfunction was attenuated in cells lacking 53BP1,
resulting in a median cumulative distance traveled of 4.4±0.2 µm with a speed of 220
nm/min-1 (Figures 4.14b, c). These data established that telomeres become more mobile
when they are deprived of their normal protection and that this change in their dynamic
behavior is promoted by 53BP1.
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Figure 4.14. Effect of 53BP1 absence on the mobility of dysfunctional telomeres
a-b, Graph of the frequency distribution of the number of eGFP/mCherry-traced telomeres
plotted against the cumulative distance they traveled in 20 minutes. (a) TRF2F/-53BP1+/- and (b)
TRF2F/-53BP1-/- MEFs, expressing eGFP-TRF1 and mCherry-BP1-2 markers were imaged
untreated (grey bars) or 72 hours post Hit&Run Cre retroviral infections (red bars). 55 telomeres
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in 11 cells were analyzed for each genotype and treatment. The median values and s.d. are
indicated. P-values were calculated using a two-tailed Mann-Whitney test.
c, Summary of the median speed and median cumulative distance traveled in 20 minutes,
recorded in three independent imaging sessions. Cells with the indicated genotypes, expressing
eGFP-TRF1 and mCherry-BP1-2 markers were imaged at 72 hours after mock or Hit&Run Cre
infections. The difference between experiments 1/3 and experiment 2 might be due to the
different cell lines used ((A/B) vs (C/D) as indicated).

53BP1 functions to expand the two dimensional territory that dysfunctional telomeres
sample
We also examined the maximum displacement from their starting point for individual
telomeres during a 20-minute imaging session, which is a measure for the territory that
these telomeres sampled. Previous data have indicated that chromosomal sites have a
limited range of motion, showing constrained diffusion within a territory with a diameter
≤0.5 µm 255,256. We asked whether functional telomeres were similarly constrained.
Indeed, we found that functional telomeres in TRF2F/-53BP1+/- and TRF2F/-53BP1-/MEFs sampled territories with comparable median diameters of 0.51-0.53 µm (Figure
4.15a-c). Next, we determined whether dysfunctional telomeres had the dynamic
potential to explore larger nuclear compartments compared to functional telomeres.
Noticeably, induction of telomere dysfunction in TRF2F/-53BP1+/- cells caused a 2-fold
increase in the median maximum displacement. Whereas functional telomeres in 53BP1proficient cells were constrained within a territory with a median diameter of 0.51±0.29
µm, dysfunctional telomeres moved within a significantly larger region with a median
diameter of 1.2±0.3 µm (Figures 4.15a, c). Again, 53BP1 deficiency affected the extent
of territory expansion upon induction of telomere dysfunction. For dysfunctional
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telomeres in TRF2F/-53BP1-/- cells, we calculated that the median maximum displacement
from their starting point only slightly increased to 0.8±0.15 µm (Figures 4.15b, c). These
data established that 53BP1 also functions to expand the territories explored by
dysfunctional telomeres.
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Figure 4.15. Effect of 53BP1 absence on the size of the territory sampled by dysfunctional
telomeres
a-b, Graph of the frequency distribution of the number of eGFP/mCherry-traced telomeres
plotted against maximum displacement from starting point registered in 20 minutes. (a) TRF2F/53BP1+/- and (b) TRF2F/-53BP1-/- MEFs, expressing eGFP-TRF1 and mCherry-BP1-2 markers
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were imaged untreated (grey bars) or 72 hours post Hit&Run Cre retroviral infections (red bars).
55 telomeres in 11 cells were examined for each genotype and treatment. The median values and
s.d. are indicated. P-values were calculated based on a two-tailed Mann-Whitney test.
c, Summary of maximum displacement from starting point registered in 20 minutes, from three
independent imaging sessions, recorded 72 hours after mock or Hit&Run Cre infections. Cells
with the indicated genotypes expressed the eGFP-TRF1 and mCherry-BP1-2 markers. The
difference between experiments 1/3 and experiment 2 might be due to the different cell lines used
((A/B) vs (C/D) as indicated).
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mCherry-BP1-2 is a neutral marker
The presence of the mCherry-BP1-2 DNA damage marker did not affect the outcome.
Comparable cumulative distance and maximum displacement results were obtained after
deletion of TRF2 from 53BP1+/- or 53BP1-/- cells that expressed the eGFP-TRF1 marker
but lacked the 53BP1 fragment (Figure 4.16a, b; Videos 9-16).

Videos 9-16. Dynamic movement of functional and dysfunctional telomeres in 53BP1proficient and 53BP1-deficient cells in the absence of mCherry-BP1-2
Representative TRF2F/-53BP1+/- (Videos 9, 11-13) and TRF2F/-53BP1-/- (Videos 10, 14-16) cells
were imaged untreated (Videos 9-10) or 72 h after Hit&Run Cre infection (Videos 11-16). Zstacks of eGFP-TRF1 signal were acquired every 30 sec over 20 min. Videos constructed from
deconvolved and projected frames are supplemented in a DVD.
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Figure 4.16. Confirmation of results in cells expressing mCherry-BP1-2 marker
a, Graph of the frequency distribution of the number of eGFP-traced telomeres plotted against the
cumulative distance they traveled in 20 minutes. (left) TRF2F/-53BP1+/- and (right)
TRF2F/-53BP1-/- MEFs, expressing eGFP-TRF1 only, were imaged untreated (grey bars) or 72
hours post Hit&Run Cre retroviral infections (red bars). 60 telomeres in 12 cells were analyzed
for each genotype and treatment. The median values and s.d. are indicated. P-values were
calculated based on a two-tailed Mann-Whitney test.
b, Graph of the frequency distribution of the number of eGFP-traced telomeres plotted against
maximum displacement from starting point registered in 20 minutes in cells from (a).
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Outliers may determine the rate of NHEJ of dysfunctional telomeres
The median results described above were derived from analysis of populations of
telomeres. When we looked at the maximum displacement of individual telomeres, we
noticed that a substantial fraction (>10%) of the dysfunctional telomeres in 53BP1proficient cells roamed well beyond 2 µm whereas none of the 115 functional telomeres
analyzed moved beyond that distance (Figure 4.15 and 4.16). When 53BP1 was not
present, not only the median maximum displacement diminished, but also only one out of
115 dysfunctional telomeres in 53BP1 null cells sampled an area beyond 2 µm. Given
that the diameter of an average MEF nucleus is 20 µm, dysfunctional telomeres, for
which we recorded a maximum displacement from their starting point greater than 2 µm
in 20 minutes, would have the capacity to probe a significant fraction of the nuclear
volume over the course of G1 (6 hours), when NHEJ of dysfunctional telomeres takes
place 237. Assuming that the rate of NHEJ correlates with the probability of an encounter
between two telomeres, the ability of 53BP1 to expand the territory visited by
dysfunctional telomeres could be an explanation for its effect on telomere fusion.
Preliminary MSD analysis further corroborated this conclusion. The area covered
by the most mobile dysfunctional telomeres in 53BP1-proficient cells was found to
increase proportionally to time, whereas dysfunctional telomeres in 53BP1-deficient cells
remained corralled within limited territories that did not expand as a function of time
(Figure 4.17). We propose that the telomeres sampling the largest territories have the
greatest chance of meeting a fusion partner, and thereby undergo NHEJ repair.
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Figure 4. 17. MSD analysis
a-b, Graph of the square displacement (SD) of two representative eGFP-traced telomeres, imaged
in TRF2F/-53BP1+/- (a) or TRF2F/-53BP1-/- (b) MEFs at 72 hours after Hit&Run Cre retroviral
infection, plotted against time. The displacement from starting position (t=0) was calculated at
each time-point (frame), squared, and plotted against time. The plots depict the random back and
forth movement of individual telomeres
c, Graph of the mean square displacement (MSD) of 60 eGFP-traced telomeres, imaged in
TRF2F/-53BP1+/- (red line) or TRF2F/-53BP1-/- (blue line) MEFs at 72 hours after Hit&Run Cre
retroviral infection, plotted against time. For each telomere, the displacement from starting
position (t=0) was calculated at each time-point (frame) and squared. The mean value for 60
telomeres in each cell line was plotted against time. Plots indicate that although individual
telomeres can have eratic motion (a, b), on average, telomeres tend to move away from starting
point as time progresses.
d, Same as in (c) but telomeres from TRF2F/-53BP1+/- MEFs were separated in two populations,
fast (24 telomeres, green line) and slow (36 telomeres, orange line). The movement of the fast
telomeres has the characteristics of free diffusion (dashed line). On the other hand, the plot of the
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slow telomeres overlaps with the plot of the telomeres imaged in TRF2F/-53BP1-/- MEFs (blue
line. The plateau these plots reach is characteristics for diffusion in constrained space.

ATM, but not DNA ligase IV, is required for increased mobility of deprotected
telomeres
Since cells lacking 53BP1 failed to execute NHEJ of dysfunctional telomeres, we tested
whether the absence of the NHEJ reaction itself might explain the slower movement of
the telomeres. To test this hypothesis, we introduced the eGFP-TRF1 telomere marker
into TRF2F/-lig4-/-p53-/- MEFs, which are impaired for NHEJ. As before, we performed
live-cell imaging with these cells at 72 hours after mock or Hit&Run Cre retroviral
infections. Similarly to what we observed above in TRF2F/-53BP1+/- cells, eGFP-TRF1marked telomeres in TRF2F/-lig4-/-p53-/- cells exhibited a considerable increase in their
mobility upon TRF2 deletion. Whereas functional telomeres in these cells traveled over a
median distance of 3.94±0.81 µm in 20 minutes and covered territory with a diameter of
0.34±0.15 µm, dysfunctional telomeres traveled over a median distance of 5.16±1.36 µm
in 20 minutes and doubled the median diameter of their territory to 0.68±0.32 µm (Figure
4.18a, c, d). Therefore, with respect to the dynamic behavior exhibited by dysfunctional
telomeres, DNA ligase IV deficiency did not appear to make a difference, despite its
essential role in NHEJ. We concluded that the attenuation in the movement of the
dysfunctional telomeres in 53BP1-deficient cells was not due to lack of their processing
by NHEJ.
On the other hand, we hypothesized that ATM kinase, the upstream regulator of
53BP1, which is required for efficient telomere fusions, may also be involved in
promoting the mobility of dysfunctional telomeres. To test this model, we performed
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time-lapse microscopy with TRF2F/-ATM-/- cells, expressing the eGFP-TRF1 telomere
marker. As before, we imaged live cells untreated or 72 hours after Cre-mediated TRF2
deletion. Indeed, in absence of ATM, dysfunctional telomeres failed to gain their
maximal mobility. In Cre-treated TRF2F/-ATM-/- cells, the median cumulative distance
traveled by dysfunctional telomeres in 20 minutes was 3.93±1.11 µm (Figure 4.18b, c),
similar to the range of motion we recorded for functional telomeres in ATM-deficient
cell, 3.44±0.68 µm. The difference between the territories covered by functional and
dysfunctional telomeres in ATM-deficient cells was also not significant (Figure 4.18d).
Thus, one mechanism by which ATM signaling may promote NHEJ is through 53BP1.
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Figure 4. 18. Effect of ATM or DNA ligase IV deficiency on the dynamics of dysfunctional
telomeres
a-b, Graphs of the frequency distribution of the number of eGFP-traced telomeres plotted against
the cumulative distance they traveled in 20 minutes. (a) TRF2F/-Lig4-/-p53-/- and (b) TRF2F/-ATM/-

MEFs, expressing eGFP-TRF1, were imaged untreated (grey bars) or 72 hours post Hit&Run

Cre retroviral infections (green bars). 50 telomeres in 10 cells were examined for each genotype
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and treatment. The median values and s.d. are indicated. P-values were calculated using a twotailed Mann-Whitney test.
c-d, Summary of (c) median speed and median cumulative distance traveled in 20 minutes and
(d) median maximum displacement from starting point registered in 20 minutes, from two
independent experiments, performed 72 hours after mock or Hit&Run Cre infections of cells with
the indicated genotypes, expressing eGFP-TRF1.

Increased mobility is a local event, limited to the chromatin surrounding a DSB
Next, we tested whether the increase in mobility was limited to the damaged chromatin as
would be expected if 53BP1 acts locally. We reasoned that if chromatin mobility was a
global response to DNA damage, functional telomeres should become more mobile upon
the induction of damage elsewhere in the genome. We used a modest amount of IR (1
Gy) to induce ~100 chromosome-internal DSBs and examined the mobility of
chromosome ends, tagged with the telomeric marker eGFP-TRF1. We tracked telomeres
immediately after the induction of DNA damage, or after 2 hours recovery. In both cases,
we found that the mobility of the telomeres was unaffected by IR arguing that increased
mobility is a local event taking place at the site of damage where 53BP1 accumulates
(Figure 4.19).
It could be argued that since dysfunctional telomeres have been eliciting a DNA
damage signal continuously for two days prior to imaging, the chromatin might be in an
altered state. This model is contradicted by evidence suggesting that TIF factors are
constantly exchanged between the chromatin and the nucleoplasmic pool, and therefore
TIFs are always “freshly” assembled 83. The ideal experiment to test whether telomere
dysfunction affects global chromatin behavior would be to examine a random genomic
locus in the presence or absence of telomere dysfunction. However, we could not perform
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this experiment because we did not have an appropriate fluorescently-labeled marker.
Instead we analyzed the dynamics of protected telomeres after the induction of genome
wide damage by IR in the absence of a functional NHEJ repair pathway by tracing the
mobility of eGFP-TRF1-containing telomeres in irradiated lig4-/-p53-/- cells (Figure 4.19,
green bars). Our results clearly indicate that the presence of unrepaired DSBs for
extended periods of time did not affect the mobility of telomeres (as an example of
undamaged chromatin).

Figure 4.19. Increased mobility is a local event
Graph of the frequency distribution of the number of eGFP-traced telomeres plotted against the
cumulative distance they traveled in 20 minutes. TRF2F/- or TRF2F/-lig4-/-p53-/- cells, expressing
eGFP-TRF1 telomere marker, untreated (grey) or treated with 1 Gy of γ-irradiation, were imaged
for 20 minutes immediately after irradiation (orange) or after 2 hours of recovery (red and green).
50 in 10 cells telomeres were examined for each treatment. The median values and s.d. are
indicated.
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Summary of findings in Chapter 4
In this chapter, we uncovered a novel aspect of the NHEJ repair of dysfunctional
telomeres. We found that telomere NHEJ is dependent on the DNA damage response
factor, 53BP1, which localized to H4-K20diMe and γ-H2AX/MDC1-containing
chromatin at TIFs. We established that the interactions of 53BP1 with chromatin
modifications were required not only for its stable association with dysfunctional
telomeres, but also for its role in promoting NHEJ of deprotected chromosome ends.
In the second part of the chapter, we described a live-cell imaging assay, in which
we could quantitatively analyze the dynamic features of sites of DSBs (dysfunctional
telomeres) before and after the induction DNA damage (TRF2-deletion induced telomere
dysfunction). The hypothesis we tested was based on the argument that the homogeneous
distribution of dysfunctional telomeres throughout the nucleus in G1 impedes NHEJ,
which requires close proximity of its substrates. Therefore, we reasoned that a
mechanism must exist to translocate telomeres within the nucleus in order to establish
fusion partners. In confirmation, we found that induction of telomere dysfunction
activated a 53BP1-dependent mechanism, which promoted the dynamic behavior of
telomeric sites, increasing both their speed and the diameter of their territory by a factor
of two. In addition, we found that ATM but not DNA ligase IV contributed to this
pathway. In the following chapter we have probed the mechanism by which 53BP1
promotes the dynamic behavior of dysfunctional telomeres.
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CHAPTER 5: DISSECTING THE MECHANISM THAT
PROMOTES MOBILITY OF DYSFUNCTIONAL
TELOMERES
Introduction
In the previous chapter, we presented data suggesting that upon deprotection, the
dynamic behavior of telomeres alters. We showed that while functional telomeres explore
limited territories within the nucleus, chromosome ends perceived as DSBs acquire
increased mobility and sample larger territories. We suggested that this active behavior,
promoted by 53BP1, directly augments the probability that two dysfunctional telomeres
encounter each other. In this chapter we examine in more detail the nature of the
increased mobility of dysfunctional telomeres and address the pathways that might be
responsible for promoting the dynamic behavior of unrepaired sites of DNA damage.

Increased mobility of dysfunctional telomeres is not specific to TRF2 deletion
In the first place, we tested whether increased mobility of dysfunctional telomeres is
specific to TRF2 deletion and the resulting activation of the ATM-dependent DNA
damage-signaling pathway. We examined another instance of telomere dysfunction,
induced by POT1a/b deletion, which activates ATR signaling and leads to the
accumulation of 53BP1 at dysfunctional telomeres 197,228.
We introduced eGFP-TRF1 and mCherry-BP1-2 markers into POT1aF/-POT1bF/S
MEFs and performed live-cell imaging 72 hours after Cre-mediated deletion of POT1a/b.
As before, in cells treated with Hit&Run Cre, we tracked eGFP-TRF1-containing
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dysfunctional telomeres that co-localized with mCherry-BP1-2 signals, and compared
their mobility to eGFP-TRF1-marked functional telomeres in cells that were not treated
with Cre (Figure 5.1a). The median cumulative distance traveled by POT1a/b-depleted
telomeres in 20 minutes was 4.8±0.9 µm, while POT1a/b-containing telomeres covered
only 3.2±0.7 µm during the same time period (Figure 5.1b). The analysis, however, was
complicated by the fact that cells lacking POT1a/b had undergone massive
endoreduplication, a known consequence of POT1a/b loss 197. The unresolved association
of sister chromatids may have limited the mobility of chromosome ends and therefore,
the results were difficult to interpret. Nevertheless, the increase in mobility was
statistically significant (Mann-Whitney test; p<0.0001) (Figure 5.1b; Videos 26-27).
Based on these data, we concluded that increased mobility of dysfunctional
telomeres is most likely not limited to TRF2-deletion but can occur as a consequence of
POT1a/b loss as well. These experiments also suggest that both ATM and ATR signaling
can activate this pathway, most likely through γ-H2AX phosphorylation, which in turn
plays a crucial role in the recruitment of 53BP1.
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Figure 5.1. Effect of POT1a/b deletion on the mobility of dysfunctional telomeres
a, Traces (multicolored) of individual eGFP-marked telomeres (in white) tracked for 20 minutes
in a representative POT1aF/-POT1bF/S cell, expressing eGFP-TRF1 and mCherry-BP1-2 markers,
imaged (Left) untreated (Video 26) or (Right) 72 hours after Hit&Run Cre retroviral infections
(Video 27). Videos are supplemented in a DVD.
b, Graph of the frequency distribution of the number of eGFP/mCherry-traced telomeres plotted
against the cumulative distance they traveled in 20 minutes. 40 telomeres from 8 cells were
analyzed in MEFs treated as described in (a). The median values and s.d. are indicated. P-value
was calculated using a two-tailed Mann-Whitney test.
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53BP1 does not affect the thermal persistence length of the chromatin fiber
As described in Chapter 4, 53BP1 requires extensive contacts with chromatin
modifications in order to efficiently execute its role in promoting NHEJ. When the
binding between 53BP1 and H4-K20diMe is disrupted or when the interaction mediated
through γ-H2AX/MDC1 is impaired, NHEJ of dysfunctional telomeres occurs
inefficiently and with delayed kinetics. Furthermore, when both contacts are removed
simultaneously, NHEJ is drastically inhibited; strongly arguing that 53BP1 needs to be
chromatin-bound in order to promote the repair of dysfunctional telomeres.
We asked whether 53BP1 might be involved in altering chromatin compaction
when bound at sites of DNA damage. We imagined that the increased dynamics of
dysfunctional telomeres might be due to a change in the rigidity of the chromatin fiber. In
this scenario, the mobility we observe is not due to a dynamic, active process, but a
consequence of the intrinsic characteristics (thermal persistence length) of the chromatin
fiber at the site of damage. Of particular interest in this regard are residues located in the
vicinity of H4-K20. Acetylation at H4-K16 has been implicated in altering the higher
order chromatin structure by preventing compaction in vitro 257. It is possible that when
53BP1 is bound to chromatin, it might promote or prevent this histone modification, thus
regulating the higher order status of the nucleosome array. Alternatively, 53BP1 could
function similarly to the transcriptional repressor L3MBTL1, which has been shown to
compact chromatin through its association with histone methylation marks, including H4K20diMe among others 258.
Following a protocol that has previously been used to demonstrate that gene-rich
domains are enriched for open chromatin fibers259,260, we performed sucrose gradient
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fractionation of chromatin isolated from TRF2F/-53BP1+/- and TRF2F/-53BP1-/- MEFs,
untreated or 96 hours after Cre-mediated deletion of TRF2. In this protocol, chromatin
fragments are separated based on their shape as well as their size. Open/unstructured
chromatin sediments slower compared to compact/rigid chromatin fibers despite having
the same length of DNA. Following micrococcal nuclease (MNase) digestion and
gradient sedimentation, we resolved the DNA fractions on agarose gel and hybridized to
a telomere-specific probe to analyze the telomeric chromatin (Figure 5.2). As a control,
we hybridized to a general (Bam) repeat-specific probe to detect bulk genomic DNA
(Figure 5.2). As previously reported, we noted that the nucleosome ladder in telomeric
chromatin was more diffuse in the top (small molecular weight) fractions compared to
bulk chromatin 261. However, we did not observe any difference in the structure of the
chromatin fiber between functional and dysfunctional telomeres, consistent with

262

. In

addition, no detectable distinction was noted between 53BP1-proficient and 53BP1deficient cells. These findings suggested that 53BP1 does not alter the persistence length
of the chromatin fiber.
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Figure 5.2. Analysis of the effects of 53BP1 absence and telomere dysfunction on the
structure of telomeric chromatin
Chromatin isolated from TRF2F/-53BP1+/- and TRF2F/-53BP1-/- nuclei, harvested untreated or 96
hours after Hit&Run Cre infections were digested by MNase, and the fragments were separated
on a 6-40% sucrose gradient. The gradient was fractionated from top (fraction 4) to bottom
(fraction 12). The DNA purified from each fraction was resolved by agarose gel electophoresis
and examined by Southern blotting. Blots were probed with telomere-repeat-specific (Sty11)
probe to examine telomeric DNA. Blots were stripped and reprobed with a Bam repeat-specific
(Bam) probe to detect total DNA.
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The mobility of dysfunctional telomeres is an active process
Since we did not obtain evidence for a structural change in the chromatin at telomeres,
we tested whether chromatin mobility is mediated through a dynamic mechanism.

Actin
Actin is the main component of multiple dynamic processes in the cell, such as cell
motility, cell division, vesicle and organelle movement. In addition, actin has been
implicated in many nuclear processes, including chromatin dynamics and gene
expression 263. Finally, rapid telomere movement during meiotic prophase I in yeast has
recently been linked to dynamic actin cables 264,265.
In order to test whether actin plays a role in promoting the mobility of
dysfunctional telomeres, we used a well-characterized actin inhibitor, Latrunculin A,
which inhibits actin polymerization and disrupts microfilament organization by
sequestering actin monomers.
This and other experiments in this chapter were performed in TRF2F/-53BP1+/- or
TRF2F/-53BP1-/- MEFs, expressing eGFP-TRF1 telomere marker, in which we have
confirmed that induction of telomere dysfunction led to increased telomere mobility in
53BP1-proficient, but not 53BP1-deficient cells (Figure 5.3a). In addition, we verified
that each experiment showed efficient TRF2 deletion and expression of eGFP-TRF1
marker (Figure 5.3b).
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Figure 5.3. Representative example of controls performed in all imaging experiments in
Chapter 5
a, Graph of the frequency distribution of the number of eGFP-labeled telomeres plotted against
the cumulative distance they traveled in 20 minutes. TRF2F/-53BP1+/- and TRF2F/-53BP1-/- MEFs,
expressing eGFP-TRF1 marker, were imaged untreated (grey bars) or 72 hours post Hit&Run Cre
retroviral infections (red and green bars). 50 telomeres in 10 cells were analyzed for each
genotype and treatment. The median values and s.d. are indicated. P-values were calculated using
a two-tailed Mann-Whitney test.
b, Immunoblots of whole cell lysates from cells in (a) probed with Abs raised against mouse
TRF2 and TRF1. A non-specific band from the TRF2 blot was used as a loading control.

Treatment of TRF2F/-53BP1+/- cells with 0.1 µg/ml (~0.25 µM) Latrunculin A did
not have an effect on the mobility of dysfunctional telomeres (Figure 5.4a). Since the
recommended final concentration ranges from 0.1 to 10 µg/ml, it is possible that we were
not inhibiting actin efficiently. Increasing the drug concentration to 1 µg/ml, however, led
to dramatic changes in cell shape; the fibroblasts rounded up and detached from the
imaging plate within minutes, making time-lapse imaging impossible. We also tried to
use alternative actin inhibitors, such as Cytochalasin B and D, which shorten actin
filaments by blocking monomer addition, at the recommended 10 µM concentration, but
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the consequences for cell shape were similar. If 0.1 µg/ml Latrunculin A is enough to
inhibit the dynamic properties of actin in the nucleus, we can conclude that the movement
of dysfunctional telomeres is not an actin-driven process. On the other hand, the data
cannot exclude that higher drug concentrations might be required to inhibit such activity.

Dynein, Light Chain 8
A recent study reports on a potential interaction between 53BP1 and light chain 8 (LC8)
of dynein, a motor protein that walks along cytoskeletal microtubules 266. This interaction
appears to be of functional significance since in its absence p53 fails to accumulate in the
nucleus following DNA damage. We tested whether this interaction contributed to the
dynamics of dysfunctional telomeres. The binding between 53BP1 and LC8 can be
disrupted by the introduction of a Tat-tagged KSTQT peptide (Tat-LC8), which mimics
the LC8-interaction motifs in 53BP1 and competes for the binding cleft of LC8. Although
we introduced the recommended concentration of Tat-LC8 or control Tat-KSAAA (TatCon) peptides into the imaging medium of Cre-treated TRF2F/-53BP1+/- cells for 24 hours
prior to the imaging session, we did not observe an effect on the movement of
dysfunctional telomeres (Figure 5.4b). This negative result, however, was not
interpretable. Since our analysis was performed in SV40-immortalized cells, we could
not replicate the previously published effect on p53 localization. Therefore, we could not
exclude that the peptide might not have been functional in our experimental setting.
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Microtubules
Since disrupting the interaction between 53BP1 and LC8 led to inconclusive results, we
sought a more general way of suppressing microtubule dynamics. The microtubule
network has several important roles in the cell, including vesicular transport and mitotic
spindle formation, but it is excluded from the nucleoplasm in interphase mammalian
cells.
A potential role for microtubules in nuclear processes has been studied
extensively in S. pombe, where the oscillatory nuclear movement (also referred to as
horse-tail movement) characteristic of meiotic prophase is dependent on cytoplasmic
dynein. The horse-tail movement, driven by cytoplasmic dynein–dynactin complexes in
combination with telomere clustering, is thought to facilitate the pairing of homologous
chromosomes as a prerequisite for accurate chromosome segregation 267,268.
In addition, a network that provides a physical link between the nucleus and
cytoplasmic microtubules has recently been identified in fission yeast. This connection is
established by SUN and KASH domain-containing proteins as well as by an inner nuclear
membrane protein called, Ima1 269. Ima1 simultaneously interacts with heterochromatin
regions within the nucleus and is enriched at sites of microtubule-organizing centers. In
this manner, cytoplasmic microtubules are mechanically coupled to nuclear chromatin,
suggesting the existence of a robust framework for communication between the
cytoplasmic cytoskeleton and the nuclear interior 269.
We asked whether microtubules contributed to telomere movement. Microtubules
can be efficiently and specifically inhibited by treatment with nocodazole, a well-known
anti-neoplastic agent that results in the depolymerization of microtubules. Nocodazole is
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often used as a tool for cell cycle synchronization, arresting cells in G2- or M-stages of
the cell cycle.
72 hours post Cre-mediated deletion of TRF2 from TRF2F/-53BP1+/- MEFs, we
introduced into the imaging medium a low, non-toxic dose of nocodazole (1 µg/ml) for a
short period (2 hours) before performing time-lapse microscopy. Treatment with
nocodazole had a profound effect on the movement of dysfunctional telomeres (Video
17-19). Whereas dysfunctional telomeres in DMSO (dimethyl sulfoxide)-treated cells,
traveled 5.17±1.15 µm in 20 minutes, in cells treated with nocodazole, dysfunctional
telomeres covered only 3.40±0.99 µm (Figure 5.4c). The decrease in mobility was also
evident by eye as shown in the whole-nuclei tracking of dysfunctional telomeres in
control and nocodazole-treated cells (Figure 5.5).
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Videos 17-21. Role of microtubule inhibition on the mobility of dysfunctional telomeres
Representative TRF2F/-53BP1+/- cells imaged 72 h after Hit&Run Cre infection in the presence of
DMSO (Video 17), 1 µg/ml Nocodazole (Video 18-19) for 1 hour, 1 hour recovery after the
treatment with 1 µg/ml Nocodazole (Video 20), or 20 µM taxol (Video 21) for 1 hour. Z-stacks of
eGFP-TRF1 signal were acquired every 30 sec over 20 min. Videos constructed from
deconvolved and projected frames are supplemented in a DVD.
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Figure 5.4. Role of cytoskeleton dynamics on the mobility of dysfunctional telomeres
a-c, Graphs of the frequency distribution of the number of eGFP-labeled telomeres plotted against
the cumulative distance they traveled in 20 minutes. TRF2F/-53BP1+/- MEFs, expressing eGFPTRF1 marker, were imaged 72 hours after Hit&Run Cre retroviral infections. Prior to imaging

181

cells were incubated with DMSO only (grey bars) or with (a) 0.1 µg/ml Latrunculin A for 30
minutes, (b) 50 µM Tat-tagged LC8-specific peptide overnight, or (c) 1µg/ml Nocodazole for 2
hours (red bars). 50 telomeres in 10 cells were analyzed for each treatment. The median values
and s.d. are indicated. P-values were calculated using a two-tailed Mann-Whitney test.

Figure 5.5. Effect of nocodazole treatment on the mobility of dysfunctional telomeres
Traces (multicolored) of individual eGFP-labeled telomeres (in white) tracked for 20 minutes in a
representative TRF2F/-53BP1+/- cell, expressing eGFP-TRF1 marker, imaged 72 hours after
Hit&Run Cre retroviral infections. Prior to imaging cells were incubated for 2 hours with (Left)
DMSO only or (Right) 1µg/ml Nocodazole.
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Disruption of microtubules did not affect chromatin mobility in general since
there was no effect of nocodazole on the movement of functional telomeres in TRF2F/53BP1+/- MEFs not treated with Cre (Mann-Whitney test; p=0.0168) (Figure 5.6).

Figure 5.6. Effect of nocodazole treatment on the mobility of functional telomeres
Graph of the frequency distribution of the number of eGFP-labeled telomeres plotted against the
cumulative distance they traveled in 20 minutes. TRF2F/-53BP1+/- MEFs, expressing eGFP-TRF1
marker were treated for 2 hours prior to imaging with DMSO only (grey bars) or with 1µg/ml
Nocodazole (red bars). 50 telomeres in 10 cells were analyzed for each treatment. The median
values and s.d. are indicated. P-value was calculated using a two-tailed Mann-Whitney test.
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In contrast to actin inhibitors, nocodazole did not affect cell adhesion and there
were not any obvious changes in nuclear shape. Moreover, 53BP1 TIF formation in
nocodazole treated cells was unaffected (Figure 5.7).

Figure 5.7. Effect of nocodazole treatment on 53BP1 TIF formation
Fluorescence images of representative TRF2F/-53BP1+/- MEFs, infected with Hit&Run Cre
retrovirus for 72 hours, fixed after treatment with DMSO only or 1 µg/ml Nocodazole for 2
hours, and process for IF-FISH. IF was performed with an Ab specific to 53BP1 (red). Telomeric
DNA was detected with a CCCTAA-repeat specific FISH probe (green) (gives a strong nucleolar
non-specific background). DNA was stained with DAPI. Images were merged and enlarged.
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Moreover, the effect of nocodazole was fully reversible. After imaging in the
presence of nocodazole, cells were washed and incubated for one hour in medium that
did not contain nocodazole. Dysfunctional telomeres imaged after the recovery period
had fully regained their mobility (Figure 5.8a, b; Video 20). In fact, there was no
difference in the distribution of the mobility of telomeres from DMSO-treated cells and
from cells that were allowed to recover after nocodazole treatment (Mann-Whitney test;
p=0.9698) (Figure 5.8a).
This important control ensured that nocodazole treatment did not lead to
permanent changes in the nucleoplasm, such as ATP depletion, which would affect
nuclear dynamics irreversibly. Finally, the effect of nocodazole was highly reproducible
between independent experiments, establishing the robust contribution of microtubule
dynamics to the mobility of dysfunctional telomeres.
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Figure 5.8. Test for the reversibility of the effect of nocodazole treatment on the mobility of
dysfunctional telomeres
a, Graph of the frequency distribution of the number of eGFP-labeled telomeres plotted against
the cumulative distance they traveled in 20 minutes. TRF2F/-53BP1+/- MEFs, expressing eGFPTRF1 marker, were imaged 72 hours after Hit&Run Cre infections. Prior to imaging, cells were
treated with DMSO only (grey bars) or with 1µg/ml Nocodazole (red bars) for 2 hours. Cells
imaged in the presence of Nocodazole were washed and imaged 1 hour later in the absence of
Nocodazole (green bars). 50 telomeres in 10 cells were analyzed for each treatment. The median
values and s.d. are indicated. P-values were calculated using a two-tailed Mann-Whitney test.
b, Table demonstrating the reversibility of the effects of Nocodazole treatment on the mobility of
eGFP-TRF1-marked dysfunctional telomeres in Cre-treated TRF2F/-53BP1+/- MEFs in 2
independent experiments, performed as in (a).
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Microtubule polymerization is required to promote the dynamic movement of
dysfunctional telomeres
In addition to nocodazole, two other drugs are commonly used to inhibit microtubule
dynamics: taxol and vincristine. Similarly to nocodazole, taxol leads to mitotic arrest but
in contrast to nocodazole, it stabilizes microtubules, thus preventing the microtubule
dynamics required in mitosis. Vincristine, on the other hand, affects microtubules
differently, depending on its concentration. At low doses (<10 nM), vincristine
suppresses microtubule dynamics and therefore acts similarly to taxol, while at high
concentrations (100 nM ~ 1 µM), it acts like nocodazole to promote depolymerization.
Taxol treatment did not change the mobility of dysfunctional telomeres in TRF2F/53BP1+/- MEFs 72 hours post Cre infection (Figure 5.9a; Video 21), suggesting that
unless depolymerization is induced, the microtubule network can support telomere
dynamics. Consistent with this model, in two separate imaging sessions, high but not low
dose of vincristine reduced the dynamics of dysfunctional telomeres (Figure 5.9b, c).
The effects of nocodazole and high dose vincristine provided independent
evidence that microtubules play an essential role in promoting the increased movement of
dysfunctional telomeres. This finding establishes a potential model for the dynamic
behavior of deprotected chromosome ends (see Discussion). However, how 53BP1,
which accumulates at chromatin in the vicinity of DSBs, mediates the movement along
cytoplasmic microtubules remains to be established.
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Figure 5.9. Effects of the microtubule inhibitors, taxol and vincristine, on the mobility of
dysfunctional telomeres
a, Graph of the frequency distribution of the number of eGFP-labeled telomeres plotted against
the cumulative distance they traveled in 20 minutes. TRF2F/-53BP1+/- MEFs expressing eGFP-
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TRF1 marker were imaged untreated (grey bars) or 72 hours after Hit&Run Cre retroviral
infections (red bars). Prior to imaging, Cre-treated cells were incubated with 20 µM Taxol for 1
hour (green bars). 50 telomeres in 10 cells were analyzed for each treatment. The median values
and s.d. are indicated. P-values were calculated using a two-tailed Mann-Whitney test.
b-c, Graphs of the frequency distribution of the number of eGFP-labeled telomeres plotted
against the cumulative distance they traveled in 20 minutes. In two independent experiments,
presented in (b) and (c), TRF2F/-53BP1+/- MEFs expressing eGFP-TRF1 marker were imaged 72
hours after Hit&Run Cre retroviral infections. Prior to imaging, cells were incubated for 2 hours
with DMSO only (grey bars), or with 10 nM (red bars) or 1 µM Vincristine (green bars). 50
telomeres in 10 cells were analyzed for each treatment. The median values and s.d. are indicated.
P-values were calculated using a two-tailed Mann-Whitney test.

53BP1 promotes chromatin mobility by inhibiting HDAC activity
We also explored a potential functional interaction between 53BP1 and HDAC4 (Histone
deacetylase 4). In a recent study, Kao et al. report on the recruitment of HDAC4 to
53BP1-containing IRIFs 270. Furthermore, they establish that similarly to γ-H2AX, the
persistence of HDAC4 at sites of DNA damage correlates with the presence of unrepaired
DSBs, suggesting that the resolution of HDAC4 IRIFs is linked to repair. Interestingly,
silencing of HDAC4 by RNAi also decreases the levels of 53BP1 protein and vice versa,
establishing a potential co-regulation link between these two factors.
We asked whether HDACs play a role in promoting the movement of
dysfunctional telomeres by treating cells with the general HDAC inhibitor, Trichostatin A
(TSA). TSA is a potent and selective inhibitor of class I and II mammalian HDACs, and
successfully interferes with the removal of acetyl groups from histones. Consequently,
TSA has the potential to alter nuclear processes that are regulated by chromatin
acetylation.
189

We treated TRF2F/-53BP1+/- and TRF2F/-53BP1-/- cells, from which TRF2 has
been efficiently depleted, with varying doses of TSA for 24 hours prior to imaging. Cells
tolerated 10 and 50 ng/ml TSA for 24 hours without detrimental effects, but appeared to
die upon treatment with higher doses (100 ng/ml).
First, we examined the effects of TSA on the movement of dysfunctional
telomeres in Cre-treated 53BP1-proficient cells and observed that TSA did not affect the
mobility in this setting (Figure 5.10a). Our analysis demonstrated that telomeres acquired
increased dynamic behavior upon TRF2 deletion both in the presence and in the absence
of the drug. Therefore, HDAC activity was not required to promote increased dynamics
of deprotected chromosome ends.
Next, we analyzed how TSA treatment affected the movement of dysfunctional
telomeres in Cre-treated 53BP1-deficient cells, where mobility is suppressed due to the
absence of 53BP1. In these cells, TSA had a notable effect in promoting the movement of
dysfunctional telomeres (Videos 22-23). Whereas, in control, DMSO-treated cells, we
recorded a median cumulative displacement of 4.63±0.76 µm, in TSA-treated cells this
number significantly increased to 6.08±1.10 µm (Mann-Whitney test; p<0.0001) (Figure
5.10b). In fact, as a consequence of TSA treatment, dysfunctional telomeres in 53BP1null cells moved with comparable kinetics to dysfunctional telomeres in 53BP1-wild type
cells. Therefore, inhibition of HDAC activity could rescue 53BP1 deficiency. The effect
of TSA on augmenting the mobility of dysfunctional telomeres in Cre-treated TRF2F/53BP1-/- cells was highly reproducible in three independent experiments (Figure 5.10c).
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Videos 22-25. Role of HDAC inhibitors on the mobility of dysfunctional telomeres in the
absence of 53BP1
Representative TRF2F/-53BP1-/- cells imaged 72 h after Hit&Run Cre infection and treated for 24
hours with DMSO (Video 22), 50 ng/ml Trichostatin A (Video 23), 50 nM SAHA (Video 24), or
1 mM Valproic acid (Video 25). Z-stacks of eGFP-TRF1 signal were acquired every 30 sec over
20 min. Videos constructed from deconvolved and projected frames are supplemented in a DVD.
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Figure 5.10. Effect of the HDAC inhibitor, TSA, on the mobility of dysfunctional telomeres
in 53BP1-proficient and 53BP1-deficient cells
a, Graph of the frequency distribution of the number of eGFP-labeled telomeres plotted against
the cumulative distance they traveled in 20 minutes. TRF2F/-53BP1+/- MEFs, expressing eGFPTRF1 marker, were imaged 72 hours after Hit&Run Cre retroviral infections. Prior to imaging
cells were incubated for 24 hours with DMSO only (grey bars), 10 ng/ml TSA (red bars), or 50
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ng/ml TSA (green bars). 50 telomeres in 10 cells were analyzed for each treatment. The median
values and s.d. are indicated. P-values were calculated using a two-tailed Mann-Whitney test.
b, Graph of the frequency distribution of the number of eGFP-labeled telomeres plotted against
the cumulative distance they traveled in 20 minutes. TRF2F/-53BP1-/- MEFs, expressing eGFPTRF1 marker, were imaged 72 hours after Hit&Run Cre retroviral infections. Prior to imaging
cells were incubated for 24 hours with DMSO only (grey bars) or 50 ng/ml TSA (red bars). 50
telomeres in 10 cells were analyzed for each treatment. The median values and s.d. are indicated.
P-value was calculated using a two-tailed Mann-Whitney test.
c, Table summarizing three independent experiments, performed as in (b). The median
cumulative distance ± s.d. traveled in the absence and in the presence of 50 ng/ml TSA and Pvalue in each experiment are indicated.

This result was further confirmed using two independent HDAC inhibitors: the
‘second generation’ inhibitor SAHA (suberoylanilide hydroxamic acid, also called
Vorinostat in clinical trials for cancer treatment) (Video 24) and valproic acid, a less
potent, but nevertheless highly selective HDAC inhibitor (Video 25). In both cases,
introduction for 24 hours prior to imaging into the medium of Cre-treated TRF2F/-53BP1/-

cells led to significant increase in the dynamics of dysfunctional telomeres (Figure

5.11a). Furthermore, the data reproduced closely the effect of TSA treatment.
On the other hand, we confirmed that enhanced mobility was not recorded in
TRF2F/-53BP1-/- cells, not treated with Cre (Figure 5.11b). This negative control verified
that telomere dysfunction is required in order to promote mobility.
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Figure 5.11. Effect of the HDAC inhibitors, TSA, SAHA and VPA, on the mobility of
dysfunctional and functional telomeres in 53BP1-deficient cells
a, Graph of the frequency distribution of the number of eGFP-labeled telomeres plotted against
the cumulative distance they traveled in 20 minutes. TRF2F/-53BP1-/- MEFs, expressing eGFPTRF1 marker, were imaged 72 hours after Hit&Run Cre retroviral infections. Prior to imaging,
cells were incubated for 24 hours with DMSO only (grey bars), 50 ng/ml TSA (red bars), 50 nM
SAHA (green bars), or 1 mM Valproic acid. 50 telomeres in 10 cells were analyzed for each
treatment. The median values and s.d. are indicated. P-values were calculated using a two-tailed
Mann-Whitney test.
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b, Graph of the frequency distribution of the number of eGFP-labeled telomeres plotted against
the cumulative distance they traveled in 20 minutes. TRF2F/-53BP1-/- MEFs, expressing eGFPTRF1 marker, were imaged in the absence of Cre. Prior to imaging, cells were incubated for 24
hours with DMSO only (grey bars), 50 ng/ml TSA (red bars), 50 nM SAHA (green bars). 50
telomeres in 10 cells were analyzed for each treatment. The median values and s.d. are indicated.
P-value was calculated using a two-tailed Mann-Whitney test.

Altogether, these data suggest that HDAC activity is inhibitory to chromatin
mobility. Our findings also argue that 53BP1 represses HDAC activity at dysfunctional
telomeres. By combining these two arguments, we propose that chromatin mobility is
regulated by a double negative pathway, in which 53BP1 inhibits HDAC activity, which
in turn suppresses chromatin mobility. This model explains why treatment with an
HDAC inhibitor boosts chromatin dynamics only in the absence of 53BP1. Presumably in
the presence of 53BP1, HDAC activity is already suppressed by 53BP1 and therefore,
treatment with HDAC-specific drugs does not have any additional consequences for
mobility.
It is not known whether in our experiments HDAC inhibition altered the
acetylation status of chromatin or of other factors. Interestingly, it has been shown that
the microtubule component tubulin is acetylated by HDAC6. Acetylated tubulin
associates mostly with stable microtubules and appears to be absent from dynamic
structures such as growth cones and leading edge of fibroblasts 271. Therefore, it is
possible that the enhanced mobility of dysfunctional telomeres that we observed in
53BP1-deficient cells upon treatment with HDAC inhibitors may be due to enhanced
tubulin acetylation, which leads to microtubule stabilization and prevents its
depolymerization. This model could be tested with the HDAC inhibitor, trapoxin (TPX),
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which does not affect the tubulin-specific HDAC6 but inhibits the histone-specific
HDACs.
In sum, we have found that acetylation may play a role in chromatin dynamics. In
order to understand the pathway that promotes the mobility of dysfunctional telomeres, it
would be important to determine the acetylation target and to dissect the role of HDACs
in chromatin dynamics.

Evidence for microtubule-dependent proofreading during HDR
So far, we have presented evidence for a 53BP1- and microtubule-dependent mechanism
that promotes the mobility of distant DNA ends. However, we consider it unlikely that a
special mechanism has evolved to promote long-distance joining. Although in our model
system we detect how chromatin mobility facilitates the synapsis of distant ends, we
believe that the primary function of this pathway may be to promote the reverse behavior
-- to separate inappropriate associations during DNA repair. We imagine that this
proofreading mechanism would be most critical during HDR, where repair occurring
between non-sister chromatids can lead to genome instability. In agreement with this
model, faulty HDR events that involve non-sister chromatids have been reported to occur
with higher frequency in the absence of 53BP1 272 and can be detected on metaphase
spreads of cells treated with IR as quadri-radial chromosomes.
Since we have implicated microtubules in chromatin mobility, we tested whether
treatment with the microtubule inhibitor nocodazole caused a similar spectrum of
irradiation-induced chromosome aberrations as 53BP1 deficiency. Cells were irradiated
with 5 Gy and allowed to recover for 12 hours in the presence or in the absence of
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nocodazole before harvesting metaphase spreads. In support of our model, the presence
of nocodazole led to a 6-fold increase in the number of radial events per chromosome
(Figure 5.12), providing compelling evidence that microtubule dynamics might be
involved in promoting the fidelity of HDR. In the future, we plan to exclude any nonspecific effects of the nocodazole treatment by repeating this experiment in the presence
of taxol. Taxol and nocodazole similarly stall cell cycle progression in M phase but based
on our earlier findings we expect taxol not to affect chromatin mobility (Figure 5.9). In
addition, we plan to address whether 53BP1 and microtubules function in the same
pathway.

Figure 5.12. Effect of nocodazole on IR-induced DSB repair
Metaphase spreads of MEFs treated with 5 Gy and allowed to recover for 12 hours in the absence
or in the presence of 1 µg/ml nocodazole. Metaphases were stained with DAPI and shown in
inverse grey. Table summarizing the number of radial events scored per chromosome. The total
number of chromosome scored in each instance is also indicated.
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Summary of findings in Chapter 5
In this chapter we have defined the mechanism that promotes the mobility of deprotected
chromosome ends.
First of all, we established that POT1a/b-deficient telomeres behave similarly to
TRF2-deficient telomeres, suggesting that there is nothing unique about losing TRF2mediated protection of chromosome ends. In addition, the increase in mobility occurred
regardless of the kinase (ATM or ATR) that activated the response to telomere
dysfunction. Therefore, by extrapolation, we argue that all sites of DNA damage (suffices
they contain 53BP1) could be subject to this dynamic mechanism.
Next, by using inhibitors to target specific cellular processes, we found that the
movement of dysfunctional telomeres relies on the microtubule network and is inhibited
by microtubule depolymerization. The potential existence of mechanical coupling
between 53BP1-containing chromatin and cytoplasmic microtubules has exciting
implications for the process of DNA repair (see Discussion). We imagine that it might be
mediated by a nuclear envelope-associated factor, similar to the earlier introduced Ima1,
which bridges nuclear heterochromatin and cytoplasmic microtubule organizing centers.
In addition, we have found an interesting connection between the acetylation
status of cells containing dysfunctional telomeres and the dynamic behavior of their
chromosome ends. We argue that 53BP1 functions to inhibit deacetylation, which in turn
is inhibitory to mobility. We imagine that 53BP1 might promote acetylation or prevent
deacetylation of a specific residue(s) (e.g. H4-K16Ac, which is adjacent to the docking
site of 53BP1, H4-K20diMe). Similarly to Ima1, which recognizes heterochromatin, a
nuclear envelope factor may exist that couples acetylated chromatin to cytoplasmic
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microtubules. Alternatively, as discussed earlier, the acetylation status may be affecting
tubulin dynamics.
Finally, we have exciting preliminary evidence suggesting that the mobility
mechanism that we have described as an integral part of NHEJ of distant ends may
function to disassemble inappropriate repair interactions, such as between non-sister
chromatids during HDR. We discuss the implications of this finding in the Discussion
chapter.
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CHAPTER 6: DISCUSSION
In this thesis, we have applied TRF2-deficient dysfunctional telomeres as a model system
to study the regulation of signaling and repair pathways activated in response to DSBs.
Using this system, we have provided conclusive evidence that the MRN complex is the
only sensor in the ATM pathway. In addition, we have established a previously unknown
role for 53BP1 in NHEJ of dysfunctional telomeres, and we have uncovered a novel
mechanism through which 53BP1 promotes repair of distant sites. We have shown that
53BP1 acts by increasing chromatin mobility through a mechanism reliant on
microtubules and the acetylation status of chromatin. Finally, we have found preliminary
evidence for a microtubule-dependent mechanism that promotes chromosome integrity
by preventing inappropriate repair of DSBs. Altogether, these data indicate that 53BP1 is
an essential component of the DSB response and reveal its indispensable role for
maintaining genome integrity.

TIF factors contribute to NHEJ by promoting the stable association of 53BP1 at
dysfunctional telomeres
In an effort to understand the regulation of the NHEJ pathway at dysfunctional telomeres,
we have characterized its genetic requirements. Our findings indicate that 53BP1,
localized at the chromatin of dysfunctional telomeres, is essential for this process. This
conclusion implies that all DNA damage response factors that are required for the
recruitment of 53BP1 to deprotected chromosome ends would also have a role in repair.
We have established that prolonged stabilization of 53BP1 at dysfunctional telomeres is
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mediated by the same pathway that promotes its association with IRIFs at chromosomeinternal DSBs (Figure 1.2). In agreement, we have found that factors that participate in
this well-characterized pathway also promote the rate of NHEJ of dysfunctional
telomeres. Specifically, we have examined the role of the NBS1 component of MRN,
which signals the presence of dysfunctional telomeres as well as the roles of H2AX and
MDC1, which promote 53BP1 binding to deprotected chromosome ends. Our studies
indicate that all of these factors function in a common pathway to promote NHEJ since
the absence of ATM 228, NBS1, H2AX, or MDC1 causes an identical phenotype with
respect to NHEJ of dysfunctional telomeres: a 2-3 fold reduction in the rate of the repair
process. These data are consistent with the modest decrease in CSR detected in B-cells
deficient for ATM, NBS1, H2AX, or MDC1 (see Introduction for more details and
references). The data are also comparable to previously published results from in vitro
assays, which attribute a minor role to these factors in the repair of chromosome-internal
DSBs (see Introduction for more details and references). In contrast, studies examining
the contribution of these factors to V(D)J recombination showed ATM-, NBS1-, H2AX-,
or MDC1-deficient mice can acquire a mature immune system (see Introduction for more
details and references). One caveat of V(D)J recombination is that it only monitors the
presence or absence of final repair products but does not measure the rate of the process.
As a consequence, even if V(D)J recombination occurs more slowly, it may still give rise
to a mature immune system. In contrast, in our analysis of telomere NHEJ we can
examine the kinetics of repair at consecutive time points after TRF2 deletion. Therefore,
we believe that our assay provides a more precise indicator for the role of these genes in
NHEJ.
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Additionally, it was not clear whether IRIF factors contribute directly to NHEJ
during CSR, or whether the reduced rate of class switching is an indirect consequence of
altered cell cycle progression. In this regard, ATM, NBS1, and to a more modest extent
MDC1, are known contributors to the G1/S, intra-S-phase and G2/M transition
checkpoints (see Figure 1.1 and introduction for more details). This question was
addressed in our studies. In the absence of MDC1, we observed defective NHEJ of
dysfunctional telomeres without any perturbations either in the proliferation rates or in
the activation of the two main checkpoint effectors in the ATM pathway, p53 and Chk2.
Our observations strongly argue that the effect of MDC1 deficiency on fusion rates is not
mediated through changes in cell cycle progression.
We propose that the main contribution of TIF factors to NHEJ is their ability to
associate with extended domains of chromatin at deprotected chromosome ends and to
form a scaffold for the recruitment of DNA repair factors. This process requires both the
initial recognition of dysfunctional telomeres by the MRN complex and the γ-H2AXMDC1-NBS1-mediated signal amplification. We argue that, amongst these TIF factors,
the ultimate transducer to the NHEJ pathway is 53BP1, whereas the other factors play
secondary roles by mediating its prolonged association with chromatin.

Evidence for an MRN and ATM-independent DNA damage response pathway
Interestingly, 53BP1 deficiency leads to a more severe phenotype compared to depletion
of the other TIF factors, causing a 50-fold decrease in the rate of NHEJ. This observation
argues that 53BP1 can promote the NHEJ pathway in a TIF-independent manner,
possibly through its highly specific but transient interaction with H4-K20diMe. In
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support of this model, we have presented evidence that 53BP1 promotes NHEJ of
dysfunctional telomeres via two independent pathways – one that is dependent on the
ability of 53BP1 to bind to H4-K20diMe and one that is mediated by H2AX/MDC1 and
their ability to promote extensive 53BP1-containing TIFs. Simultaneous disruption of
both of these pathways causes an additive phenotype that is functionally equivalent to
53BP1 deficiency. Accordingly, we argue that these two independent mechanisms are
necessary and sufficient to stimulate 53BP1-mediated NHEJ.
It follows from this argument that 53BP1, bound to H4-K20diMe, is the driver for
the delayed fusion events observed in NBS1- or ATM-deficient MEFs. This finding is
puzzling because H4-K20diMe is a constitutive chromatin mark and not a DNA damagespecific modification. It has been speculated that changes in the chromatin structure
might be required to expose the dimethylated mark on H4-K20, and it has been proposed
that phosphorylation of H2AX might be the trigger 138. However, our data argue against a
role for H2AX. We have established that a functional MRN complex is absolutely
required for the ATM-dependent phosphorylation of H2AX but, as mentioned above,
residual NHEJ products are still observed in absence of ATM or NBS1. In these cases, it
is not clear how 53BP1 specifically recognizes H4-K20diMe at dysfunctional telomeres.
To answer this question, we hypothesize the existence of an ATM-, MRN-, H2AX-, and
MDC1-independent pathway that would allow 53BP1 to engage H4-K20diMe at sites of
DNA damage in the absence of these factors. It is possible that this may be an entirely
novel DNA damage response pathway that is activated in response to TRF2 loss.
However, we favor an alternative model. Previously, Kastan and colleagues have
proposed that an ATM-independent pathway alters chromatin structure upon loss of DNA
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integrity 11. However, in view of our data indicating that increased chromatin mobility in
response to DNA damage is a local, and not a global event, we believe this structural
change to be limited to the chromatin adjacent to DNA lesions. To date, players in a
pathway of this kind have not been identified. Arguing against this model are
experiments that have examined the effects of telomere deprotection on nucleosome
structure without detecting any changes 262. However, it is possible that these studies did
not address subtle changes in nucleosome organization.

53BP1 supports NHEJ of dysfunctional telomeres by promoting mobility of distant
DNA ends
The 50-fold reduction in the rate of end-joining that we observe in absence of 53BP1 is
unexpected for several reasons. First, this phenotype is comparable to the phenotype
previously noted in DNA ligase IV-deficient cells, establishing 53BP1 as an essential
component of the NHEJ pathway at dysfunctional telomeres. Secondly, previous
characterization of the role of 53BP1 in NHEJ-mediated repair of DSBs has yielded
conflicting results. Whereas a recent study has reported a role for 53BP1 in the NHEJmediated repair of an I-SceI cut, previous investigations have found that 53BP1 does not
contribute significantly to the repair of chromosome-internal DSBs (see Introduction for
more detail and references). In addition, 53BP1-deficient mice do not have an overt
defect in V(D)J recombination 136, although a previously unappreciated role of 53BP1 in
a subset of joining events was recently reported 273. In accordance with a possible role for
53BP1 in NHEJ, CSR is significantly impaired in 53BP1-null B-cells (at least
15-fold) 134,136.
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We have proposed that the phenotypic variability can be explained by the ability
of 53BP1 to promote the dynamic mobility of DNA ends. Quantitative analysis of timelapse movies recording the movement of dysfunctional telomeres have revealed that
deprotected telomeres exhibit a 53BP1-dependent two-fold increase both in their rate of
movement and in the diameter of the territory that they sample. This change in chromatin
mobility is a novel aspect of the response to DNA damage. We speculate that a
mechanism promoting the mobility of damaged sites is of key importance for longdistance repair, such as the joining of dysfunctional telomeres and CSR.
Dysfunctional telomeres are homogeneously distributed throughout the nucleus in
G1, when NHEJ takes place 237. Similarly, the distance between two constant regions in
the immunoglobulin locus of a B-cell can be a hundred kilobases apart. So far, no
mechanism has been identified in CSR to promote the synapsis of these two regions prior
to their ligation. In contrast, a dynamic mechanism would play less significant role in
NHEJ during V(D)J recombination and in the repair of chromosome-internal DSBs,
where the ends are presumably synapsed by the RAG complex and Ku, respectively
162,274

. In accordance with thid model, the joining of distal but not proximal gene

segments in the process of V(D)J recombination was found to be preferentially impaired
in absence of 53BP1 273.

The rate of NHEJ and the probability of encounter
One outstanding question raised by our model is how the two-fold difference in mobility
that we observe between 53BP1-proficient and -deficient dysfunctional telomeres
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accounts for the 50-fold difference in fusion rates. We believe that this inconsistency can
be explained by the following two arguments.
First, our analysis was performed on projected, two-dimensional images and
therefore, a two-fold increase in diameter would correspond to an eight-fold expansion of
the three-dimensional space. In addition, we monitored telomere behavior for relatively
short periods of time (20 minutes). Given that it takes approximately five days for the
majority of telomeres in a cell lacking TRF2 to fuse, we expect the difference to be
larger.
Second, we suggest that the fastest moving telomeres, not their median rate,
determine the rate of NHEJ. In this respect, we noted that in 53BP1-proficient cells, more
than 10% of dysfunctional telomeres explored territories with diameter greater than two
µm, whereas in 53BP1-deficient cells, less than 1% exhibited comparable dynamic
features. In an average nucleus with diameter of 20 µm, the most mobile dysfunctional
telomeres, observed in 53BP1-wild type cells, are poised to explore a significant fraction
of the nuclear volume in relatively short periods of time, thereby increasing their chances
of encountering a fusion partner. The absence of these outliers in the 53BP1-null setting
might directly cause the absence of NHEJ events.

Increased mobility of dysfunctional telomeres requires microtubules
We have found that the dynamic movement of dysfunctional telomeres is inhibited by
drugs that cause microtubule depolymerization, whereas it is not prevented by
microtubule stabilizing drugs or by actin inhibitors. These data strongly argue that the
enhancement in mobility is driven by an actin-independent, microtubule-mediated
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mechanism, thus implicating a role for microtubules in an essential nuclear process in
mammalian interphase cells, the process of DNA repair. A few previous studies have
linked microtubules to interphase nuclear events. A well-known example is the ‘horsetail’ movement in meiotic prophase in fission yeast during which the nucleus oscillates
on astral microtubules between the two poles of the cell 267,268. The oscillatory nuclear
movement is led by the spindle pole body, to which telomeres are attached, causing the
chromosomes to drag along. Another example is the recent description of a set of proteins
in fission yeast that physically couple centromeric heterochromatin to microtubule
organizing centers at the nuclear envelope, presumably in order to buttress the nuclear
envelope against cytoskeletal forces 269. Finally, 53BP1 has been found to interact
directly with dynein, one of the major motor proteins that move along microtubules 266. It
is very likely that a motor protein is involved in promoting the movement of
dysfunctional telomeres. Abrogation of microtubule dynamics, which can generate
movement by itself, does not affect the mobility of dysfunctional telomeres, whereas
microtubule depolymerization, which disrupts the tracks along which motors translocate,
has a dramatic impact.
In sum, our results have suggested that dynamic mobility of 53BP1-containing
chromatin is promoted by microtubules, with the movement most likely being generated
by a motor protein. In the future, it will be important to determine the link between
nuclear sites of DNA damage and cytoplasmic microtubules. Based on the findings of
King et al. 269, we speculate that dysfunctional telomeres may be recruited to the nuclear
envelope prior to their repair by the NHEJ pathway. Recently, two reports have described
the occurrence of telomere-led rapid prophase movement of chromosomes in S.
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cerevisiae that is preceded by the clustering of telomeres in bouquet structures at the
nuclear envelope, although, in this case, the basis for motility was found to be dependent
on actin 264,265. The potential latching of dysfunctional telomeres onto the nuclear
envelope would reduce the complexity in the search for a fusion partner from a threedimensional problem to a two-dimensional problem. We are in the process of testing this
hypothesis. An additional implication of the findings of King et al. is that there might be
a specialized factor that couples modified chromatin in TIFs to the nuclear envelope. In
their experiments, they identified the trans-nuclear envelope factor Ima1 as a
heterochromatin-specific binder. It is not known whether Ima1 or a factor with an
analogous function plays a role in repair.

Increased mobility of dysfunctional telomeres is promoted by chromatin acetylation
We envision that chromatin marked by a specific modification might be linked to a
mobile structure at the nuclear envelope. In support of that model, we have found that
dynamic behavior of dysfunctional telomeres depends on histone acetylation. We
observed that treatment with HDAC inhibitors selectively augmented the mobility of
dysfunctional telomeres in 53BP1-deficient cells, indicating that HDAC activity is
inhibitory to mobility in these cells. Importantly, we did not observe similar effects in
cells with functional telomeres or in 53BP1-proficient cells with uncapped telomeres.
Based on these data, we conclude that the effects of HDAC inhibition are specific to the
response to telomere dysfunction. In addition, since the effects of HDAC inhibition only
become apparent in the absence of 53BP1, it follows that the role of 53BP1 may be to
promote histone acetylation or to prevent histone deacetylation. One possibility is that
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tubulin acetylation regulates chromatin dynamics. Another possibility is that 53BP1
directly promotes histone acetylation, prevents deacetylation, or influences the interaction
of acetylated histones with acetyl-specific binding partners.
In this regard, several publications have reported on the hyperacetylated state of
the activated immunoglobulin region during the process of CSR 275-277. These
observations are not unexpected because transcription is known to be important for CSR
since AID-mediated induction of DSBs occurs through a transciption-dependent
mechanism. Recently, it has been shown that telomeres are also transciptionally active
278

. Therefore, the effects of HDAC inhibitors on mobility might be specific to

transcribed regions. However, in constrast to the immunoglobulin locus, telomeric
chromatin is of heterochromatic nature, as evidenced by the hypoacetylated 279 and
hypermethylated states of telomeric H3/H4 280. In addition, telomeres can silence the
transcription of adjacent genes by a mechanism known as the telomere position effect
(TPE) 281,282. TPE in human cells can be alleviated by treatment with an HDAC inhibitor,
indicating that it is a consequence of chromatin hypoacetylation. Finally, at the
immunoglobulin locus, acetylation occurs exclusively in an AID-dependent manner,
which directly links the deposition of acetylation marks to the induction of DSBs and
possibly to its role in promoting NHEJ repair 275,277. It remains to be determined whether
acetylation of histones occurs at all sites of DNA damage, including at dysfunctional
telomeres, and whether such chromatin marks function to promote chromatin mobility
and repair.
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Future directions for studying how dynamic behavior influences the rates of NHEJ
We have shown by live-cell imaging that mobility of dysfunctional telomeres is mediated
by microtubules and that it is dependent on the acetylation status of chromatin. In order to
solidify the connection between these processes and the repair of dysfunctional
telomeres, we are currently testing whether treatments with drugs that affect mobility also
impact the formation of end-to-end fusions. The role of microtubules has been difficult to
address because microtubule inhibitors cause an acute cell cycle arrest at the G2/M
transition or in M phase. This precludes the analysis of NHEJ of dysfunctional telomeres,
which requires the cumulative effect of G1 events over at least three days to yield a
robust signal. On the other hand, it is known that fusions also occur in non-cycling cells
that are TRF2-deficient. Therefore, we plan to treat TRF2-deficient G0-arrested cells
with nocodazole or taxol and assay directly whether microtubules are required for end-toend fusions by telomere blot. Because the two drugs impact microtubule stability
differently, we expect to see absence of fusion events in nocodazole-treated cells but no
effect in cells treated with taxol. We plan to test in a similar manner the role of
acetylation by treating TRF2-deficient cells with HDAC inhibitors and examining their
effect on telomere fusions.

Telomeres as a model for DSB repair
Our analysis has been performed in the context of dysfunctional telomeres, which are a
unique substrate for the NHEJ pathway, since their deprotection generates a single DNA
end rather than two ends as in the case of all other types of DSBs. In addition, telomeres
are composed of repetitive DNA sequences that are bound by the telomere-specific
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shelterin complex. Nevertheless, we believe that the molecular events that take place
during telomere deprotection upon TRF2 loss recapitulate the sequence of events that
occur in response to DSBs. This parallel is substantiated by previous reports indicating
that the DNA damage response to TRF2 loss is ATM-dependent; it involves the
recruitment of all known IRIF factors to chromosome ends to form TIFs; it causes the
activation of checkpoint signaling; and it results in NHEJ-mediated repair of deprotected
chromosome ends (see Introduction for more details and references). Therefore, we
believe that our findings may apply to chromosome-internal DSBs as well.
One direct piece of evidence arguing that mobility is not a specific consequence
of the removal of TRF2 from chromosome ends is that we observed a similar change in
the dynamic behavior of telomeres whose protection was impaired by POT1a/b deletion.
Telomere dysfunction in absence of POT1a/b is mechanistically different from the DNA
damage events activated by TRF2 deletion, as it involves signaling through the ATR
pathway and does not lead to NHEJ-mediated joining of telomeres 197,228. A common
feature of both TRF2 and POT1a/b loss, however, is TIF formation, including
accumulation of 53BP1, arguing that dynamic mobility may be a consequence of all
53BP1-containing chromatin.
Hence we have no reason to suspect that TRF2-depleted dysfunctional telomeres,
as a substrate to the NHEJ pathway, are treated differently from DSBs except that a repair
partner is not immediately available. Therefore, we propose that our findings may apply
to the repair of all DNA ends that are located at a distance. In addition, we speculate that
dynamic behavior of chromatin may also be advantageous at IRIF-marked chromosomeinternal DSBs under certain circumstances (discussed below).
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A dynamic view of DNA repair involving distant DNA ends
Based on the findings in this thesis, we propose a novel model for how cells deal with the
problem of repairing sites of damage that are located at a distance. Although our results
are based on an experimental system that is rather unique and does not have immediate
biological relevance, a similar set of events is thought to occur in the immune system
where efficient repair of programmed DSBs during V(D)J recombination and CSR is
essential for the diversification of the immune system.
We propose that activation of the DNA damage signaling pathways, whose
purpose is to prevent cell cycle progression, also lays down the groundwork for a series
of histone modifications. The first of these events, the PIKK-dependent phosphorylation
of H2AX, functions to recruit a number of DNA damage response factors, including the
MRN complex, H2AX, MDC1, RNF8, 53BP1, and others, to sites of damage. A feedforward amplification loop, which is interwoven into multiple protein-protein
interactions, promotes the accumulation of these DNA damage response factors in large
structures that can extend for several megabases. We propose that among these factors,
53BP1, which also associates with dimethylated H4-K20, functions to promote H3 and/or
H4 acetylation or alternatively, prevents their deacetylation. We hypothesize that the
acetylation status of the chromatin at a site of DNA damage determines its ability to
acquire increased mobility, possibly by coupling the chromatin at the site of damage to
microtubules in the cytoplasm. We argue that DNA ends that have acquired microtubulemediated dynamic behavior are in turn more likely to encounter a partner to repair with.
In our model, the process of NHEJ is enhanced by a mechanism that promotes the
temporary association of DNA lesions with the nuclear envelope. We envision that such
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mechanism would allow sites of damage to establish a connection with the cytoplasmic
microtubule network in order to acquire dynamic potential. In addition, we imagine that
local concentration of distant ends in a two-dimensional space will increase their chance
for repair.
Whereas most chromosome-internal DSBs are held together so that mobility will
not affect their repair, the increased mobility of dysfunctional telomeres would be
expected to significantly improve the chance of fusion of two spatially separated
chromosome ends. Similarly, during the process of CSR, mobility of DNA ends may be
essential to promote the efficiency of NHEJ. Inability to switch regions impairs the
development of B-cells and limits the scope of the immune response. In addition, delayed
repair of AID-induced DSBs may increase the chance for translocation events. In support
of this model, translocations between the immunoglobulin region and the region where
the proto-oncogene c-myc is located have been found to occur with increased frequency
in 53BP1-deficient B-cells 106. Translocations between these two loci are welldocumented as one of the direct causes of B-cell lymphoma.

Mobility may be a novel mechanism to promote accuracy of DNA repair
The ability of 53BP1 to promote the mobility of DNA ends contradicts its role in
preventing translocations. We argue that at chromosome-internal DSBs, the bridging
between the two ends established by Ku is enough to counteract chromatin mobility
stimulated by 53BP1. On the other hand, if an occasional separation between the two
ends at a DSB occurs, mobility would be instrumental in bringing the two ends back
together.
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This argument suggests that increased mobility cannot harm NHEJ-mediated
repair of a chromosome-internal DSB but does not explain how 53BP1 protects from
translocations. Since we consider it unlikely that 53BP1 evolved to promote longdistance NHEJ, we would like to extend our hypothesis and claim that 53BP1-mediated
mobility can actually function as a quality-control mechanism during the repair of DSBs.
We argue that in S-phase, 53BP1-containing mobile DNA ends would be prevented from
repairing on a non-sister chromatid. In our model, microtubules provide the dynamic
force required to counteract incorrect repair events that lack sister cohesion. This safety
mechanism would ensure that only pairing between sister chromatids, which are tightly
held together through cohesion, will lead to productive progression of the repair pathway
(predominantly HDR). Our hypothesis is, in this respect, analogous to the ‘horse-tail’
movement described earlier, where microtubule-mediated chromatin oscillations in
prophase have been proposed to contribute to the correct pairing of homologous
chromosome by applying a dynamic force to counteract incorrect associations 267. In
support of this model, it has been found that, following treatment with modest doses of
IR, 53BP1 is instrumental in preventing the formation of radial chromosomes, which are
indicative of incorrect HDR events between non-sister chromatids 272. We have found
preliminary evidence for similar genomic instability occurring as a consequence of
microtubule inhibition. Therefore, we argue that a 53BP1- and microtubule-dependent
mechanism exists to proofread repair events in S-phase and to disrupt inappropriate nonsister interactions. If this model were correct, it would implicate 53BP1 as a critical
component of the HDR pathway, in addition to its role in the NHEJ pathway, which we
have studied in this thesis.
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Concluding remarks
In conclusion, we have proposed a unifying mechanism to explain the contribution of
DNA damage response factors to the NHEJ pathway. Our analysis explains why 53BP1
stands out among these factors, by virtue of promoting the dynamic behavior of DNA
ends. In addition, we have uncovered the nature of this dynamic mechanism. We have
found evidence for a novel microtubule-driven process that acts on interphase cells to
promote chromatin mobility during NHEJ and HDR. We propose that the primary role of
this dynamic mechanism may be to correct inaccurate repair in S-phase, and that, as a byproduct, it also functions to accelerate the repair of distant DNA ends. Finally, we have
found that histone modifications, including phosphorylation, methylation, and acetylation
marks work synchronously to stimulate these processes.
This work exemplifies how telomeres can be used as an experimental tool to
study various aspects of the DNA damage response. Using dysfunctional telomeres as a
model system, we have resolved a previously controversial question and unequivocally
established that the MRN complex is the only sensor in the ATM pathway. We have also
characterized a previously unknown mechanism of how 53BP1 contributes to the NHEJ
pathway. In the process, we have uncovered a novel aspect of the repair of dysfunctional
telomeres that is mediated through a dynamic mechanism. Based on our findings, we
have put forward a model speculating that this mechanism may be required to promote
the fidelity and efficiency of DNA repair at all lesions. In the future, telomeres can be
used as a tool to further dissect this pathway as well as to characterize novel aspects of
the DNA damage response.
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MATERIALS AND METHODS
Constructs
Full-length human MDC1 was cloned from pcDNA3251 into a N-3xFLAG-pLPC-puro
retroviral expression vector by restriction enzyme digestion cloning. The construct was
used for transient overexpression of MDC1 in 293T cells.
Full-length human 53BP1 was cloned by PCR into a N-myc-pLPC-puro retroviral
expression vector. The D1521A mutation was introduced by a PCR-based mutagenesis
strategy using the following mutagenesis primers: 5’AAATTGCTCTTTGATGCTGGGTACGAATGTGAT-3’ and 5’ATCACATTCGTACCCAGCATCAAAGAGCAATTT-3’. The mutation was confirmed
by sequencing. Wild-type and D1521A rescue alleles were introduced into TRF2F/53BP1-/- cells by five consecutive retroviral infections with virus-containing supernatants
from Phoenix cells, delivered at 12-h intervals. Puromycin selection was applied.
Infection with the empty vector was used as a negative control.
Fluorescently amino-terminally tagged mCherry-BP1-2 and eGFP-TRF1 were
cloned by PCR into pLPC-puro and pWzl-hygro, respectively. In-frame fusions were
confirmed by sequencing. mCherry-BP1-2 and eGFP-TRF1 constructs were
consecutively introduced into TRF2F/- 53BP1+/- and TRF2F/- 53BP1-/- cells by retroviral
infections, followed by puromycin (4 days) and hygromycin (7 days) selection,
respectively.
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Mammalian cell culture
Refer to list of cell lines in Appendix 1.
Mouse embryonic fibroblasts (MEFs) were obtained from E13.5 embryos of
timed pregnancies using standard techniques and were grown in DMEM containing 15%
Fetal Bovine Serum (Gibco), supplemented with 100 U/ml penicillin (Sigma), 0.1 µg/ml
of streptomycin (Sigma), 2 mM L-glutamine (Invitrogen), 0.1 mM non-essential amino
acids (Invitrogen), 1 mM sodium pyruvate (Sigma), and 50 µM β-mercaptoethanol
(Chemicon). Primary MEFs were immortalized at passage 2 with pBabe SV40-LT (a gift
from G. Hannon) using retroviral protocol given below.
SV40-LT transformed and p53-/- MEFs, Pheonix ecotropic packaging cell line
(ATCC), IMR90 primary lung fibroblasts (ATCC), BJ fibroblasts (Clontech), BJ-hTERT,
A-T fibroblasts (ATCC), and F02-98 fibroblasts (refer to table below for details and
references) were grown in DMEM supplemented with 100 U/ml penicillin (Sigma), 0.1
µg/ml of streptomycin (Sigma), 2 mM L-glutamine (Invitrogen), 0.1 mM non-essential
amino acids (Invitrogen), and 15% Fetal Bovine Serum (Gibco). HeLa 1.2.11, HeLa 204,
HeLa 1.3, 293T, and Phoenix amphotropic packaging cell line (ATCC) were grown in
DMEM supplemented as above except for the serum which was replaced with 10%
Bovine Calf Serum (HyClone). All cells were grown at 37°C in the presence of 5% CO2
and 95% relative humidity. Cells were passaged by pre-rinsing with room temperature
trypsin-EDTA (Gibco, 0.25%) followed by incubation in trypsin-EDTA for 2-5 min.
Tripsin was inactivated by adding serum-containing medium. Cells were counted with a
Counter Z1 Particle counter and seeded onto a new plate as desired.
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Retroviral gene delivery
24 h prior to transfection, 5x106 Phoenix packaging cells were plated in 10 cm dishes.
For infection of mouse cells, Phoenix ecotropic cells were used, whereas for infection of
human cells, Phoenix amphotropic cells were used. Prior to infection the medium was
changed. Phoenix cells were transfected with 20 µg of the appropriate plasmid DNA by
CaPO4 coprecipitation (described below). The media was refreshed 5-8 h later. 36 h
after transfection, media was collected and was filtered through a 0.4 µm filter. Polybrene
was added to a final concentration of 4 µg/mL and the virus containing medium was used
to infect desired cells plated 24 h earlier at a density of 5x105 cells per 10 cm dish. Fresh
media was added to the virus producing cells and same cells were used for a total of 3-4
consecutive infections delivered at 12-h intervals. 12 h after the last selection, if
appropriate, cells were split into fresh media containing antibiotics for selection
(puromycin 2 µg/ml, hygromycin 90 µg/ml). Selection was maintained for 3 days in the
presence of puromycin and 7 days in the presence of hygromycin, until uninfected control
cells had died.

Knockdown of protein levels
Protein levels of desired targets were stably reduced in human and mouse cells using
shRNAs expressed from the pSUPERIOR retroviral vector (OligoEngine). Retrovirus
was produced in ampho- or eco-tropic Phoenix cells and used to infect human or mouse
cells, respectively, 4 times at 12-hr intervals, followed by puromycin selection.
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The following target sequences were cloned into pSUPERIOR and confirmed by
DNA sequencing:
luciferase control: 5’-CGTACGCGGAATACTTCGA-3’ (Dharmacon);
hMDC1 sh1: 5’-GCAGAAGCCAATCAGCAAA-3’;
hMDC1 sh2: 5’-AGAGGGACAATGATACAAA-3’;
hMDC1 sh3: 5’-GTCTCCCAGAAGACAGTGA-3’; 110
mMDC1 sh4: 5’-ACAGCATGCAGTAATTGAA-3’;
mMDC1 sh5: 5’-ACACAGCCGTTCTGTCTAA-3’;
hH2AX sh3: 5’ –CAACAAGAAGACGCGGAATC-3’; 109
hMre11.4: 5’-CCTGCCTCGAGTTATTAAG-3’; 283
hMre11.5: 5’-CTGCGAGTGGACTATAGTG-3’; 283
hMre11.6: 5’-GATGCCATTGAGGAATTAG-3’; 283
h53BP1.1: 5’-GCCAGGTTCTAGAGGATGA-3’; 127
h53BP1.2: 5’-GATACTCCTTGCCTGATAA-3’; 127
CtIP sh1: 5’ -GCAGACCTTTCTCAGTATA-3’; 58
CtIP sh2: 5’ -GCATTAACCGGCTACGAAA-3’; 58
Efficient knockdown of human MDC1, Mre11, 53BP1, H2AX, and mouse CtIP
were verified by immunoblotting. Mouse MDC1 protein was detected by
immunofluorescence and reduction of RNA levels after shRNA treatment was confirmed
by reverse transcriptase PCR. RT-PCR was performed using oligo-dT ThermoScript RTPCR system (Invitrogen). RNA was isolated from approximately 106 cells using Qiagen
RNAeasy kit. 3 µg RNA was reverse transcribed using ThermoScript RT-PCR system
(Invitrogen) using oligo dT priming and the protocol provided by the manufacturer. The
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primers used for PCR after cDNA synthesis are: mMDC1 (forward
CTGTCCCTGAACTGGCTGTACCAG and reverse
GGTAGATGACATTTCCAAATTGGA) and GAPDH (forward
TGAAGGTCGGTGTGAACGGATTTGGC and reverse
CATGTAGGCCATGAGGTCCACCAC) served as a control.
Protein levels of human MDC1 were transiently downregulated by siRNA using a
previously published target (5’-ACAGTTGTCCCCACAGCCC-3’ 110) using
Oligofectamine (Invitrogen) transfection protocol supplied by the manufacturer and
performed in OPTI-MEM medium (Invitrogen) in the absence of serum and antibiotics.

Introduction of Cre recombinase
Cre recombinase was introduced using the retroviral infection technique described above.
MEFs were infected 3 times at 12 h intervals with pMMP Hit&Run Cre 284 retrovirus.
Mock infection was used as negative control. No selection was applied. The experimental
time-points were counted as h or days after the second retroviral infection, presumably at
the point of protein expression and were referred to as h or days post infection.
For live cell imaging, 4 Hit&Run Cre infections were performed, the first and the
second spaced by 12 h and the last 3 infections spaced by 6 h. Cells were plated on
imaging plates 12 hours after the last infection or at least 48 hours prior to imaging. No
selection was applied.
For long term analyses that required selectable Cre expression, infection with
retrovirus expressing pWzl-hygro-Cre or empty vector, as a negative control, was
performed, followed by hygromycin selection. The experimental time-points were
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counted as h or days after the second retroviral infection, presumably at the point of
protein expression and were referred to as h or days post infection.
Alternatively, Cre recombinase was delivered via adenoviral infection. Cells were
infected in suspension with virus at concentration of 1000 pfu/cell. Infection was
repeated on attached cells 8-12 h later. The experimental time-points were similarly
counted after the second infection and were referred to as h or days post infection.
Cells were harvested by trypsiniziation at indicated timepoints post infection,
counted, and processed according to each experiment.

Inhibition of TRF2 function in human cells
TRF2-DN and control β-gal adenovirus were used at 100 pfu/cell for HeLa 204, HeLa
1.3, and IMR90 cells. Cells were infected in suspension and the medium was changed 24
h later. Cells were harvested for analysis 48 h post infection. For immunofluorescence
analysis, cells/virus suspension was plated on coverslips.

Growth analysis
For growth curves following Cre infections, 5x105, 2.5x105, and 1.25x105 cells were
plated on 10 cm dishes 24 h post retroviral infection and counted, respectively 72, 96, and
120 h post infection. Alternatively, 5x105 cells were plated on a 10 cm dish 24 h after the
retroviral infections and harvested, counted, and replated at the same density at 72 h.
These cells were harvested and counted at 120 h post infection. Growth curve was
presented as cumulative cell numbers plotted against time or as PDs plotted against time.
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PDs were determined by the following formula: PD = original PD + [ln(# cells at
passage/#cells seeded)/ln(2)] using Excel and.

Calcium phosphate transfection of 293T and Phoenix cells
16-24 h prior to transfection, 3-4 x 106 293T cells were plated in 10 cm dishes. Cells were
transfected with 10 µg total DNA of the appropriate plasmids using CaPO4
coprecipitation. For each plate, 428 µl H20, 62 µl 2M CaCl2, and 10 µg total plasmid
DNA were mixed with an equal amount of 2 x HBS (50 mM HEPES pH 7.05, 10 mM
KCl, 12 mM dextrose, 280 mM NaCl, 1.5 mM Na2PO4). During the process of mixing
the solution was aerated by blowing air through a 2 ml pipette with a Pipet-aid
(Drummond). Media was refreshed 5-8 h after transfection.

Co-IP of overexpressed proteins in 293T cells
For immunoprecipitation of proteins transiently expressed in 293T cells, transfection was
performed as above. 48 h after transfection, cells were harvested, washed with PBS, and
resuspended in 200-500 µl of lysis buffer (50 mM Tris-HCl pH 7.4, 1% Triton X-100,
0.1% SDS, 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 100 µM PMSF, with a complete
mini-protease inhibitor tablet [Roche] per 10 ml). The NaCl concentration was raised to
400 mM, and the lysate was incubated on ice for 5 min. The NaCl concentration was
reduced to 200 mM with an equal volume of cold water and cell debris were removed by
centrifugation at 13K for 10 min at 4°C. 50 µl of 2 x Laemmli buffer was added to 50 µl
of lysate and set aside as the “Input.” 5 µl of anti-myc Ab (9E10, Oncogene) were added
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to 800 µl of lysate. Samples were nutated at 4°C for 5 h. 60 µl of a Protein G sepharose
slurry (50% [v/v] Protein-G sepharose [Amersham] in PBS in 1 mg/ml BSA) were added
and samples were nutated at 4°C for an additional 60 min. Beads were washed 4 times at
4°C with lysis buffer, and immunoprecipitated protein was eluted with 60 µl 2 x Laemmli
buffer. Samples were boiled for 5 min before loading onto SDS-PAGE gels.

IPs of endogenous proteins
IPs of endogenous proteins were performed in BJ-hTERT, HeLa 1.2.11, and MEFs.
Cells were harvested by trypsinization and the cell pellet was resuspended on ice for 30
min in Buffer C (20 mM HEPES-KOH, pH 7.9, 420 mM KCl, 25% glycerol, 0.1 mM
EDTA, 5 mM MgCl2, and 0.2% NP-40, with freshly added 1 mM DTT, 100 µM PMSF,
and 1 mini-protease inhibitors tablet (Roche) per 10 ml). Cells were centrifuged at 15K
for 10 min at 40C and the supernatant as dialyzed for at least 6 h against Buffer D (20
mM HEPES-KOH, pH 7.9, 100 mM KCl, 25% glycerol, 0.1 mM EDTA, containing
freshly added 1 mM DTT and 100 µM PMSF). After dialysis, the lysate was centrifuged
again and the cleared supernatant was used for IPs. 10% of IP volume was set aside as
input. 5 µl of desired antibodies (Appendix II) were added to the lysate and samples were
nutated overnight at 40C. 60 µl of a Protein G sepharose slurry (50% [v/v] Protein-G
sepharose [Amersham] in PBS in 1 mg/ml BSA) were added and samples were nutated at
4°C for an additional 60 min. Beads were washed 4 times at 4°C with Buffer C, and
immunoprecipitated protein was eluted with 60 µl 2 x Laemmli buffer. Samples were
boiled for 5 min before loading onto SDS-PAGE gels. The phosphatase inhibitors, 10
mM NaF and 50 mM β-glycerophosphate were added to Buffers C and D.
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Whole cell lysates and Western blots
Cells were lysed in 2 × Laemmli buffer (100 mM Tris-HCl, pH 6.8, 200 mM DTT, 3%
SDS, 20% glycerol, 0.05% bromophenol blue) at 104 cells per microlitre, denatured for
7 min at 100 °C, and sheared with a 28 gauge insulin needle before loading the equivalent
of 1 × 105 cells per lane. Protein samples were separated by SDS-PAGE and blotted onto
nitrocellulose membranes. Membranes were blocked in 5% milk in PBST (0.5% Tween20 in PBS) for 30 min at RT and nutated with primary antibodies (Appendix II) in 5% or
0.1% milk in PBST overnight at 4°C. Membranes were washed 3 times in PBST, nutated
in secondary antibody in 5% milk in PBST for 1 hr at RT, and washed 3 times with PBST
at RT. Blots were developed with enhanced chemiluminescence (Amersham).

Chromatin Immunoprecipitation (ChIP)
Cells were trypsinized and washed with PBS, fixed in 1% formaldehyde in PBS for 60
min at RT, washed in PBS, and lysed in 1% SDS, 50 mM Tris-HCl pH 8.0, 10 mM
EDTA at a density of 1x107 cells/ml. Lysates were sonicated on ice for 10 cycles of 20
seconds each (0.5 seconds on/0.5 seconds off) on power setting 5 on a Misonix Sonicator
3000. Two 50 µl aliquots of lysates were set aside at 4°C to represent “Total” DNA. 200
µl of lysate was diluted with 1.2 ml 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA,
16.7 mM Tris-HCl pH 8.0, and 150 mM NaCl. Antibody (20 µl crude serum or 4 µl
affinity purified antibody; Appendix II) was added and cells were nutated overnight at
4°C. 30 µl protein G sepharose beads (Amersham; blocked with 30 µg BSA and 5 µg
sheared E. coli DNA) was added and samples were nutated for an additional 30 min at
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4°C. Beads were pelleted by centrifugation and pellets were washed with 0.1% SDS, 1%
Triton X-100, 2 mM EDTA pH 8.0, 20 mM Tris-HCl pH 8.0, 150 mM NaCl. The second
wash was the same except with 500 mM NaCl. Subsequent washes were with 0.25 M
LiCl, 1% NP-40, 1% Na-deoxycholate, 1 mM EDTA pH 8.0, 10 mM Tris-HCl pH 8.0, 1
mM EDTA. Chromatin was eluted from beads with 500 µl 1% SDS, 0.1M Na2CO3. 450
µl 1% SDS, 0.1M Na2CO3 was added to the “Total” fractions, and these were
subsequently processed along with the rest of the samples. 20 µl 5M NaCl was added and
samples were incubated for 4 hr at 65°C to reverse cross-links. At this point, 20 µl 1M
Tris-HCl pH 6.5, 10 µl 0.5 M EDTA, and 20 µg DNase free RNase A was added and
samples were incubated at 37°C for 30 min 40 µg proteinase K was added and samples
were digested for 60 min at 37°C and extracted with phenol. 20 µg of glycogen was
added and samples were mixed. 1 ml ethanol was added and DNA was precipitated
overnight at -20°C. Precipitated DNA was dissolved in 100 µl H20, denatured at 95°C for
5 min, and blotted onto Hybond membranes in 2 x SSC (0.3M NaCl, 0.03M Sodium
citrate). “Total” fractions were diluted 1/4, 1/8, and 1/16 and blotted as well.
Membranes were treated with 1.5M NaCl, 0.5 N NaOH for 10 min and then with 1 M
NaCl, 0.5 M Tris-HCl pH 7.0 for 10 min Hybridization was performed with a γ32-P
endlabeled [CCCTAA]4 probe as described for in gel hybridization of genomic DNA.
Membranes were washed 4 times in 2 x SSC and exposed overnight to a PhosphorImager
screen. Screens were developed using a STORM 820 Phosphorimager (Molecular
Dynamics). ImageQuant software was used to quantify the percent of total telomeric
DNA that was precipitated by each antibody.
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In-gel analysis of telomeric DNA from mouse cells
For the analysis of mouse genomic DNA, 1x106 or 0.5x106 MEFs were resuspended in
PBS and mixed 1:1 (v/v) with 2% agarose (SeaKem agarose) to obtain 5 × 105 cells per
agarose plug. Plugs were digested overnight with 1 mg/ml Proteinase K (in buffer
containing 10 mM Tris-HCl pH 7.9, 250 mM EDTA, 0.2% sodium deoxycolate, 1%
sodium lauryl sarcosine), washed extensively with TE buffer (10 mM Tris-HCl, pH 8.0,
1 mM EDTA) and incubated overnight at 37 °C with 60 U MboI. The following day, the
plugs were washed once in TE and once in water, and were equilibrated in 0.5 × TBE.
Plugs were loaded on a 1% agarose/0.5 × TBE gel and run for 24 h using CHEF-DRII
PFGE apparatus (BioRad) in 0.5 × TBE running buffer. The settings were as follows:
initial pulse, 5 min; final pulse, 5 min; 6 V/cm;14°C. Gels were dried and then
prehybridized in Church Mix (0.5M Na2HPO4 pH 7.2, 1 mM EDTA, 7% SDS, 1% BSA)
for 1 hr at 50°C. Hybridization was performed overnight at 50°C in Church Mix with 4
ng of a γ-32P-ATP end-labeled probe, [CCCTAA]4 (See below for labeling protocol).
The gel was washed at 55°C: 3 times for 30 min each in 4X SSC and one time for 30 min
in 4X SSC, 0.1% SDS and exposed to a PhosphorImager screen overnight.
Subsequently, the gel was denatured in 0.5 M NaOH, 1.5 M NaCl for 30 min, neutralized
with two 15 min washes in 0.5 M Tris-HCl pH 7.5, 3 M NaCl, prehybridized in Church
mix for 1 hr at 55°C, and hybridized with the same probe as above overnight at 55°C.
The gel was washed and exposed as above. The single-stranded G-overhang signal was
quantified with ImageQuant software and normalized to the total telomeric DNA
quantified after denaturation.
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In-gel analysis of telomeric DNA from human cells
DNA was isolated from human cells, resuspended in TNE (10 mM Tris-HCl, pH 7.4, 100
mM NaCl, 10 mM EDTA) and digested overnight in 1 mg/ml Proteinase K in TENS
buffer (TNE containing 0.1% SDS) at 370C, followed by phenol-chloroform extraction
and isopropanol precipitation in the presence of sodium acetate. The isolated DNA was
resuspended in TNE, containing 100 µg/ml RNase A and incubated for 30 min at 370C,
followed by a second round of Proteinase K digestion and phenol-chroroform
extraction/isopropanol precipitation. The purified DNA, dissolved in TE, was digested
overnight with AluI and MboI in the presence of RNase A. The final concentration of the
digested DNA was measured by Hoechst fluorimetry. Equal amounts of DNA from each
sample were loaded on a 0.7% agarose gel in 1 x TAE with ethidium bromide and
separated by electophoresis for 1 h at 30 V and then at 45V until the 1.3 Kb marker was
at the bottom of the gel. The gel was photographed with a ruler next to the markers and
processed as described above for in-gel analysis of telomeric DNA in mouse cells.

γ -32P end labeling of oligonucleotides with T4 polynucleotide kinase (PNK)
2 µl H20, 1 µl 10X T4 DNA PNK buffer (NEB), 1 µl 10 U/µl T4 DNA PNK (NEB), 1 µl
50 ng/µl [CCCTAA]4 oligonucleotide and 5 µl 10.0 mCi/ml γ-32P (NEN) were mixed and
incubated for 45 min at 37°C. 80 µl TES (10 mM Tris-HCl pH 8.0, 10 mM EDTA pH
8.0, 0.01% SDS) were added to stop the reaction. The probe was loaded onto a 3 ml G25
Sephadex column equilibrated with TNES (10 mM Tris-HCl pH 7.4, 10 mM EDTA, 100
mM NaCl, 1% SDS). The column was washed with 700 µl TNES and the probe was
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eluted with 600 µl TNES and diluted into 25 ml of Church mix (0.5M Na2HPO4 pH 7.2, 1
mM EDTA, 7% SDS, 1% BSA).

Telomere fluorescence in situ hybridization (FISH)
Cells were grown to approximately 80% confluence on 10 cm dishes and incubated for 1
h 15 min in 0.1 µg/ml colcemide (Sigma) for human cells and 0.2 µg/ml colcemide
(Sigma) for mouse cells. Cells were harvested by trypsinization, centrifuged at 1K for 5
min, and resuspended in 0.075M KCl prewarmed to 37°C. Cells were incubated at 37°C
for 15 min with occasional inversion. Cells were centrifuged at 1K for 5 min and the
supernatant was decanted. Cells were loosened by tapping in the remaining (~200 µl)
supernatant. 500 µl of cold 3:1 methanol:glacial acetic acid fixative was added dropwise
while cells were mixed gently on a vortexer (<1000 rpm). Another 500 µl fixative was
added slowly while cells were being mixed. Tubes were then filled to 10 ml with the
fixative and fixed at 4°C for at least 24 h. To prepare metaphase spreads, cells were
centrifuged at 1K rpm for 5 min and the supernatant was decanted. Cells were
resuspended in the remaining fixative (~300 µl) and 100 µl were dropped from
approximately 6 inches onto glass slides, which had been soaked in cold water. Slides
were washed with fresh fixative and placed on a humidified heating block set to 70°C for
1 min. Spreading efficiency was checked under a light microscope. Slides were dried
overnight. Alternatively, 100 µl of cells resuspended in fixative were dropped on dry
slides in a temperature-controlled chamber (settings at 200C and 50% humidity)
(Thermotron). Slides were washed with fresh fixative and allowed to dry overnight in the
chamber.
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If only DAPI staining was desired, slides were rehydrated in PBS for 5 min,
stained with DAPI in PBS for 5 min, washed in PBS for 5 min, and allowed to dry before
mounting.
For peptide nucleic acid (PNA) FISH, slides, prepared as above, were washed in
PBS once and fixed in 4% formaldehyde for 2 min at room temperature. After extensive
PBS washes, spreads were digested for 10 min at 37 °C with 1 mg/ml- pepsin dissolved in
10 mM glycine, pH 2.2. Slides were then washed in PBS, fixed again in 4%
formaldehyde for 2 min at room temperature, and washed in PBS before dehydration by
consecutive 5-min incubations in 70%, 95% and 100% ethanol. After air-drying,
Hybridizing Solution (70% formamide, 1 mg/ml blocking reagent (Roche), 10 mM TrisHCl, pH 7.2) containing FIu-OO-(AATCCC)3 PNA probe (Applied Biosystems) was
added and spreads were denatured by heating for 3 min at 80 °C on a heat block. Spreads
were then allowed to hybridize in the dark for 2 h at room temperature. Two 15-min
washes were performed in a mixture containing 70% formamide, 10 mM Tris-HCl,
pH 7.0, and 0.1% BSA, followed by three washes in a mixture containing 0.1 M TrisHCl, pH 7.0, 0.15 M NaCl and 0.08% Tween-20, with DAPI added to the second wash to
counter-stain the chromosomal DNA. Slides were mounted in antifade reagent (ProLong
Gold, Invitrogen), and digital images were captured with a Zeiss Axioplan II microscope
with a Hamamatsu C4742-95 camera using Improvision OpenLab software.
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Immunofluorescence
Cells were grown on coverslips. Cells were rinsed with PBS, fixed with 2%
paraformaldehyde in PBS for 10 min at RT and washed twice with PBS for 5 min. Cells
were either stored in PBS with the addition of 0.02% azide or processed immediately. If
extraction was desired, prior to fixation, cells were treated with Triton X-100 extraction
buffer (0.5% Triton X-100, 20 nM HEPES-KOH pH 7.9, 50 mM NaCl, 3 mM MgCl2,
300 mM sucrose). Extracted cells were fixed with 3% paraformaldehyde, 2% sucrose for
10 min at RT, and washed twice with PBS. Cells were permeabilized with Triton X-100
buffer after fixation. After permeabilization, cells were washed three times with PBS and
blocked with PBG (0.2% (w/v) cold water fish gelatin (Sigma), 0.5% (w/v) BSA (Sigma)
in PBS) for 1 h at RT. Cells were incubated with primary antibody (Appendix II) diluted
in PBG for 2 h at RT or overnight at 4°C, washed 3 times with PBG at RT, incubated
with secondary antibody diluted 1:250 in PBG for 1 h at RT, and washed 3 times with
PBS. To the second PBS wash 0.1 µg/ml 4,6-diamidino-2-phenylindole (DAPI) was
added. Coverslips were sealed onto glass sides with embedding media (ProLong Gold
Antifade Reagent, Invitrogen). Digital images were captured with a Zeiss Axioplan II
microscope with a Hamamatsu C4742-95 camera using Improvision OpenLab software.

Immunofluorescence-FISH
Cells were grown on coverslips and fixed for 10 min in 2% paraformaldehyde at room
temperature followed by PBS washes (γ-H2AX, MDC1 and 53BP1) or fixed for 10 min
in methanol:acetone (1:1) at -20°C followed by dehydration and rehydration in PBS for
5 min (NBS1). Coverslips were blocked for 30 min in blocking solution (1 mg/ml BSA,
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3% goat serum, 0.1% Triton X-100, 1 mM EDTA in PBS). Next, the cells were incubated
with primary antibodies (Appendix II) diluted in blocking solution for 1 h at room
temperature. After PBS washes, coverslips were incubated with Alexa 488- or
Rhodamine-Red-X-labelled secondary antibody raised against mouse or rabbit (Jackson)
for 30 min and washed in PBS. At this point, coverslips were fixed with 2%
paraformaldehyde for 10 min at room temperature, washed extensively in PBS,
dehydrated consecutively in 70%, 95% and 100% ethanol for 5 min each, and allowed to
dry completely. Hybridizing solution (70% formamide, 1 mg/ml blocking reagent
(Roche), 10 mM Tris-HCl, pH 7.2, containing PNA probe FITC-OO-(AATCCC)3
(Applied Biosystems) was added to each coverslip and the cells were denatured by
heating for 10 min at 80 °C on a heat block. After 2 h incubation at room temperature in
the dark, cells were washed twice with washing solution (70% formamide, 10 mM TrisHCl, pH 7.2) and twice in PBS. DNA was counterstained with DAPI and slides were
mounted in antifade reagent (ProLong Gold, Invitrogen). Digital images were captured
with a Zeiss Axioplan II microscope with a Hamamatsu C4742-95 camera using
Improvision OpenLab software.
To detect expression and localization of fluorescently marked proteins, cells were
fixed for 10 min in 2% paraformadehyde at room temperature. Digital images of
fluorescent eGFP and mCherry signals were captured as described above.
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BrdU analysis
Cells on coverslips were incubated for 1 h in 10 µm BrdU at 370C; fixed in
75% ethanol, 25% 0.05 M glycine (pH 2.2) for 45 min at -200C, washed twice in PBS,
and processed for IF using α-BrdU-FITC-conjugated antibody. DNA was counterstained
with DAPI. Digital images were captured with a Zeiss Axioplan II microscope with a
Hamamatsu C4742-95 camera using Improvision OpenLab software. The fraction of
BrdU positive cells was scored.

Senescence-associated β -gal staining
TRF2-DN or empty vector control were expressed in amphotrophic Phoenix cells from
pWzl-hygro. Virus containing supernatant was used to infect IMR90 cells 3 times at 12 h
intervals, followed by hygromycin selection for 10 days. At this point, equal number of
TRF2-DN and control cells was plated and 48 h later senescence-associated βgalactosidase staining was performed. After PBS wash, cells were fixed for 5 min in
Fixing solution (2% formaldehyde and 0.2% glutaraldehyde in PBS). Cells were washed
once more in PBS before staining with Staining solution (1 mg/ml X-gal, 150 mM NaCl,
2 mM MgCl2, 5 mM K3F(CN)6, 5 mM K4F(CN)6, 40 mM NaPi pH 6.0) at 37oC for 6 to
16 h. The plates were then washed twice with PBS and photographed.
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Live-cell imaging
TRF2F/-53BP1+/- and TRF2F/-53BP1-/- cells, expressing eGFP-TRF1 (to visualize
telomeres) and mCherry-BP1-2 (h53BP1 aa 1220-1711, to mark sites of DNA damage),
or TRF2F/-53BP1+/-, TRF2F/-53BP1-/-, TRF2F/-Lig4-/-p53-/-, and TRF2F/-ATM-/- cells
expressing eGFP-TRF1 only, untreated or treated with Cre, were seeded onto MatTek
glass bottom plates and grown for 2 days before imaging. Imaging was performed 72-84
h after Cre-mediated deletion of TRF2. Right before imaging, cells were changed into
Leibovitz’s L-15 medium (Gibco) supplemented with 30% Fetal Bovine Serum, 100
U/ml penicillin (Sigma), and 0.1 µg/ml of streptomycin (Sigma) and were allowed to
equilibrate for 30 minutes. During the imaging session, the temperature was maintained
at 37°C with an environmental chamber. Cells were monitored using a DeltaVision RT
microscope system (Applied Precision) with a PlanApo 60x 1.40 n.a. objective lens
(Olympus America, Inc.). 5 mm Z-stacks at 0.5 mm steps in both eGFP and mCherry
channels were acquired using SoftWoRx software with 50 msec and 30 msec exposure
time, respectively, every 30 seconds over 20 minutes (t=40 frames) at 2 x 2 binning with
512 x 512 pixels in final size. Images were deconvolved and projected in two dimensions
using SoftWoRx software.
The tracking analysis of eGFP-TRF1-marked telomeres was performed with
ImageJ software for at least 10 cells for each genotype 285. Cells were registered by
StackReg plugin using both Translation and Scaled Rotation options. Next, particles were
tracked using Particle Detector and Tracker plugin with the following parameters for
particle detection and tracking (radius=2 pixels; cutoff=2 pixels; percentile=1; link
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range=1; displacement=5 pixels). The x and y coordinates of each trajectory were output
for further calculation.
Per cell, 5 telomeres were chosen for analysis based on two criteria: first, they
were continuously tracked for at least 35 out of 40 frames and second, they co-localized
with the mCherry-BP1-2 dysfunctional telomere marker for at least 18 min. In order to
correct for cell mobility, the average x and y values of the 5 telomeres were calculated in
each frame and this was used as a reference point. All data output in pixels (standard
ImageJ output) were converted to meters by the formula, 1 pixel = 0.2156 mm, based on
the characteristics of the objective.
The following formulas were used to calculate the distance traveled between two
timepoints, cumulative distance traveled and average speed of an individual telomere, T
(xTt=n, yTt=n) relative to the reference point R (xRt=n, yRt=n):

Displacement, Dn, between two timepoints t=n-1 and t=n:
Dn = sqrt(((xTt=n - xRt=n) - (xTt=n-1 - xRt=n-1))^2 + ((yTt=n - yRt=n) - (yTt=n-1 - yRt=n-1)^2))
[mm];

Cumulative Distance traveled in 20 min (t=40), Dcum:
Dcum = sum (D1, D2, … , D40) [mm];

Average Speed, S:
S = Dcum/20 [nm min-1].
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To calculate the displacement from the starting point (t=0) for a given telomere T
(xTt=n, yTt=n) at t=n, the following calculation was performed based on a reference point,
R, defined as above:

Displacement from origin, Dori,t:
Dori, t = sqrt(((xTt=n - xRt=n) - (xTt=0 - xRt=0))^2 + ((yTt=n - yRt=n) - (yTt=0 - yRt=0))^2).

Maximum displacement from starting point, Dori MAX, for a given telomere
recorded during an imaging session was used as a measure of the territory that the
telomere has sampled during the imaging session and calculated as shown below:
Dori MAX = max (Dori, 1, Dori, 2, … Dori, 40).

Statistical analysis was performed using Prism Software. Mann-Whitney test (also
referred to as rank sum test), which compares two unpaired groups without assuming
Gaussian distribution, was applied to calculate the statistical significance values.

Treatment with drugs and IR
Cells were treated with the following drugs diluted in imaging medium:
Actin inhibitors:
Latrunculin A, 0.1 µg/ml, 1 h prior to imaging
Cytochalasin B, 10 µM, 15 min prior to imaging
Cytochalasin D, 10 µM, 15 min prior to imaging
Microtubule inhibitors:
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Nocodazole, 1 µg/ml, 1 h prior to imaging
Taxol (paclitaxel), 20 µM, 1 h prior to imaging
Vincristine, 10 nM, 1 h prior to imaging
1 µΜ,1 h prior to imaging
HDAC inhibitors:
Trichostatin A: 10 ng/ml, 24 h prior to imaging
50 ng/ml, 24 h prior to imaging
100 ng/ml, 24 h prior to imaging (lethal)
SAHA: 50 nM, 24 h prior to imaging
Valproic acid: 1 mM, 24 h prior to imaging

IR treatment:
For live-cell imaging experiments, wild-type or Lig4-/-p53-/- cells, expressing
eGFP-TRF1, plated on imaging plates, were irradiated with 1 Gy γ-irradiation from Ce
source and imaged immediately (with 10 min delay to setup the imaging) or allowed to
recover for 2 h.
For metaphase analysis, wild-type cells were irradiated in suspension with 5 Gy,
and plated in the presence or absence of 1 µg/ml nocodazole. Cells were harvested 12 h
post-IR and processed for metaphase analysis by DAPI staining as described above.
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FAR assay
Subconfluent HeLa 204 human cells or TRF2F/+p53-/- MEFs were pre-cooled on ice
before irradiation with a range from 10 to 60 Gy. DNA was embedded in 0.8% agarose
plug, approximately 1x106 cells/plug. Plugs were digested overnight with Proteinase K
(as in In-gel detection of telomeric DNA) and washed extensively in TE before loading in
0.8% agarose/0.5 x TBE gel and ran for 65 hours using CHEF-DRII PFGE apparatus
(BioRad, Hercules, CA) in 0.5 x TBE running buffer (initial pulse, 50 s; final pulse, 5000
s; 1.5 V/cm; at 14oC). The gels were processed further by Southern blotting for telomeric
and Bam repeats (see below).

FAR (fraction of activity released) ratio represents the ratio of the signal in the lane
(released from the well) to the total signal (lane + well). 20 Gy was chosen as the least
amount of DNA damage that allowed reproducible analysis of the repair slope. For the
PIKK inhibitor experiment, HeLa 204 cells were irradiated with 20 Gy and harvested
immediately (0 time point) or allowed to recover for the indicated time at 37oC in
medium that contained 50 µM wortmannin or 10 mM caffeine as indicated.

Southern blotting for telomeric, human-specific Alu and mouse-specific Bam repeats
For Southern blotting, the gel was depurinated for 30 min in 0.25 M HCl, denatured 2x30
min in 1.5 M NaCl; 0.5 M NaOH and neutralized 2x30 min in 1 M Tris HCl pH 7.4; 1.5
M NaCl before blotting onto Hybond membrane for 24 hours in 20xSSC (3 M NaCl; 0.3
M Sodium Citrate). DNA was crosslinked in Stratalinker and pre-hybridized for 1 hour in
Church mix at 65oC before incubating with radioactively labeled probes specific to the
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human Alu repeats (for human cells) or mouse Bam repeats (for mouse embryo
fibroblasts). Briefly, 50 ng probe was mixed with random hexamer primers and boiled for
5 min. After cooling down on ice, 32P-dCTP, unlabeled dATP, dGTP and TTP and
Klenow polymerase were added and the reaction was allowed to proceed for at least 90
min at RT. The labeled probe was subsequently isolated over G-50 column and the eluate
was denatured for 5 min at 100oC before diluting immediately in Church mix. An excess
(500 ng) of unlabeled denatured probe DNA was added at this point. Telomere-specific
probe was prepared as described above using a Sty11 probe, which containts 700 bp of
telomeric repeats, and for the labeling reaction, a telomeric sequence-specific
(CCCTAA)3 oligo was used. After overnight hybridization with radioactively labeled
probe at 65oC, the blot was washed at 65oC in Church wash (40 mM NaPi pH 7.2; 1 mM
EDTA pH 8.0; 1% w/v SDS) and exposed onto a PhosphorImager screen. Signals were
quantified with ImageQuant software.

Sucrose-gradient sedimentation
To prepare columns, 5.5 ml of 6% sucrose/TEEP80 (10 mM Tris-HCl, pH 8.0, 1 mM
EDTA,1 mM EGTA, 80 mM NaCl and freshly added 250 µM PMSF) were carefully
added dropwise on top of a layer of 5.5 ml of 40% sucrose/TEEP80 (containing blue dye)
in 12 ml polyallomer centrifuge tubes (Beckman). Tubes were consecutively frozen at 200C and thawed at 40C 3 times. The blending of the dye was used as a visual indicator
for gradient formation. After the third freeze, gradients can be stored at -200C for several
months.
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To prepare nuclei, cells were trypsinized, suspended in growth medium, and
harvested by centrifugation in an RT6000 centrifuge at 1.5 K for 5 min. Cells were
suspended in buffer A (100 mM KCl, 10 mM Tris [pH 7.5], 3 mM MgCl2, 1 mM CaCl2,
0.5 mM phenylmethylsulfonyl fluoride), washed twice with buffer A, and then
resuspended in buffer A with 0.6% Nonidet P-40 to lyse cells. After gently mixing and
incubating on ice for 5 min, nuclei were harvested at 2K for 5 min and resuspended in
buffer A without NP-40 at 4 x 106 cells/ml. Nuclei were homogenized in a dounce with
10 strokes with a tight B-type pestle. Aliquots of 150 µl were digested for 5 min at 30°C
with MNase (Roche Diagnostics) at 7.5 U/ml. Reactions were stopped by adding EDTA
to a final concentration of 10mM. Tubes were centrifuged at 5K for 5 min and the pellet
was carefully washed with buffer A, without pipetting. Tube were re-centrifuged and 300
µL of TEEP20 (10 mM Tris-HCl, pH 8.0, 1 mM EDTA,1 mM EGTA, 20 mM NaCl and
freshly added 250 µM PMSF) was added on top of the pellet. To allow chromatin to
dissolve tubes were incubated overnight at 40C. The following day the tubes were
centrifuged to remove nuclear debris and the supernatant was layered on top of the 6-40%
sucrose gradient. 10% of supernatant was saved as input.
Sucrose gradient sedimentation was performed in Optima 100XL Ultracentrifuge
(Beckman Coulter) with SW41 rotor at 41,000 rpm for 2.5 h at 40C. Gradient was
fractionated by carefully pipetting 1 ml fractions from top to bottom. Fractions were
digested overnight with 1 mg/ml Proteinase K in the presence of 0.1% SDS. DNA was
purified by phenol-chloroform extraction and ethanol precipitation. DNA pellet was air
dried and resuspended in 60 µl TE by shaking for 1 h at 550C.
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15 µl of DNA was loaded from each sample on a 0.8% agarose gel/ 0.5 x TBE
and separated in 0.5 x TBE by gel elecrophoresis at 25 V for 2 h, 45 V overnight, and 90
V until the 300 bp molecular marker ran out. Southern blotting was performed and the
blot was hybridized overnight to a radioactively labeled Styll probe (described above).
The following day, blots were washed 3 x 15 min in Church wash and exposed onto a
PhosphorImager screen overnight. Blots were stripped by treating the membrane with
boiling 0.1% SDS in water and allowing it to cool to RT. The membrane was washed
briefly in 2 x SSC before an overnight hybridization to a radioactively labeled Bam probe
(described above).
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APPENDIX I - LIST OF CELL LINES
Human cell lines
Name

Organism/organ

Notes

293T

Human/kidney

highly tranfectable;
express SV40-LT antigen

A-T

Human, A-T patient

fibroblast; ATM-deficient

BJ

Human/foreskin

primary fibroblast

BJ-hTERT

Human/foreskin

BJ cells immortalized with hTERT

F02-98

Human, Seckel patient

fibroblast; hypomorphic ATR allele

HeLa 1.2.11

Human/epithelial

derived from HeLa2; long telomeres

HeLa 1.3

Human/epithelial

HeLa 1.2.11 derivative; long telomeres

HeLa 204

Human/epithelial

HeLa1.2.11 derivative;
heterogeneous telomere length

IMR90

Human/lung

primary fibroblast

Retrovirus packaging cell lines
Phoenix, eco

Human/epithelial

293T derivative; retroviral packaging

Phoenic, ampho

Human/ epithelial

293T derivative; retroviral packaging

Mouse embryonic fibroblasts
TRF2F/- p53-/-

Mouse/ E13.5 MEF

Ref.

190

TRF2F/+ p53-/-

Mouse/ E13.5 MEF

Ref.

190

TRF2F/- lig4-/- p53-/-

Mouse/ E13.5 MEF

Ref.

190

TRF2F/- 53BP1-/-

Mouse/ E13.5 MEF

SV40-LT transformed, this work

TRF2F/- 53BP1+/-

Mouse/ E13.5 MEF

SV40-LT transformed, this work

TRF2F/+ 53BP1-/-

Mouse/ E13.5 MEF

SV40-LT transformed, this work

TRF2F/- ATM-/-

Mouse/ E13.5 MEF

SV40-LT transformed, Ref.

228

TRF2F/- ATM+/-

Mouse/ E13.5 MEF

SV40-LT transformed, Ref.

228

TRF2F/F MDC1-/-

Mouse/ E13.5 MEF

SV40-LT transformed, this work

TRF2F/F MDC1+/+

Mouse/ E13.5 MEF

SV40-LT transformed, this work

TRF2F/F NBS1F/-

Mouse/ E13.5 MEF

SV40-LT transformed, this work

TRF2F/F NBS1F/+

Mouse/ E13.5 MEF

SV40-LT transformed, this work

Mouse/ E13.5 MEF

SV40-LT transformed, this work

NBS1

F/-
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APPENDIX II - LIST OF ANTIBODIES
ID

antigen

Type

Applications

Origin

371

hTRF1

Rb,
poly

IF 1:1000
Western 1:1000
Crude serum; ChIP

de Lange lab

647

hTRF2
(baculoviral-FL)

Rb
poly

Western 1:2000
Crude serum; ChIP

Zhu, de Lange
lab

765

hRap1

Rb,
poly

IF 1:2000
Western 1:2000
Crude serum; ChIP

Li, de Lange
lab

864

hTin2

Rb,
poly

Western 1:2000
Crude serum; ChIP

Ye, de Lange
lab

874

hMre11

Rb,
poly

Western 1:5000
Crude serum; ChIP

Zhu, de Lange
lab

1048

hPOT1

Rb,
poly

Crude serum; ChIP

Loayza, de
Lange lab

1252

mRap1

Rb,
poly

Western 1:5000

Celli, de
Lange lab

1254

mTRF2

Rb
poly

Western 1:5000

Celli, de
Lange lab

mTRF1

mTRF1

Rb,
poly

Western 1:1000

Overbeek/de
Lange lab

9E10

c-myc peptide

Mo
mono

Western 1:1000

Calbiochem

9E10

c-myc peptide

Mo
mono

IF 1:5000

Sigma

M2

Flag peptide

Mo
mono

Western 1:10,000
Crude serum; ChIP

Sigma

11

HA peptide

Mo
mono

Western 1:1000
IF 1:1000
Crude serum; ChIP

Covance

GTU88

γTubulin

Mo
mono

Western 1:5000

Sigma
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ID

antigen

Type

Applications

Origin

DO-1

p53

Mo,
mono

Western 1:300

Santa Cruz

F-5

p21

mo,
mono

Western 1:500

Santa Cruz

α-γH2AX

γH2AX-P (S139)

Mo
mono

IF 1:1000

Upstate

α-ATM-P

ATM-P (S1981)

Mo
mono

Western 1:500
IF 1:500

Cell Signaling

α-NBS1-P

Human NBS1-P
(S343)

Rb,
poly

IF 1:500

Abcam

11175

mH2AX

Rb,
poly

Western 1:1000

Abcam

MAT3

ATM

Mo,
mono

Western 1:1000

Abcam

Chk2

Chk2

Mo,
mono

Western 1:300

BD
Transduction
Lab

93’6

mNBS1

Rb
poly

Western 1:5000
IF 1:5000
Purified Ab; ChIP

Petrini lab,
MSKCC

11169

hMDC1

Rb,
poly

Western 1:1000
IF 1:500

Abcam

300-757A

mMDC1

Rb,
poly

Western 1:500

Bethyl Labs

αMDC1

mMDC1

Mo,
mono

IF 1:20

Chen lab,
Yale U

α53BP1

h53BP1

Mo
mono

IF 1:50
Recognizes human only

Halazonetis,
The Wistar
Institute, PA

100-304

h53BP1

Rb
poly

IF 1:1000
Recognizes mouse and
human 53BP1

Novus

100-305

h53BP1

Rb,
poly

Western 1:1000
Recognizes mouse and
human

Novus
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ID

antigen

Type

Applications

Origin

H-300

mCtIP

Rb,
poly

Western 1:250

Santa Cruz
Biotechnology

Rb: Rabbit; Mo: mouse; poly: polyclonal; mono: monoclonal
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